https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200578/morie.gertz.latest.approaches.to.treat.waldenstrom.s.disease.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200577/rajshekhar.chakraborty.immunotherapy.as.anti-amyloid.strategies.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200576/rajshekhar.chakraborty.targeted.treatment.in.relapsed.al.amyloidosis.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200575/stefan.schnlan.cytogenetics.and.risk.assessment.in.al.amyloidosis.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200574/marc.raab.trispecifics.t-cell.and.bispecific.nk-cell.engagers.in.myeloma.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200573/evren.alici.role.of.nk.cells.in.myeloma.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200572/krina.patel.developing.an.open-access.car-t.from.discovery.to.licensing.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200571/elias.mai.personalized.tumour.tracking.by.mass.spectrumetry.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200569/samer.al.hadidi.sequencing.of.bcma.treatment.adcs.bites.or.car-t.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200568/sham.mailankody.when.to.use.gprc5d.targeted.treatment.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200567/fredrik.schjesvold.bcma-adcs.combination.treatments.for.relapsed.mm.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200566/meral.beksac.when.to.start.treatment.to.prevent.organ.damage.in.relapsed.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200565/marc.raab.precision.medicine.in.multiple.myeloma-.future.or.reality.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200564/luciano.costa.mrd-directive.therapies.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200563/nico.gagelmann.management.of.side.effects.of.car.ts.and.bispecifics.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200562/martin.kaiser.treatment.decision.making.in.high-risk.multiple.myeloma.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200561/ola.landgren.mrd.driven.or.qol.driven.maintenance.in.older.patients.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200560/johan.lund.adcs.or.bites.or.car.t.in.frail.patients.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200559/klaus.podar.is.there.a.limit.for.induction.therapy.in.multiple.myeloma.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200558/charlotte.pawlyn.who.s.the.frail.patient.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200557/elias.mai.double.vs.single.standard.maintenance.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200554/mohamad.mohty.debate.transplant.vs.car.t.cells.transplant.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200552/roberto.mina.newly.diagnosed.multiple.myeloma.patients.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200550/franoise.bodere.debate.mri.or.pet.ct.who.is.the.winner.pet.ct.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200547/jens.hillengass.imaging.in.plasma.cell.dyscrasias.how.when.and.how.often.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200546/karlo.perica.car.t.cell.transcriptional.programs.that.define.efficacy.and.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200545/tom.cupedo.molecular.drivers.of.multiple.myeloma.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200543/martin.kaiser.debate.to.treat.or.not.to.treat.smouldering.multiple.myeloma.no.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200542/meletios.dimopoulos.debate.to.treat.or.not.to.treat.smouldering.multiple.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200539/madhav.dhodapkar.immune.evolution.in.plasma.cell.dyscrasias.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200538/alberto.orfao.flowcytometric.characterization.of.mgus.and.smm.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200537/sigrun.thorsteinsdottir.screening.a.healthy.population.for.precursors.html 2026-04-01 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4200536/kenneth.c.anderson.how.i.brought.translational.medicine.from.bench.to.bedside.html 2026-03-17 weekly 0.5 https://elearning.esh.org/esh/2026/8th-translational-research-conference-mm/4194181/faculty.presenters.conference.book.%28pdf%29.html 2026-02-18 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194180/faculty.presenters.conference.book.%28pdf%29.html 2026-02-18 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194179/faculty.presenters.conference.book.%28pdf%29.html 2026-02-18 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194176/faculty.presenters.closing.remarks.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194175/faculty.presenters.roundtable.discussion.strategy.to.design.future.trials.or.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194174/peter.dreger.what.is.the.role.of.cellular.immunotherapies.in.cll.a.critical.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194172/paula.cramer.do.we.need.to.perform.trials.on.the.optimal.sequencing.of.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194171/faculty.presenters.panel.discussion.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194170/jean.lemoine.bcr.as.a.therapeutic.target.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194169/jessica.schmidt.strategies.to.enhance.the.efficacy.of.cart.cells.in.cll.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194168/marco.haselager.3d.cll.spheroid.model.recapitulates.lymph.node.phenotypes.and.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194167/sigrid.skanland.in.vitro.strategies.to.predict.treatment.outcomes.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194166/faculty.presenters.panel.discussion.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194164/matthew.davids.venetoclax.resistance.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194163/kerry.rogers.btk.resistance.and.mutations.for.different.btk.inhibitors.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194161/faculty.presenters.roundtable.discussion.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194160/william.wierda.debate.the.therapeutic.sequence.is.more.relevant.than.the.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194159/alessandra.tedeschi.debate.fixed.duration.therapy.is.the.standard.of.are.with.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194158/kerry.rogers.debate.continuous.btk.inhibitor.treatment.is.still.the.standard.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194157/justin.taylor.role.of.btk.degraders.in.cll.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194156/faculty.presenters.panel.discussion.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194155/paolo.ghia.amplify.captivate.and.other.trials.-.lessons.to.be.learned.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194154/othman.al-sawaf.lessons.to.be.learned.from.the.cll17.trial.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194153/rawstron.andy.mrd.as.a.driver.for.treatment.optimization.%28flair%29.html 2026-03-19 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194152/faculty.presenters.discussion.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194151/shih-shih.chen.proliferative.reservoire.in.cll.the.dynamics.of.the.cells.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194149/martina.seiffert.t.cells.and.the.response.to.bispecific.antibodies.or.car-t.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194148/faculty.presenters.panel.discussion.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194147/jennifer.brown.insights.from.sequoia.and.alpine.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194146/christof.schneider.the.cll.10.000.project.value.of.the.relevant.genetic.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194145/romain.guize.clonal.evolution.of.cll.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194143/faculty.presenters.panel.discussion.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194142/barbara.eichhorst.novel.therapies.using.checkpoint.inhibitors.and.kinase.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194141/adam.kittai.new.rt.recommendations.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194140/ferran.nadeu.prevention.of.evolution.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194139/davide.rossi.genomic.characterization.of.rt.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194138/faculty.presenters.panel.discussion.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194137/davide.bagnara.chronic.lymphocytic.leukemia.as.a.result.of.a.multiclonal.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194136/andreas.agathangelidis.is.stereotyped.bcr.ready.to.use.in.the.clinics.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194135/sameer.parikh.mbl.clinical.implications.%28role.of.genetic.abnormalities%29.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194134/julia.almeida.mbl.in.different.forms.%28high.vs.low.risk%29.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/4th-translational-research-conference-cll/4194133/faculty.presenters.welcome.words.html 2026-03-16 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194127/faculty.presenters.closing.remarks.html 2026-03-12 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194126/faculty.presenters.panel.discussion.html 2026-03-12 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194125/christian.recher.case-based.lecture.treating.npm1mut.aml.molecular.relapse.html 2026-03-04 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194124/geoffrey.l.uy.case-based.lecture.is.there.a.role.for.maintenance.therapy.in.aml.html 2026-03-04 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194123/nicola.stefano.fracchiolla.case-based.lecture.leukaemia.in.pregnancy.html 2026-03-04 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194120/charles.craddock.case-based.lecture.post-transplant.therapies.in.aml.-.for.html 2026-03-04 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194119/jurjen.versluis.case-based.lecture.post-transplant.cyclophosphamide.options.html 2026-03-04 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194117/michael.heuser.interactive.case.does.everyone.with.intermediate.risk.aml.html 2026-03-04 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194116/faculty.presenters.discussion.html 2026-03-12 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194115/josep-maria.ribera.debate.2.-.blina-tki.is.enough.to.cure.ph-positive.all.no.html 2026-03-04 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194114/matthew.j.wieduwilt.debate.2.-.blina-tki.is.enough.to.cure.ph-positive.all.yes.html 2026-03-04 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194113/faculty.presenters.introduction.html 2026-03-12 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194112/faculty.presenters.discussion.html 2026-03-12 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194111/sren.lehman.older.secondary.aml.management.in.the.real.life.html 2026-03-04 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194110/keith.pratz.what.s.the.best.way.to.use.venaza.in.elderly.aml.html 2026-03-04 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194108/faculty.presenters.panel.discussion.html 2026-03-12 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194107/wendy.stock.case-based.lecture.when.and.how.to.incorprorate.immunotherpy.into.html 2026-03-04 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194106/marion.strullu.case-based.lecture.infant.all.html 2026-03-04 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194105/shira.dinner.case-based.lecture.novel.immunotherapies.for.t-all.html 2026-03-04 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194104/marlise.luskin.interactive.case.is.cure.possible.for.older.adults.with.html 2026-03-04 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194103/faculty.presenters.discussion.html 2026-03-12 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194102/mariam.nawas.how.to.make.patients.transplant-eligible.html 2026-02-17 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194101/heidi.klepin.sarcopenia.nutrition.geriatric.assessment.prior.therapy.html 2026-03-04 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194100/faculty.presenters.discussion.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194099/victoria.potter.debate.1.-.mrd.is.a.proper.surrogate.endpoint.in.aml.no.html 2026-03-04 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194098/harry.erba.debate.1.-.mrd.is.a.proper.surrogate.endpoint.in.aml.yes.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194097/michael.heuser.introduction.html 2026-03-12 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194096/faculty.presenters.panel.discussion.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194095/jean-baptiste.micol.case-based.lecture.molecular.genetic.classification.of.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194094/michael.khn.case-based.lecture.rare.subsets.that.could.benefit.from.menin.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194093/david.teachey.case-based.lecture.newly.identified.high-risk.t-all.subsets.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194092/eric.deconinck.interactive.case.bpdcn.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194091/faculty.presenters.satellite.symposium.understanding.the.treatment.landscape.html 2026-02-17 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194090/faculty.presenters.panel.discussion.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194089/ibrahim.aldoss.case-based.lecture.ph.like.all.new.approaches.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194088/eunice.wang.case-based.lecture.menin.inhibitors.-.where.are.we.now.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194087/richard.stone.case-based.lecture.venetoclax.added.to.intensive.chemotherapy.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194086/courtney.dinardo.interactive.case.how.to.incorporate.idh.inhibitor.frontline.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194085/faculty.presenters.panel.discussion.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194084/thomas.cluzeau.case-based.lecture.is.a.curative.approach.possible.in.p53.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194083/nicolas.boissel.case-based.lecture.adult.all.indications.for.allogeneic.hsct.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194082/pau.montesinos.case-based.lecture.flt3.inhibitors.in.first-line.treatment.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194081/christoph.rllig.interactive.case.induction.treatment.in.elderly.fit.aml.what.html 2026-02-17 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194080/selina.luger.individualizing.treatments.of.aml.the.future.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2026/5th-how-to-diagnose-and-treat-acute-leukaemias/4194079/faculty.presenters.welcome.words.html 2026-03-09 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188844/faculty.presenters.closing.remarks.html 2025-10-31 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188843/faculty.presenters.panel.discussion.html 2025-10-31 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188842/paresh.vyas.development.of.new.therapeutics.based.on.alloreactive.responses.to.html 2025-10-22 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188841/marina.konopleva.bcl2.targeting.html 2025-10-18 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188840/andrew.wei.activating.sting.for.therapeutic.benefit.in.tp53.mutated.aml.html 2025-10-31 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188839/faculty.presenters.panel.discussion.html 2025-10-31 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188838/joshua.zeidner.incorporating.menin.inhibitors.for.frontline.aml.html 2025-10-31 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188837/eytan.stein.response.and.resistance.to.menin.inhibitors.in.patients.with.aml.html 2025-10-31 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188836/brunangelo.falini.targeting.npm1.html 2025-10-23 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188834/faculty.presenters.panel.discussion.html 2025-10-31 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188833/christopher.hourigan.patient-personalized.aml.mrd.monitoring.using.whole.html 2025-10-31 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188832/michael.heuser.advances.and.clinical.significance.of.molecular.detection.of.html 2025-10-31 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188831/faculty.presenters.panel.discussion.html 2025-10-31 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188830/courtney.dinardo.hope.or.hype.the.role.of.hma-based.triplet.combinations.html 2025-10-17 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188829/eirini.papapetrou.ras.pathway.mutations.in.aml.mechanisms.and.therapeutic.html 2025-10-17 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188827/faculty.presenters.panel.discussion.html 2025-10-27 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188826/markus.manz.combinatorial.adaptor-mediated.targeting.of.aml.with.car.t.cells.html 2025-10-17 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188825/saar.gill.cellular.immunotherapy.for.aml.html 2025-10-17 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188821/ningqing.liu.targeting.human.baf.complex.to.battle.acute.myeloid.leukemia.html 2025-10-22 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188819/faculty.presenters.panel.discussion.html 2025-10-27 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188814/faculty.presenters.panel.discussion.html 2025-10-27 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188811/faculty.presenters.satellite.symposium.breaking.new.ground.in.aml.treatment.html 2025-11-06 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188810/faculty.presenters.conference.book.%28pdf%29.html 2025-10-13 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188809/faculty.presenters.panel.discussion.html 2025-10-27 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188808/steven.chan.metabolic.dependencies.and.therapeutic.interventions.in.clonal.html 2025-10-16 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188806/gerwin.huls.evolution.of.clonal.hematopoiesis.html 2025-10-16 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188805/faculty.presenters.panel.discussion.html 2025-10-27 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188804/kelly.bolton.aging.clonal.hematopoiesis.and.aml.html 2025-10-27 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188802/siddartha.jaiswal.determinants.of.pre-malignant.clonal.expansion.of.html 2025-10-27 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188801/marcin.wlodarski.genetic.predisposition.and.aml.html 2025-10-27 weekly 0.5 https://elearning.esh.org/esh/2025/7th-international-conference-acute-myeloid-leukemia/4188800/faculty.presenters.welcome.words.html 2025-10-27 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188789/jorge.cortes.closing.remarks.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188788/nicholas.a.othieno-abinya.twenty.years.of.managing.chronic.myeloid.leukaemia.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188785/dan.s.kaufman.advances.in.natural.killer.cell.%28nk%29.cancer.therapy.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188784/ekaterina.chelysheva.selected.abstract.molecular.response.in.pregnant.chronic.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188783/nirmalya.roy.moulik.selected.abstract.treatment-free.remissions.%28tfr%29.in.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188782/daniela.kov.selected.abstract.chronic.myeloid.leukemia.%28cml%29.treatment.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188781/stephanie.sembill.selected.abstract.dynamics.and.outcomes.of.second-line.html 2025-10-16 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188780/dragana.milojkovic.keynote.presentation.the.new.eln.recommendations.what.is.in.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188779/alessandro.donada.family.matters.clonal.memory.of.cell.division.in.blood.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188778/michael.scherer.targeted.readout.of.dna.methylation.states.in.single.cells.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188777/david.kent.a.track.of.the.clones.new.tools.to.study.clonal.evolution.of.blood.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188776/delphine.rea.on.the.road.to.better.cml.care.bridging.research.biology.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188775/nienke.lokhorst.selected.abstract.interim.analysis.of.a.multicentre.study.of.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188774/carla.maria.boquimpani.selected.abstract.asciminib.once.or.twice.daily.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188773/ekaterina.chelysheva.selected.abstract.first.preliminary.results.of.a.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188772/weiming.li.selected.abstract.olverembatinib.%28hqp1351%29.as.second-line.therapy.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188771/jorge.cortes.selected.abstract.efficacy.and.safety.of.asciminib.in.patients.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188769/takeshi.kondo.asxl1.mutation.induces.tki.resistance.in.cml.cells.through.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188766/dennis.kim.selected.abstract.dna.methylation.instability.as.a.biomarker.for.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188763/susan.branford.keynote.presentation.whole.genome.sequencing.reveals.that.the.html 2025-10-24 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188762/els.mansell.targeting.mitochondrial.metabolism.to.rescue.hematopoietic.stem.html 2025-10-16 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188760/ian.ganley.illuminating.mitochondrial.autophagy.html 2025-10-16 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188759/faculty.presenters.general.discussion.html 2025-10-21 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188758/david.ross.exploring.new.biomarkers.in.mpn.html 2025-10-21 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188757/john.mascarenhas.new.developments.in.the.treatment.of.myelofibrosis.the.future.html 2025-10-21 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188756/stefan.constantinescu.targeting.mutated.calreticulins.in.myeloproliferative.html 2025-10-21 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188755/gerlinde.wernig.lessons.learned.from.fibrosis.in.mpn.and.beyond.html 2025-10-21 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188754/faculty.presenters.introduction.html 2025-10-21 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188753/ilaria.stefania.pagani.selected.abstract.complex.metabolic.reprogramming.html 2025-10-21 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188752/xiaoshuai.zhang.selected.abstract.integrating.genomic.and.transcriptomic.html 2025-10-21 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188751/briandy.fernandez-marrero.selected.abstract.a.coordinated.stress-adaptive.html 2025-10-21 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188749/alexander.anderson.evolutionary.therapy.for.metastatic.cancer.html 2025-10-21 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188748/faculty.presenters.satellite.symposium.balancing.tolerability.and.efficacy.in.html 2025-10-17 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188747/satu.mustjoki.cml.immunology.the.journey.from.bone.marrow.lymphocytosis.to.nk.html 2025-10-21 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188742/marieke.essers.extrinsic.and.intrinsic.interferon.signaling.in.healthy.and.html 2025-10-21 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188739/franois-xavier.mahon.asciminib.shows.superior.tolerability.vs.nilotinib.in.html 2025-10-21 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188738/tiffany.ricketts.tyrosine.kinase.inhibition.alters.macrophage.polarization.in.html 2025-10-21 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188737/vivian.oehler.next.generation.sequencing.from.dried.blood.spots.in.low-.and.html 2025-10-21 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188734/jorge.cortes.welcome.html 2025-10-21 weekly 0.5 https://elearning.esh.org/esh/2025/esh-icmlf-27th-annual-john-goldman-conference/4188724/faculty.presenters.conference.book.%28pdf%29.html 2025-10-02 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184275/nathalie.javidi-sharifi.drug.testing.functional.therapeutic.vulnerabilities.in.html 2025-10-17 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184274/scott.rodig.spatial.profiling.of.b.cell.malignancies.html 2025-10-17 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184273/florian.scherer.innovative.liquid.biomarkers.in.cns.lymphoma.html 2025-10-17 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184268/toby.a.eyre.the.role.of.non-covalent.btk.inhibitors.such.as.pirtobrutinib.and.html 2025-10-17 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184267/jared.johnson.an.atlas.of.substrate.specificities.for.the.human.serine.html 2025-10-17 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184266/veronika.bachanova.nk.cell.based.therapies.in.lymphoid.malignancies.html 2025-10-17 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184265/matthew.j.frank.new.autologous.cart.beyond.cd19.cart.including.cd22.cart.html 2025-10-17 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184264/michael.green.mechanisms.of.resistance.to.chimeric.antigen.receptor-t.cells.html 2025-10-17 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184263/catherine.thieblemont.trispecific.and.other.novel.antibodies.in.development.html 2025-10-17 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184262/martin.hutchings.bispecific.antibodies.-.alone.or.in.combination.sequencing.html 2025-10-17 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184261/laurie.sehn.bispecific.antibodies.in.lymphoma.-.state.of.the.art.html 2025-10-17 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184260/parry.erin.multi-omic.profiling.of.follicular.lymphoma.reveals.changes.in.html 2025-10-13 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184258/ash.alizadeh.the.landscape.of.tumor.cell.states.and.ecosystems.in.lymphoma.html 2025-10-13 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184257/martina.seiffert.microenvironment.of.lymphoid.malignancies.html 2025-10-13 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184256/ryan.morin.evolution.of.follicular.lymphoma.html 2025-10-13 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184255/jos.ignacio.martn-subero.epigenomic.characterization.of.lymphoid.neoplasms.html 2025-10-13 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184254/catherine.wu.genetic.changes.-.chronic.lymphocytic.leukemia.html 2025-10-13 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184252/riccardo.dalla-favera.somatic.genetics.of.diffuse.large.b.cell.lymphoma.html 2025-10-13 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184250/elias.campo.mantle.cell.lymphoma.the.basic.biology.and.genomics.html 2025-10-13 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184249/jennifer.g.abelin.immunopeptidomics.of.lymphoma.html 2025-10-13 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184248/thomas.oellerich.what.do.we.learn.from.proteomics.for.the.biology.of.lymphoma.html 2025-10-13 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4184247/ari.melnick.epigenetic.changes.in.lymphoma.html 2025-10-13 weekly 0.5 https://elearning.esh.org/esh/2025/8th-translational-research-conference-lymphoid-/4183809/faculty.presenters.conference.book.%28pdf%29.html 2025-09-10 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183614/faculty.presenters.conference.book.%28pdf%29.html 2025-08-29 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183612/frederick.locke.case-based.lecture.allogeneic.car-t.html 2025-10-01 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183611/alvaro.urbano-ispizua.case-based.lecture.pioneers.of.academic.car.t.production.html 2025-10-01 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183610/anne.marijn.kramer.case-based.lecture.the.potential.of.sequential.cars.in.lbcl.html 2025-10-01 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183609/pere.barba.spanish.car.review.sequencing.therapies.html 2025-10-01 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183607/claire.roddie.uk.car.review.b-all.html 2025-10-01 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183606/roch.houot.lysa.car.review.survivorship.issues.html 2025-10-01 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183605/caron.jacobson.car.t-cells.in.the.real.world.cibmtr.data.for.fl.and.mcl.html 2025-10-01 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183604/max.s.topp.real.world.data.on.bispecifics.in.lbcl.html 2025-10-01 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183602/max.s.topp.bispecific.rct.html 2025-10-01 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183601/caron.jacobson.high-risk.1l.lbcl.car.t-cell.vs.bispclinical.trial.pro-car.t-cell.html 2025-10-10 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183599/jonathan.clark.patient.perspective.html 2025-10-10 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183598/roch.houot.age.and.comorbidities.and.impact.on.patient.selection.html 2025-10-10 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183597/ulrich.jger.sequencing.and.selection.criteria.of.patients.local.practice.html 2025-10-10 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183596/jonathan.clark.global.access.and.intranational.access.based.on.socioeconomics.html 2025-10-10 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183595/guido.ghilardi.case-based.lecture.t-cell.and.other.malignancies.post-car.html 2025-10-10 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183594/kai.rejeski.case-based.lecture.cytopenias.and.infections.post-car-t.and.html 2025-10-10 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183593/philipp.karschnia.case-based.lecture.neurologic.toxicity.following.bcma.car-t.html 2025-10-10 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183592/maik.luu.case-based.lecture.the.role.of.the.microbiome.html 2025-10-10 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183591/johannes.huppa.case-based.lecture.antigen.recognition.via.tcrs.cars.and.tces.-.html 2025-10-10 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183590/frederick.locke.interactive.case.relapse.at.6m.after.cd19.car.possible.html 2025-10-10 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183589/marion.subklewe.mechanism.of.action.and.resistance.to.bispecifics.html 2025-10-10 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183588/lucila.nassif.kerbauy.central.south.america.html 2025-10-06 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183587/candice.hendricks.africa.html 2025-10-06 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183585/michelle.poon.asia.html 2025-10-06 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183583/monique.minnema.pro.bispecific.antibody.html 2025-10-06 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183582/saad.usmani.pro.car-t.html 2025-10-06 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183580/hans.ulrich.scherer.case-based.lecture.car-t.in.autoimmune.disease.html 2025-10-06 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183579/catherine.thieblemont.case-based.lecture.car-t.in.other.inhl.road.to.approval.html 2025-10-06 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183578/carlos.ramos.case-based.lecture.car-t.and.bispecifics.in.chl.and.tcl.html 2025-10-06 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183577/marie.jos.kersten.interactive.case.refractory.classic.hodgkin.lymphoma.html 2025-10-06 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183576/niels.van.de.donk.case-based.lecture.next.generation.of.cars.and.bispecifics.html 2025-10-06 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183575/saad.usmani.case-based.lecture.multiple.myeloma.and.car-t.html 2025-10-06 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183573/monique.minnema.interactive.case.high-risk.myeloma.html 2025-10-06 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183572/yasmina.serroukh.case-based.lecture.%28t%29fl.-.consolidation.allo.transplantation.html 2025-10-06 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183571/caron.jacobson.case-based.lecture.tfl.-.relapsed.after.car-t.options.html 2025-10-06 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183570/catherine.thieblemont.case-based.lecture.fl.-.role.of.car-t.and.bispecifics.html 2025-10-06 weekly 0.5 https://elearning.esh.org/esh/2025/3rd-how-i-manage-car-t-therapies-and-bispecific/4183569/caron.jacobson.interactive.case.follicular.lymphoma.%26.transformed.follicular.html 2025-10-06 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171820/james.labelle.role.of.bh3.mimetics.against.all.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171818/rayne.h.rouce.car.t.cells.for.relapsed.refractory.t-cell.malignancies.html 2025-05-14 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171817/rong.fan.single-cell.multi-omics.reveals.car.t.cell.heterogeneity.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171816/sara.ghorashian.dual.cd19.cd22.car.targeting.of.all.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171814/teena.bhatla.targeting.cd38.in.t-all.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171813/sabina.chiaretti.blinatumomab.tki.in.ph%2B.all.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171811/jun.j.yang.pharmacogenomics.of.inotuzumab.response.in.all.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171810/izidor.sosic.targeted.protein.degradation.design.principles.and.opportunities.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171807/emmanuelle.clappier.contrasting.values.of.kmt2a.and.bcr.abl1.mrd.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171806/philippe.rousselot.activities.of.european.group.on.adult.all.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171805/smita.bhatia.systemic.exposure.to.thiopurines.in.children.with.acute.html 2025-05-14 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171803/christian.kratz.genetic.predisposition.to.acute.lymphoblastic.leukaemia.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171802/michal.bar-natan.secondary.all.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171801/sarah.k.tasian.down.syndrome-associated.all.html 2025-05-14 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171800/ilaria.iacobucci.all.associated.with.clonal.hematopoiesis.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171799/lisa.russell.ig-myc.rearrangements.in.all.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171798/kathrin.bernt.interrogating.the.biology.of.high-risk.features.in.b-all.using.html 2025-05-14 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171797/charles.mullighan.discoveries.from.single.cell.rna.sequencing.in.b.cell.all.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171796/owen.p.smith.t-all.risk.stratification.back.to.the.future.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171795/takaomi.sanda.molecular.pathogenesis.of.t-all.the.tal1.subtype.html 2025-05-14 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171794/marc.r.mansour.non-coding.mutations.in.t-all.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4171793/david.t.teachey.treatment.resistant.progenitor.populations.in.t-all.identified.html 2025-05-28 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158266/k.martin.kortm.interactive.case.supportive.care.in.multiple.myeloma.today.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158265/wolfgang.willenbacher.case-based.lecture.bone.disease.in.multiple.myeloma.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158264/hermine.agis.case-based.lecture.is.this.myeloma.kidney.a.case.of.significantly.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158263/mario.nuvolone.case-based.lecture.how.i.treat.amyloidosis.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158262/steven.treon.interactive.case.how.i.treat.waldenstrom.s.macroglobulinemia.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158261/kenneth.c.anderson.multiple.myeloma.treatment.in.2030.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158260/nizar.j.bahlis.case-based.lecture.role.of.antigen.loss.in.car.t.cell.engaging.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158259/paola.neri.case-based.lecture.how.to.predict.outcome.of.car-t.cell.and.t-cell.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158258/hermann.einsele.case-based.lecture.bi-.and.trispecific.antibodies.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158256/adam.sperling.case-based.lecture.car-t.in.multiple.myeloma.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158255/klaus.podar.interactive.case.how.to.use.novel.immunotherapies.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158254/paula.tabares.no.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158253/noemi.puig.yes.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158252/k.martin.kortm.introduction.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158251/niels.van.de.donk.interactive.case.optimal.sequence.at.relapse.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158250/michel.delforge.case-based.lecture.novel.agents.in.relapsed.multiple.myeloma.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158249/hermann.einsele.case-based.lecture.how.to.use.t.cell.engagers.in.relapse.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158248/rakesh.popat.case-based.lecture.how.i.treat.first.relapse.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158247/claudio.cerchione.interactive.case.the.revolution.in.the.management.of.html 2025-04-18 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158246/francesca.gay.no.html 2025-04-09 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158245/leo.rasche.yes.html 2025-03-25 monthly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158244/hermann.einsele.introduction.html 2025-03-25 monthly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158243/klaus.podar.no.html 2025-04-09 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158242/omar.nadeem.yes.html 2025-04-09 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158241/heinz.ludwig.introduction.html 2025-03-25 monthly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158240/martin.kaiser.interactive.case.how.i.treat.a.high-risk.mm.patient.in.the.first.html 2025-04-09 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158239/marc.raab.case-based.lecture.precision.medicine.in.multiple.myeloma.html 2025-04-09 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158238/roman.hajek.case-based.lecture.should.we.add.immunotherapy.in.high-risk.html 2025-04-09 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158237/martin.kaiser.case-based.lecture.should.the.high-risk.patient.be.treated.html 2025-04-09 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158236/elena.zamagni.interactive.case.how.i.diagnose.the.high-risk.patient.html 2025-04-09 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158235/siobhan.glavey.interactive.case.newly.diagnosed.transplant-ineligible.patient.html 2025-04-09 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158234/alessandra.larocca.case-based.lecture.novel.therapeutic.approaches.for.frail.html 2025-04-09 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158233/monika.engelhardt.case-based.lecture.how.to.treat.the.frail.patient.html 2025-04-09 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158231/charlotte.pawlyn.interactive.case.newly.diagnosed.transplant.eligible.multiple.html 2025-04-09 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158230/heinz.ludwig.case-based.lecture.do.we.need.to.treat.high.risk.smm.html 2025-04-14 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158229/irene.ghobrial.case-based.lecture.drivers.of.progression.of.html 2025-03-25 monthly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158228/elizabeth.odonnell.case-based.lecture.high.risk.smoldering.myeloma.html 2025-04-09 weekly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4158227/hermine.agis.interactive.case.smoldering.myeloma.html 2025-04-09 weekly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152479/faculty.presenters.conference.book.%28pdf%29.html 2025-03-06 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152466/perla.eleftheriou.what.to.do.today.in.an.adult.with.thalassemia.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152465/antonis.kattamis.what.to.do.today.in.a.child.with.thalassemia.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152464/raffaella.colombatti.what.to.do.today.in.a.child.with.sickle.cell.disease.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152463/laura.breda.in.vivo.hematopoietic.stem.cell.modification.by.mrna.delivery.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152462/franco.locatelli.genome.diting.in.sickle.cell.disease.and.thalassemiath.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152461/alexis.a.thompson.gene.therapies.for.sickle.cell.disease.and.thalassemia.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152460/marianne.de.montalembert.what.new.in.scd.than.genome.editing.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152459/kevin.kuo.mitapivat.in.tdt.snd.ntdt.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152457/annamaria.aprile.inhibition.of.fgf23.is.a.therapeutic.strategy.to.target.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152455/stuart.orkin.control.of.fetal.hemoglobin.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152454/john.porter.aging.in.thalassemia.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152453/lucia.de.franceschi.aging.and.sickle.cell.disease.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152452/valentina.bollati.healthy.aging.versus.inflamm-aging.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152451/francesca.vinchi.pathophysiology.of.inflammation.in.b-thalassemia.and.sickle.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152449/jian.xu.a.glutamine.metabolic.switch.drives.erythropoiesis.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152448/simona.colla.targeting.the.hri.pathway.in.sicke.cells.and.mds.html 2025-03-24 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152446/mohandas.narla.inflammatory.signals.in.erythropoiesis.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152445/laura.silvestri.iron.and.erythropoiesis.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152444/lon.kautz.hepcidin.regulation.by.flg1.and.erfe.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152443/martina.muckenthaler.cellular.and.systemic.regulation.of.iron.metalbolism.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152442/stefano.rivella.shifting.tides.from.ineffective.to.excessive.red.blood.cell.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152441/theodosia.kalfa.metabolism.and.the.marrow.microenvironment.in.normal.red.cells.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152440/olivier.hermine.update.on.pathophysiology.in.sickle.cell.disease.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-pathophysio/4152439/ali.taher.update.on.pathophysiology.of.thalassemia.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/8thtranslational-research-conference-on-multiple-m/4152427/faculty.presenters.conference.book.%28pdf%29.html 2025-03-03 monthly 0.5 https://elearning.esh.org/esh/2025/4th-translational-research-conference-on-ALL/4151994/faculty.presenters.conference.book.%28pdf%29.html 2025-02-19 monthly 0.5 https://elearning.esh.org/esh/2025/5th-scientific-workshop-micro/4151571/faculty.presenters.conference.book.%28pdf%29.html 2025-02-06 monthly 0.5 https://elearning.esh.org/esh/2025/5th-scientific-workshop-micro/4151567/jean-emmanuel.sarry.keynote.lecture.targeting.tumor.and.host.metabolic.html 2025-02-25 monthly 0.5 https://elearning.esh.org/esh/2025/5th-scientific-workshop-micro/4151566/sattva.neelapu.car.t.cell.therapy.for.lymphoma.impact.of.the.microenvironment.html 2025-02-25 monthly 0.5 https://elearning.esh.org/esh/2025/5th-scientific-workshop-micro/4151565/jose.martinez-climent.genetically-driven.immune.microenvironment.states.and.html 2025-02-25 monthly 0.5 https://elearning.esh.org/esh/2025/5th-scientific-workshop-micro/4151563/alan.ramsay.lymph.node.cancer-associated.fibroblasts.%28ln_cafs%29.and.immune.cell.html 2025-02-25 monthly 0.5 https://elearning.esh.org/esh/2025/5th-scientific-workshop-micro/4151562/stuart.rushworth.lipid.metabolic.reprogramming.in.the.tumour.microenvironment.html 2025-02-25 monthly 0.5 https://elearning.esh.org/esh/2025/5th-scientific-workshop-micro/4151561/darja.karpova.clonal.hematopoiesis.landscape.in.frequent.blood.donors.html 2025-02-25 monthly 0.5 https://elearning.esh.org/esh/2025/5th-scientific-workshop-micro/4151560/katherine.king.infection.as.a.driver.of.clonal.hematopoiesis.html 2025-02-25 monthly 0.5 https://elearning.esh.org/esh/2025/5th-scientific-workshop-micro/4151559/paresh.vyas.identifying.and.quantitating.selective.stem.cell.advantage.of.in.html 2025-02-25 monthly 0.5 https://elearning.esh.org/esh/2025/5th-scientific-workshop-micro/4151558/cesar.nombela.arrieta.remodeling.and.regeneration.of.the.bone.marrow.html 2025-02-25 monthly 0.5 https://elearning.esh.org/esh/2025/5th-scientific-workshop-micro/4151557/bong-ihn.koh.functional.specialization.of.cranial.tissues.lessons.from.blood.html 2025-02-25 monthly 0.5 https://elearning.esh.org/esh/2025/5th-scientific-workshop-micro/4151556/mihaela.crisan.pericytes.in.the.hematopoietic.stem.cell.generating.niche.html 2025-02-25 monthly 0.5 https://elearning.esh.org/esh/2025/5th-scientific-workshop-micro/4151555/sean.morrison.the.hematopoietic.stem.cell.niche.and.implications.for.clinical.html 2025-02-25 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151450/faculty.presenters.closing.remarks.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151449/oliver.hantschel.modeling.the.structure.of.tyrosine.kinases.and.its.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151448/faculty.presenters.panel.discussion.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151447/torsten.haferlach.case-based.lecture.impact.of.artificial.intelligence.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151446/jorge.cortes.case-based.lecture.drugs.in.early.development.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151445/breccia.massimo.case-based.lecture.feedback.from.ash.in.cml.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151444/francesco.passamonti.case-based.lecture.feedback.from.ash.in.mpn.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151443/faculty.presenters.ime.symposium.anemia.in.myelofibrosis.sequencing.therapies.html 2025-04-04 weekly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151442/faculty.presenters.panel.discussion.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151441/daniela.kov.interactive.case.dose.reduction.of.tki.for.tfr.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151440/fausto.castagnetti.case-based.lecture.symptomatic.support.quality.of.life.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151438/tim.brmmendorf.case-based.lecture.dose.modification.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151437/faculty.presenters.panel.discussion.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151436/jean-jacques.kiladjian.case-based.lecture.what.do.we.know.regarding.ifn.in.2025.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151435/claire.harrison.case-based.lecture.combination.trials.in.mf.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151434/daniel.wiseman.case-based.lecture.chronic.myelomonocytic.leukaemia.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151433/deepti.radia.interactive.case.management.of.indolent.sm.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151432/faculty.presenters.satellite.symposium.expert.perspectives.optimizing.html 2025-04-04 weekly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151431/faculty.presenters.discussion.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151430/david.ross.novel.endpoints.replace.traditional.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151429/andrew.kuykendall.trial.endpoints.retain.traditional.-.blood.counts.spleen.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151428/adam.mead.debate.2.introduction.html 2025-03-21 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151427/faculty.presenters.panel.discussion.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151426/ruben.mesa.interactive.case.anaemia.in.mf.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151425/philipp.le.coutre.case-based.lecture.management.of.mpn.and.cml.according.to.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151424/adam.mead.case-based.lecture.blast.phase.risk.and.management.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151423/andreas.hochhaus.case-based.lecture.prevention.of.pleural.and.pericardial.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151422/faculty.presenters.satellite.symposium.navigating.the.therapeutic.landscape.html 2025-03-28 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151421/faculty.presenters.discussion.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151420/elisabetta.abruzzese.cml.in.pregnancy.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151419/valentin.garcia-gutierrez.failure.to.achieve.mr2.with.3.tki.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151418/mhairi.copland.recurrent.cytopenias.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151417/faculty.presenters.discussion.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151416/claire.woodley.management.of.fatigue.in.mpn.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151414/martin.griesshammer.pregnancy.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151413/faculty.presenters.discussion.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151412/giuseppe.saglio.no.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151411/hughes.tim.yes.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151410/andreas.hochhaus.debate.1.introduction.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151409/faculty.presenters.panel.discussion.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151408/delphine.rea.interactive.case.treatment.decision.in.third.line.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151407/franois-xavier.mahon.case-based.lecture.prediction.of.long.term.tfr.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151406/dragana.milojkovic.case-based.lecture.role.of.therapeutic.milestones.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151405/katerina.machova.case-based.lecture.cytogenetic.and.molecular.risk.evolution.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151404/faculty.presenters.satellite.symposium.combination.therapy.in.myelofibrosis.html 2025-04-03 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151403/faculty.presenters.panel.discussion.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151402/paola.guglielmelli.case-based.lecture.prognostication.in.myelofibrosis.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151401/andreas.reiter.case-based.lecture.diagnosis.and.management.of.eosinophilia.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151400/tiziano.barbui.case-based.lecture.do.we.treat.low.risk.pv.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151399/anna.godfrey.case-based.lecture.management.of.et.one.disease.or.more.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151398/fabio.efficace.quality.of.life.assessment.in.hematological.diseases.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151397/faculty.presenters.welcome.words.html 2025-03-17 monthly 0.5 https://elearning.esh.org/esh/2025/4th-how-to-diagnose-and-treat-cmlmpn/4151396/faculty.presenters.conference.book.%28pdf%29.html 2025-02-04 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147890/faculty.presenters.conference.book.%28pdf%29.html 2024-11-20 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147871/sigbjorn.berentsen.cold.agglutinin.disease.current.status.and.future.prospects.html 2024-11-29 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147870/maurizio.miano.bmf.and.immune.deficiencies.html 2024-11-29 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147868/antonio.risitano.residual.hemolysis.on.complement.inhibitors.climbing.our.html 2024-11-29 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147867/rgis.peffault.de.latour.novel.treatments.for.pnh.has.a.new.era.started.html 2024-11-29 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147865/ronald.taylor.inherited.complement.deficiencies.any.lesson.for.pharmacological.html 2024-11-29 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147864/faculty.presenters.roundtable.hot.treatment.decisions.in.aplastic.anaemia.html 2024-11-29 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147862/carmem.bonfim.alternative.hct.-.haplo.html 2024-11-29 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147861/andrea.bacigalupo.alternative.bmt.-.unrelated.html 2024-11-29 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147857/pedro.henrique.de.lima.prata.hsct.in.clonal.evolution.after.saa.html 2024-11-29 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147856/austin.kulasekararaj.the.meaning.of.somatic.mutations.in.acquired.aa.html 2024-11-29 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147855/valeria.visconte.clonal.dynamics.of.hematopoietic.stem.cell.compartment.in.html 2024-11-29 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147853/carlo.dufour.recognizing.inherited.marrow.failure.disorders.in.adult.age.html 2024-11-25 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147852/satu.mustjoki.deciphering.the.bone.marrow.microenvironment.and.tcr.signature.html 2024-11-25 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147851/jaroslaw.maciejewski.new.vs.old.pathophysiologic.concepts.in.aa.html 2024-11-25 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147848/sharon.savage.non-hematopoietic.complications.of.telomere.biology.disorders.in.html 2024-11-25 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147847/fabian.beier.diagnostics.algorithms.and.therapy.of.tbds.in.adults.html 2024-11-25 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147845/miguel.godinho.ferreira.zebra.fish.as.a.model.of.ibmfs.%28telomeres.and.ageing%29.html 2024-11-25 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147843/simona.pagliuca.non.transplant.strategies.for.inherited.bmfs.html 2024-11-25 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147842/deena.iskander.new.approaches.to.diamond-blackfan.anemia.html 2024-11-25 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147841/alan.warren.the.molecular.interplay.of.clonal.evolution.in.ribosomal.disorders.html 2024-11-25 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147840/miriam.erlacher.what.is.new.in.gata2.html 2024-11-25 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147838/jean.soulier.secondary.leukemia.in.inherited.bmf.with.stressed.hematopoiesis.html 2024-11-25 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147836/lisa.mcreynolds.genome-first.approaches.to.uncovering.leukaemia.etiology.html 2024-11-25 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147835/simone.feurstein.germeline.predisposition.to.leukaemia.challenges.in.variant.html 2024-11-25 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-translational-research-conference-on-bone-marrow/4147830/michael.milsom.inflammation.and.stem.cell.reserve.html 2024-11-25 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147710/faculty.presenters.closing.remarks.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147709/christian.steidl.immune.environment.in.hodgkin.s.lymphoma.time.to.chart.the.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147708/faculty.presenters.discussion.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147707/emmanuel.bachy.car-t.cells.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147706/kim.linton.bispecifics.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147704/faculty.presenters.panel.discussion.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147703/gilles.salles.case-based.lecture.relaps.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147702/jessica.okosun.case-based.lecture.firstline.therapy.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147701/faculty.presenters.panel.discussion.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147700/barbara.eichhorst.case-based.lecture.richters.transformation.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147699/francesco.bosch.case-based.lecture.optimizing.treatment.of.relapse.in.the.era.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147698/othman.al-sawaf.case-based.lecture.primary.therapy.finite.vs.continuous.and.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147697/faculty.presenters.discussion.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147696/paul.j.brckelmann.pet-adapted.intensified.chemotherapy.is.the.optimal.1st-line.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147695/ann.lacasce.checkpoint.inhibitors.should.be.standard.for.frontline.therapy.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147694/michael.crump.introduction.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147693/faculty.presenters.discussion.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147692/christian.buske.update.on.waldenstrm.macroglobulinemia.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147691/catherine.thieblemont.new.era.in.marginal.zone.lymphomas.ibtk.new.generation.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147690/luca.arcaini.high-risk.marginal.zone.lymphoma.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147689/francesco.bertoni.the.many.faces.of.splenic.and.nodal.marginal.zone.lymphoma.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147688/faculty.presenters.panel.discussion.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147687/kim.linton.case-based.lecture.bispecific.in.2024.how.and.when.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147686/margot.jak.case-based.lecture.beyond.cd19-directed.car-t.cell.therapy.current.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147685/kai.rejeski.case-based.lecture.cd19.car-t.cell.therapy.for.relapsed.refractory.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147684/andrea.kuhnl.interactive.case.patient.selection.for.car-t.cell.therapy.for.html 2024-11-15 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147683/faculty.presenters.discussion.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147682/anca.prica.primary.cns.lymphoma.when.to.use.an.intensive.therapy.approach.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147681/sirpa.lepp.optimizing.treatment.outcomes.using.biomarker-driven.approaches.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147680/faculty.presenters.discussion.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147678/stephan.mielke.allogeneic.stem.cell.transplantation.is.the.only.curative.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147677/martin.dreyling.introduction.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147676/faculty.presenters.panel.discussion.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147675/steven.horwitz.case-based.lecture.cutaneous.t-cell.lymphoma.when.to.consider.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147674/giuseppe.gritti.case-based.lecture.rare.t-cell.lymphoma.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147673/kerry.savage.case-based.lecture.the.challenge.of.relapsed.t.cell.lymphoma.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147672/franois.lemonnier.interactive.case.follicular.t.helper.cell.lymphomas.biology.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147670/faculty.presenters.panel.discussion.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147669/morgane.cheminant.case-based.lecture.relapsed.and.refractory.novel.agents.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147668/mats.jerkeman.case-based.lecture.optimal.treatment.of.older.patients.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147667/martin.dreyling.case-based.lecture.optimal.treatment.for.younger.patients.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147666/sylvain.carras.interactive.case.should.all.patients.initiate.treatment.after.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147665/faculty.presenters.panel.discussion.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147664/martine.chamuleau.case-based.lecture.what.is.the.optimal.treatment.for.burkitt.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147663/jeremy.abramson.case-based.lecture.approach.to.double.hit.lymphomas.is.there.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147662/andrew.davies.interactive.case.treatment.of.mediastinal.large.b.cell.lymphoma.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147660/faculty.presenters.welcome.words.html 2024-11-12 monthly 0.5 https://elearning.esh.org/esh/2024/4th-how-to-diagnose-and-treat-lymphoma/4147659/faculty.presenters.conference.book.%28pdf%29.html 2024-10-15 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147499/faculty.presenters.closing.remarks.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147498/faculty.presenters.panel.discussion.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147497/suzanne.lentzsch.anti-amyloid.strategies.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147496/rajshekhar.chakraborty.targeted.treatment.in.amyloidosis.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147495/ashutosh.wechalekar.diagnosis.imaging.and.response.assessment.in.amyloidosis.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147494/faculty.presenters.panel.discussion.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147493/sham.mailankody.cars.beyond.bcma.for.late.relapse.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147492/paula.rodrguez-otero.non.bcma-tce.for.late.relapse.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147491/rakesh.popat.non-immunotherapeutic.approaches.for.late.relapse.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147490/faculty.presenters.panel.discussion.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147489/ajay.nooka.novel.triplets.will.win.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147488/paula.rodrguez-otero.bcma-car.will.win.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147487/philippe.moreau.bcma-tce.will.win.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147486/faculty.presenters.panel.discussion.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147485/noopur.raje.risk.of.infection.and.the.era.of.bispecific.antibodies.and.car.t.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147484/luciano.costa.mrd-driven.treatment.of.multiple.myeloma.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147483/faculty.presenters.targeting.signalling.pathways.and.translocations.html 2024-10-17 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147482/faculty.presenters.panel.discussion.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147481/shaji.kumar.indefinite.treatment.for.frail.patients.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147479/charlotte.pawlyn.who.is.the.frail.patient.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147478/faculty.presenters.ime.symposium.how.to.sequence.bcma-directed.therapies.in.html 2024-11-13 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147477/faculty.presenters.panel.discussion.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147476/mohamad.mohty.is.there.still.a.role.for.asct.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147475/hartmut.goldschmidt.how.to.treat.and.maintain.standard-risk.multiple.myeloma.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147474/martin.kaiser.high-risk.newly.diagnosed.multiple.myeloma.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147473/faculty.presenters.panel.discussion.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147472/suzanne.lentzsch.immune.suppression.and.bone.disease.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147471/jens.hillengass.imaging.in.plasma.cell.dyscrasias.how.when.and.how.often.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147470/eileen.boyle.clonal.evolution.in.multiple.myeloma.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147469/faculty.presenters.panel.discussion.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147468/sigrn.thorsteinsdttir.smouldering.multiple.myeloma.cancer.or.condition.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147467/francesca.gay.when.to.start.treatment.for.smm.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147466/ola.landgren.can.genomics.tell.us.who.to.treat.with.smm.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147465/faculty.presenters.panel.discussion.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147463/bruno.paiva.definition.and.clinical.significance.of.mgus-like.phenotype.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147462/sigrn.thorsteinsdttir.do.we.need.to.screen.for.mgus.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147461/faculty.presenters.welcome.html 2024-10-14 monthly 0.5 https://elearning.esh.org/esh/2024/7th-translational-research-conference-on-MM/4147456/faculty.presenters.conference.book.%28pdf%29.html 2024-09-30 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145945/jorge.cortes.closing.remarks.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145944/naranie.shanmuganathan.comprehensive.and.sensitive.genomic.characterisation.of.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145943/emmanuelle.clappier.biological.significance.of.bcr-abl1.clonal.hematopoiesis.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145942/vijayalakshmi.venkatesh.it.takes.a.village.the.saga.of.the.reinvention.of.cml.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145939/jean-emmanuel.sarry.metabolism.and.drug.resistance.in.acute.myeloid.leukemia.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145938/dennis.kim.selected.abstract.propensity-score.matching.analysis.comparing.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145937/lambert.busque.selected.abstract.sex-related.differences.in.cml.outcomes.in.a.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145935/valentin.garcia.gutirrez.keynote.presentation.real-world.data.in.cml.does.it.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145932/neil.p.shah.what.have.we.learned.from.treatment.resistance.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145930/jorge.cortes.selected.abstract.asciminib.provides.long-term.durable.molecular.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145929/fabian.lang.selected.abstract.preliminary.safety.and.efficacy.of.elvn-001.a.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145928/vivian.oehler.selected.abstract.olverembatinib.%28hqp1351%29.overcomes.ponatinib.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145927/michael.mauro.keynote.presentation.incorporating.new.drugs.in.current.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145926/faculty.presenters.discussion.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145925/rdiger.hehlmann.no.-.keep.it.in.reserve.for.those.who.need.it.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145924/delphine.rea.yes.-.best.option.for.all.patients.in.2024.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145923/hughes.tim.introduction.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145922/gran.karlsson.exposing.the.stem.cells.of.chronic.myeloid.leukemia.using.html 2024-10-10 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145921/faculty.presenters.satellite.symposium.new.perspectives.in.optimising.tki.html 2024-10-02 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145919/ariel.leyte-vidal.selected.abstract.alterations.in.the.bcr.abl1.n-lobe.and.sh3.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145915/richard.van.etten.selected.abstract.systems.biology.of.cml.insights.into.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145914/nick.cross.keynote.presentation.the.evolution.and.current.status.of.predicting.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145913/jonathan.peled.microbiome.disruption.in.cancer.immunotherapy.html 2024-10-02 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145912/rizwan.romee.innate.nk.cell.memory.for.enhanced.immunotherapy.html 2024-10-02 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145909/sameer.parikh.understanding.monoclonal.b-cell.lymphocytosis.is.it.malignant.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145907/jakub.radocha.clinical.and.biologic.significance.of.mgus.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145906/linde.miles.the.expansion.and.progression.of.clonal.hematopoiesis.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145905/liran.shlush.clonal.hematopoiesis.and.risk.of.leukemia.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145904/ehab.atallah.introductory.overview.concepts.and.challenges.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145903/dl.white.selected.abstract.transcriptomic.analysis.reveals.the.intricacies.of.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145902/pavithra.shyamsunder.selected.abstract.identification.and.targeting.of.a.novel.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145900/steffen.koschmieder.keynote.presentation.novel.approaches.for.blast.phase.cml.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145899/adam.mead.gene-environment.interactions.during.progression.to.blast.phase.mpn.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145898/faculty.presenters.satellite.symposium.quality.of.life.for.patients.with.cml.html 2024-10-16 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145897/jeffrey.lipton.what.is.the.goal.of.cml.therapy.a.physicians.impression.of.a.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145896/shaun.patterson.selected.abstract.bone.marrow.common.lymphoid.progenitors.and.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145893/agnes.yong.keynote.presentation.role.of.the.immune.system.in.cml.does.it.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145892/dominique.bonnet.leukemic.stem.cells.and.the.bone.marrow.microenvironment.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145890/kendra.sweet.a.randomized.trial.of.the.addition.of.ruxolitinib.to.bcr.abl1.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145889/susan.branford.the.negative.impact.of.variants.in.blood-cancer.related.genes.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145888/daniele.sarnello.bnip3.is.required.for.hypoxia-induced.reductive.glutamine.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145885/jorge.cortes.welcome.html 2024-10-07 monthly 0.5 https://elearning.esh.org/esh/2024/26th-chronic-myeloid-leukaemia/4145884/faculty.presenters.conference.book.%28pdf%29.html 2024-09-10 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145833/halvard.bnig.automated.point-of-care.manufacturing.html 2024-09-24 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145832/dominic.grn.application.of.ai.and.machine.learning.html 2024-09-24 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145831/stephen.gottschalk.regeneration.rejuvenation.of.immune.cells.html 2024-09-24 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145829/marco.ruella.overcoming.t.cell.exhaustion.and.tumor.resistance.html 2024-09-24 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145828/alessia.potenza.harnessing.the.immune.suppressive.microenvironment.in.html 2024-09-24 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145825/leo.rasche.analyses.on.tumor.and.tme.html 2024-09-24 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145824/maik.luu.host.factors.microbiome.html 2024-09-24 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145823/marcela.maus.analyses.on.products.before.and.after.infusion.html 2024-09-24 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145821/jennifer.e.adair.nanoparticle.technology.html 2024-09-24 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145820/christian.buchholz.targeted.viral.vectors.html 2024-09-24 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145819/adi.barzel.b.cells.for.humoral.immunity.html 2024-09-24 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145816/michael.o.dwyer.nk.cells.html 2024-09-24 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145815/shin.kaneko.ipsc-derived.cells.html 2024-09-24 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145814/giulia.casorati.nkt.cell.html 2024-09-24 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145812/karl.petri.safety-validating.and.enhancing.crispr.2.0.to.improve.immune.cell.html 2024-09-20 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145811/dirk.busch.targeted.car.%26.tcr.gene.insertion.html 2024-09-20 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145808/johannes.huppa.understanding.t-cell.antigen.recognition.from.fundamental.html 2024-09-20 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145807/michael.jensen.modular.and.programmable.drug-on.car.designs.html 2024-09-20 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145806/chiara.bonini.tcr.%26.tcr-like.html 2024-09-20 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145803/aude.chapuis.tcr.targets.html 2024-09-20 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145800/larry.bacon.clinicial.managment.html 2024-09-20 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145799/matteo.doglio.autoimmune.diseases.html 2024-09-04 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145798/claire.roddie.hematology.html 2024-09-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-immune-cellular-therapy/4145759/faculty.presenters.conference.book.%28pdf%29.html 2024-08-30 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417862/faculty.presenters.closing.remarks.html 2024-05-10 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417861/faculty.presenters.panel.discussion.html 2024-05-10 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417860/claire.harrison.future.therapies.for.pv.and.et.html 2024-05-10 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417859/stephane.giraudier.biology.and.clinical.long-term.outcome.of.jak2-neg.html 2024-05-02 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417858/betty.gardie.diagnosis.and.genetics.of.congenital.erythrocytosis.html 2024-05-10 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417857/faculty.presenters.panel.discussion.html 2024-05-10 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417856/isabelle.plo.mutant.calr.as.a.therapeutic.target.html 2024-05-10 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417855/edwin.chen.pathogenicity.and.dependencies.between.mtcalr.and.mpl.html 2024-05-10 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417854/shannon.elf.mechanisms.of.transformation.by.calr.mutation.html 2024-05-10 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417853/faculty.presenters.panel.discussion.html 2024-05-10 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417852/lionel.ades.mpn.mds.overlap.new.criteria.and.current.management.html 2024-05-10 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417851/dan.royston.machine.learning.for.mpn.diagnostics.html 2024-05-10 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417850/anna.godfrey.real.world.investigation.and.diagnosis.of.triple.negative.html 2024-05-10 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417849/faculty.presenters.panel.discussion.html 2024-05-10 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417848/ross.levine.novel.mpn.therapeutics.html 2024-05-10 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417847/ruben.mesa.advances.and.remaining.gaps.in.the.treatment.of.mpns.html 2024-05-10 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417846/faculty.presenters.panel.discussion.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417844/alessandro.vannucchi.how.to.recognize.and.manage.ruxolitinib.treatment.failure.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417843/prithviraj.bose.novel.therapies.for.high.risk.mpn.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417841/faculty.presenters.panel.discussion.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417840/ann.mullally.the.conundrum.of.tp53.mutations.in.mpn.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417839/chloe.james.immunothrombosis.a.major.actor.of.mpn-associated.thrombosis.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417838/grant.challen.novel.approaches.to.modeling.mpn.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417837/bethan.psaila.ex.vivo.modeling.of.mpn.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417836/faculty.presenters.panel.discussion.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417835/raajit.k.rampal.mechanisms.of.leukemic.transformation.in.mpns.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417834/adam.mead.molecular.pathogenesis.to.leukaemic.transformation.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417832/damien.luque.paz.prognostic.impact.of.molecular.landscape.in.428.polycythemia.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417831/faculty.presenters.panel.discussion.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417830/ronald.hoffman.targeting.iron.metabolism.in.mpn.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417829/angela.fleischman.targeting.inflammation.in.mpn.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417828/faculty.presenters.panel.discussion.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417827/jyoti.nangalia.insights.from.genomic.studies.of.mpn.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417826/gerwin.huls.evolution.of.clonal.hematopoiesis.to.mpn.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417825/anthony.green.keynote.lecture.mpn.pathogenesis.-.a.riddle.wrapped.in.a.mystery.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417824/jyoti.nangalia.welcome.words.html 2024-05-06 monthly 0.5 https://elearning.esh.org/esh/2024/myeloproliferative/417409/faculty.presenters.conference.book.%28pdf%29.html 2024-04-15 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412598/guillermo.garcia-manero.us.others.html 2024-04-25 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412597/faculty.presenters.german.emsco.italian.html 2024-04-25 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412596/faculty.presenters.french.spanish.html 2024-04-25 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412595/didier.blaise.allogeneic.hsct.in.aged.patients.html 2024-04-25 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412594/didier.blaise.allo.hsct.in.patients.with.mds.html 2024-04-25 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412592/amer.m.zeidan.response.criteria.for.hr.myelodysplastic.syndromes.html 2024-04-25 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412591/mikkael.a.sekeres.hypomethylating.agent.combinations.html 2024-04-25 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412590/guillermo.garcia-manero.hmas.--.a.party.of.one.html 2024-04-25 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412589/mikkael.a.sekeres.pitfalls.of.response.assessment.in.mds.html 2024-04-25 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412588/valeria.santini.defining.and.treating.relapsed.refractory.lower-risk.html 2024-04-25 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412587/eva.hellstrm-.lindberg.standards.for.managing.anemia.html 2024-04-25 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412586/rena.buckstein.frailty.in.mds.patients.html 2024-04-25 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412585/dorothe.selimoglu-buet.a.role.for.mature.cells.of.the.leukemic.clone.in.html 2024-04-25 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412584/michaela.fontenay.myelodysplastic.syndrome.with.sf3b1.gene.mutation.html 2024-04-25 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412583/claudia.haferlach.the.many.faces.of.tp53.html 2024-04-25 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412582/torsten.haferlach.comparing.prognostic.schemas.html 2024-04-22 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412581/jaroslaw.maciejewski.ai.ml.to.predict.myelodysplastic.syndromes.response.to.html 2024-04-22 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412580/aziz.nazha.ai.ml.to.predict.myelodysplastic.syndromes.prognosis.html 2024-04-22 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412579/carsten.marr.ai.ml.to.diagnose.myelodysplastic.syndromes.html 2024-04-22 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412578/lionel.ades.who.v.icc.html 2024-04-22 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412577/klaus.metzeler.diagnosing.myelodysplastic.syndromes.ngs.html 2024-04-22 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412576/aristoteles.giagounidis.diagnosing.myelodysplastic.syndromes.classical.tools.html 2024-04-22 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412573/shahram.kordasti.the.immunome.html 2024-04-22 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412572/jean-baptiste.micol.therapy.related.myelodysplastic.syndromes.html 2024-04-22 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412571/marie.sbert.germline.mutations.html 2024-04-22 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412569/katharina.gtze.clonal.haematopoiesis.html 2024-04-22 monthly 0.5 https://elearning.esh.org/esh/2024/MYELODYSPLASTIC/412555/faculty.presenters.conference.book.%28pdf%29.html 2024-03-20 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411414/faculty.presenters.closing.remarks.html 2024-03-21 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411413/faculty.presenters.panel.discussion.html 2024-03-21 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411411/rafet.basar.nk.car.html 2024-03-21 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411410/jennifer.brown.is.there.hope.for.pi3k.inhibitors.html 2024-03-21 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411409/james.blachly.pkc.beta.html 2024-03-21 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411408/faculty.presenters.discussion.html 2024-03-21 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411407/tanya.siddiqi.car-t.cell.immunotherapy.for.cll.html 2024-03-21 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411406/arnon.kater.bispecific.antibodies.for.cll.html 2024-03-21 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411405/matthew.davids.beyond.venetoclax.other.bh3.mimetic.therapies.html 2024-03-21 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411404/faculty.presenters.panel.discussion.html 2024-03-21 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411403/lukas.frenzel.venetoclax.resistance.html 2024-03-25 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411401/jennifer.brown.resistance.to.non-covalent.btk.inhibitors.html 2024-03-21 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411400/jennifer.woyach.resistance.to.covalent.btk.inhibitors.html 2024-03-21 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411399/faculty.presenters.panel.discussion.html 2024-03-21 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411398/william.wierda.what.role.will.non-covalent.btk.inhibitors.play.html 2024-03-21 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411397/richard.furman.choosing.a.covalent.btk.inhibitor.html 2024-03-21 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411395/faculty.presenters.panel.discussion.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411394/william.wierda.defined.duration.vs.mrd.driven.time-limited.therapy.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411393/carsten.niemann.btk.-.bcl-2.combinations.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411392/barbara.eichhorst.venetoclax.antibody.combinations.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411391/faculty.presenters.discussion.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411390/adrian.wiestner.preclinical.rationale.for.combining.bispecific.antibodies.with.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411387/martina.seiffert.antitumor.immunity.in.the.lymphoid.microenvironment.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411386/faculty.presenters.panel.discussion.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411385/andrew.rawstron.mrd.how.do.we.measure.it.should.ngs.become.the.standard.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411384/pauline.robbe.genomic.complexity.by.ngs.how.does.it.relate.to.karyotype.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411383/sarka.pospisilova.are.del%2817p%29.with.concurrent.tp53.mutation.and.isolated.tp53.html 2024-03-25 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411382/faculty.presenters.panel.discussion.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411381/toby.a.eyre.therapy.of.richter.transformation.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411380/elias.campo.genomics.of.richters.are.the.seeds.of.rs.present.at.diagnosis.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411379/elisa.ten.hacken.modeling.richters.syndrome.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411378/faculty.presenters.panel.discussion.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411377/justin.taylor.genetic.evolution.of.cll.under.therapeutic.selection.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411376/kostas.stamatopoulos.focusing.on.stereotyped.b.cell.receptors.in.cll.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411375/paolo.ghia.mutated.and.unmutated.igvh.cll.two.different.diseases.why.do.they.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411374/susan.slager.is.low.count.mbl.a.precursor.to.cll.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411373/faculty.presenters.welcome.words.html 2024-03-18 monthly 0.5 https://elearning.esh.org/esh/2024/3rd-CLL/411350/faculty.presenters.conference.book.%28pdf%29.html 2024-02-28 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411238/faculty.presenters.closing.remarks.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411237/faculty.presenters.panel.discussion.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411236/daniel.wolff.case-based.lecture.steroid-refractory.gvhd.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411235/jordi.esteve.case-based.lecture.relapse.post.allo.hct.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411234/caner.saygin.case-based.lecture.therapy.related.all.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411233/judith.schaffrath.interactive.case.first.r.r.aml.in.fit.aml.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411232/faculty.presenters.panel.discussion.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411231/marc.raaijmakers.case-based.lecture.red.flags.for.germline.predisposition.html 2024-03-06 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411230/michael.drazer.case-based.lecture.controversies.around.donor.selection.and.chip.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411229/gerwin.huls.case-based.lecture.clonal.cytopenia.of.unknown.significance.%28ccus%29.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411227/faculty.presenters.discussion.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411226/yves.chalandon.con.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411225/sabina.chiaretti.pro.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411224/herv.dombret.introduction.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411223/faculty.presenters.discussion.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411222/agnieszka.wierzbowska.intensive.chemo.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411221/keith.pratz.venaza.as.first.line.treatment.before.allo.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411220/faculty.presenters.panel.discussion.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411219/lori.muffly.case-based.lecture.novel.antibody.and.car-t-cell.approaches.in.all.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411217/matthew.j.wieduwilt.case-based.lecture.is.antibody.targeting.sufficient.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411216/marion.subklewe.interactive.case.the.challenge.to.immune.targeting.of.aml.html 2024-03-14 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411215/faculty.presenters.discussion.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411214/megan.othus.real.world.derived.control.arm.vs.experimental.arm.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411212/faculty.presenters.discussion.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411211/charles.craddock.con.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411209/jordi.esteve.introduction.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411208/faculty.presenters.panel.discussion.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411207/adriano.venditti.case-based.lecture.post.remission.treatment.in.mrd-negative.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411206/alexander.perl.case-based.lecture.management.of.fl3%2Baml.after.allo.hct.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411205/david.sallman.case-based.lecture.what.to.do.with.tp53-mut.aml.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411204/lionel.ades.interactive.case.relapse.after.venaza.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411202/faculty.presenters.panel.discussion.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411201/kristen.o.dwyer.case-based.lecture.bh3.mimetics.in.all.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411200/andrew.wei.case-based.lecture.mrd.directed.therapy-.a.new.therapeutic.option.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411199/eunice.wang.case-based.lecture.menin.inhibitors.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411198/mark.litzow.interactive.case.frontline.blinatumumab.for.all.in.all.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411197/faculty.presenters.panel.discussion.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411196/etan.orgel.case-based.lecture.mixed.phenotypic.acute.leukemias.for.example.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411195/nicolas.boissel.case-based.lecture.extramedullary.cns.relapse.in.all.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411194/andrew.lane.case-based.lecture.blastic.plasmacytoid.dendritic.cell.neoplasm.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411193/marie.sbert.interactive.case.germ-line-mutation-based.aml.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411192/richard.stone.how.do.the.new.who.icc.eln.classifications.impact.clinical.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411191/faculty.presenters.welcome.words.html 2024-03-11 monthly 0.5 https://elearning.esh.org/esh/2024/leukaemias/411190/faculty.presenters.conference.book.%28pdf%29.html 2024-02-22 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405496/faculty.presenters.conference.book.%28pdf%29.html 2023-10-24 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405495/faculty.presenters.conference.book.%28pdf%29.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405454/faculty.presenters.closing.remarks.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405453/faculty.presenters.panel.discussion.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405452/eunice.wang.therapeutic.targeting.of.idh1.idh2.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405451/alexander.perl.therapeutic.targeting.of.flt3.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405450/ravi.majeti.surface.antigen.targeting.in.aml.cd47.and.beyond.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405449/peter.valk.ngs-based.molecular.mrd.monitoring.in.aml.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405448/faculty.presenters.panel.discussion.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405446/coleman.lindsley.molecular.mechanisms.driving.secondary.aml.transformation.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405445/robert.hasserjian.the.biologic.heterogeneity.of.secondary.aml.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405444/faculty.presenters.panel.discussion.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405443/eytan.stein.therapeutic.targeting.of.menin.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405442/hannah.uckelmann.therapeutic.targeting.of.npm1.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405441/matthew.walter.therapeutic.targeting.of.splicing.factors.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405439/faculty.presenters.panel.discussion.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405438/philipp.staber.functional.single.cell.assessments.in.leukemia.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405436/raphael.itzykson.harnessing.functional.assays.for.precision.medicine.in.aml.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405435/faculty.presenters.panel.discussion.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405432/courtney.dinardo.therapeutic.targeting.of.bcl-2.html 2023-11-13 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405431/faculty.presenters.panel.discussion.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405430/katherine.r.calvo.germline.predisposition.to.myeloid.malignancy.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405428/benjamin.ebert.targeted.protein.degradation.for.the.treatment.of.hematologic.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405427/faculty.presenters.panel.discussion.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405426/john.dipersio.aml.relapse.after.allo-hct.hiding.in.plain.sight.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405425/adrian.ochsenbein.targeting.of.tumor.necrosis.factor.receptors.cd70.in.leukemia.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405424/saar.gill.immunotherapeutic.targeting.of.aml.and.mds.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405423/sergio.rutella.the.immune.landscape.of.aml.and.its.correlation.with.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405422/faculty.presenters.panel.discussion.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405421/alex.kentsis.targeting.aberrant.gene.control.in.aml.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405418/faculty.presenters.panel.discussion.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405416/paresh.vyas.where.when.and.how.characterising.the.properties.of.age-related.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405415/linde.miles.interrogating.clonal.evolution.in.acute.myeloid.leukemia.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405414/faculty.presenters.panel.discussion.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405413/george.vassiliou.causes.and.consequences.of.clonal.haematopoiesis.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405412/caroline.watson.evolution.of.clonal.haematopoiesis.to.aml.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405411/mathijs.sanders.linking.mutational.processes.to.leukemic.development.html 2023-11-09 monthly 0.5 https://elearning.esh.org/esh/2023/acute-myeloid-leukem/405410/faculty.presenters.welcome.words.html 2023-11-15 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405355/michael.hallek.closing.remarks.html 2023-10-22 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405354/faculty.presenters.panel.discussion.html 2023-10-22 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405353/moritz.frstenau.circulating.tumor.dna.in.chronic.lymphocytic.leukaemia.html 2023-10-25 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405352/stefan.alig.circulating.tumor.dna.in.primary.cns.lymphoma.html 2023-10-25 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405351/ash.alizadeh.circulating.tumor.dna.as.predictor.for.survival.in.diffuse.large.html 2023-10-25 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405350/faculty.presenters.panel.discussion.html 2023-10-22 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405349/mark.roschewski.multi-targeted.therapy.for.diffuse.large.b-cell.lymphoma.html 2023-10-25 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405348/paolo.ghia.timing.and.duration.of.targeted.therapies.continuous.versus.html 2023-10-25 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405347/michael.hallek.venetoclax.in.combination.with.other.agents.in.chronic.html 2023-10-25 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405346/faculty.presenters.panel.discussion.html 2023-10-22 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405345/alexey.danilov.cdk9.inhibitors.for.double.refr.ibru.venetoclax.refractory.html 2023-10-25 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405344/daniel.krappmann.function.and.targeting.of.malt1.in.aggressive.lymphomas.html 2023-10-25 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405343/mark.roschewski.btk.inhibitors.in.aggressive.lymphoma.html 2023-10-25 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405342/faculty.presenters.panel.discussion.html 2023-10-22 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405341/karin.tarte.microenvironmental.niche.of.indolent.lymphoma.html 2023-11-03 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405339/silvia.deaglio.microenvironment.of.chronic.lymphocytic.leukaemia.html 2023-10-25 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405338/faculty.presenters.panel.discussion.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405337/georg.lenz.pi3k.inhibitors.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405336/gilles.salles.tafasitamab.cd19.%2B.len.and.novel.bispecific.ab.strategies.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405335/martin.hutchings.bispecific.antibodies.in.non-hodgkin.lymphoma.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405334/laurie.sehn.antibody-drug.conjugates.in.relapsed.refractory.non-hodgkin.lymphoma.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405333/faculty.presenters.panel.discussion.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405332/david.miklos.off-the-shelf.car.constructs.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405331/catherine.bollard.novel.conceptual.design.of.innovative.%28cart.and.nk.cell%29.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405330/jason.westin.car.t-cells.for.b-cell.lymphoma.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405329/faculty.presenters.panel.discussion.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405328/silvia.bea.landscape.and.evolution.in.mantle.cell.lymphoma.html 2023-10-31 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405327/ari.melnick.epigenetic.dysregulation.in.diffuse.large.b-cell.lymphoma.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405326/riccardo.dalla-favera.mechanisms.of.b.cell.lymphomagenesis.pervasive.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405325/faculty.presenters.panel.discussion.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405324/javeed.iqbal.t-cell.lymphoma.subtypes.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405322/catherine.wu.single.cell.analytics.in.lymphoid.malignancies.-.a.conceptual.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405321/faculty.presenters.panel.discussion.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405320/david.scott.high.grade.b-cell.lymphoma.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/LYMPHOID-MALIGNANCIES/405318/daniel.hodson.building.lymphoma.diffuse.large.b-cell.lymphoma.models.html 2023-10-30 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404819/faculty.presenters.conference.book.%28pdf%29.html 2023-09-29 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/404818/faculty.presenters.conference.book.%28pdf%29.html 2023-09-26 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404248/jorge.cortes.closing.remarks.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404246/xiaoshuai.zhang.selected.abstract.a.predictive.scoring.system.for.therapy.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404245/robert.gale.keynote.presentation.how.should.we.interpret.concussions.of.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404244/faculty.presenters.hematology.service.for.cml.patients.in.ukraine.challenges.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404243/marta.cascante.identification.and.exploitation.of.the.metabolic.reprogramming.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404242/susanne.isfort.selected.abstract.the.effect.of.body.mass.index.on.the.safety.html 2023-10-11 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404241/kohlbrenner.katharina.selected.abstract.cml-registry.%28cml.vi%29.achievement.of.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404240/carlo.gambacorti-passerini.keynote.presentation.cml.have.we.reached.the.peak.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404238/daniela.kov.selected.abstract.why.are.not.all.eligible.cml.patients.willing.to.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404237/ilaria.stefania.pagani.selected.abstract.sensitive.measurement.of.residual.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404236/dragana.milojkovic.keynote.presentation.are.current.recommendations.enough.or.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404235/guilhot.franois.from.iris.to.spirit.toward.treatment.discontinuation.for.cml.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404234/delphine.rea.selected.abstract.tyrosine.kinase.inhibitor-free.remission.after.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404233/massimiliano.bonifacio.selected.abstract.a.successful.treatment-free.remission.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404232/nirmalya.roy.moulik.selected.abstract.treatment.free.remissions.%28tfr%29.in.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404231/franois-xavier.mahon.selected.abstract.the.european.stop.tyrosine.kinase.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404230/breccia.massimo.keynote.presentation.tfr.how.do.we.move.forward.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404229/faculty.presenters.discussion.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404228/giuseppe.saglio.pro.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404227/jane.apperley.not.yet.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404226/pierre.laneuville.introduction.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404225/halvard.bnig.novel.developments.in.hsc.transplant.treatment.of.gvhd.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404222/hiroshi.ureshino.selected.abstract.kir3dl1-hla-bw.status.predict.favourable.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404221/claire.c.lucas%40chester.ac.uk.selected.abstract.bcl-xl.a.novel.biomarker.for.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404219/dennis.kim.selected.abstract.the.presence.of.somatic.mutations.prior.to.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404218/sin.tiong.ong.keynote.presentation.hidden.signatures.harnessing.the.full.power.html 2023-10-20 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404215/coleman.lindsley.clonal.hematopoiesis.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404214/ravi.majeti.cd47.targeting.in.myeloid.malignancies.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404213/caroline.heckman.the.bcl2.family.in.myeloid.malignancies.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404212/steffen.bttcher.tp53.mutations.in.myeloid.malignancies.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404211/shinya.kimura.introductory.overview.concepts.and.challenges.html 2023-10-19 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404210/hong.qian.selected.abstract.characterization.of.bone.marrow.niche.in.patients.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404209/milad.rouhimoghadam.selected.abstract.overcoming.tki-resistant.cml.utilizing.a.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404208/anna.eiring.selected.abstract.the.role.of.g0.g1.switch.gene.2.%28g0s2%29.in.lipid.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404207/simona.soverini.keynote.presentation.resistance.to.tki.mutations.and.beyond.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404206/lucy.godley.germline.predisposition.to.hematopoietic.malignancies.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404204/jerry.radich.cml.is.still.important.and.relevant.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404202/hana.komic.selected.abstract.multiomic.single-cell.characterization.of.the.html 2023-10-17 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404201/manuela.mancini.selected.abstract.setd2.h3k36me3.deficiency.hinders.proper.dna.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404199/bhatia.ravi.keynote.presentation.the.curious.case.of.the.leukemic.stem.cell.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404198/ivan.dikic.autophagy.networks.and.cancer.pathogenesis.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404197/hughes.tim.excellent.molecular.responses.and.tolerance.observed.with.frontline.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404194/susan.branford.clonal.hematopoiesis.mutants.detected.at.the.time.of.stopping.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404193/martha.zarou.leukaemia.exposure.reduces.phagocytosis.and.efferocytosis.in.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/25th-john-goldman/404190/jorge.cortes.welcome.to.mandelieu.html 2023-10-16 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403600/anna.sureda.balari.interactive.case.allo.after.car-t.html 2023-09-20 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403598/elizabeth.budde.case-based.lecture.treatment.after.car-t.failure.in.diffuse.html 2023-10-13 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403597/michael.green.case-based.lecture.car-t.resistance.mechanisms.html 2023-10-13 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403596/lukas.scheller.interactive.case.relapse.in.multiple.myeloma.after.car-t.html 2023-10-13 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403595/jordan.gauthier.interactive.case.cars.and.comorbidities.html 2023-10-13 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403594/andrea.kuhnl.case-based.lecture.diffuse.large.b-cell.lymphoma.-.uk.experience.html 2023-10-13 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403593/frederick.locke.case-based.lecture.diffuse.large.b-cell.lymphoma.-.us.experience.html 2023-10-13 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403592/gloria.iacoboni.interactive.case.mantle.cell.lymphoma.html 2023-09-20 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403591/elizabeth.budde.pro.bispecific.antibody.html 2023-10-13 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403590/jeremy.abramson.pro.car-t.html 2023-10-13 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403589/jonathan.clark.patients.view.of.car.t-cell.therapy.html 2023-10-13 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403588/hans.scheurer.patient.perspective.html 2023-10-13 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403587/marie.jos.kersten.eligibility.and.rapid.progression.html 2023-10-13 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403586/claire.roddie.interactive.case.ebmt.recommendations.html 2023-10-13 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403585/kai.rejeski.case-based.lecture.cytopenias.and.infections.html 2023-10-13 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403584/frederick.locke.case-based.lecture.immune.effector.cell.associated.html 2023-10-13 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403582/anna.sureda.balari.interactive.case.prediction.of.toxicity.in.cars.and.html 2023-09-20 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403581/loretta.nastoupil.access.in.different.ethnic.groups.html 2023-10-10 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403579/natacha.bolanos.patient.survey.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403578/frederick.thielen.future.projections.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403577/jordan.gauthier.con.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403576/frederick.locke.pro.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403575/kate.cwynarski.interactive.case.t-cell.lymphoma.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403574/loretta.nastoupil.case-based.lecture.follicular.lymphoma.and.t-cell.lymphoma.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403573/marie.jos.kersten.case-based.lecture.mantle.cell.lymphoma.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403572/claire.roddie.case-based.lecture.adult.acute.lymphoblastic.leukaemia.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403571/andr.baruchel.interactive.case.pediatric.acute.lymphoblastic.leukaemia.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403570/johannes.waldschmidt.interactive.case.clinical.study.opportunities.for.patients.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403569/monique.minnema.case-based.lecture.bispecifics.and.sequencing.in.multiple.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403568/mara-victoria.mateos.case-based.lecture.car.in.multiple.myeloma.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403567/kai.rejeski.interactive.case.car-t.and.infections.in.multiple.myeloma.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403566/pere.barba.interactive.case.follow-up.of.patients.after.successful.treatment.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403565/stephan.fricke.case-based.lecture.alternative.cell.sources.allocar-t.ipsc.nk.car.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403564/martin.hutchings.case-based.lecture.bispecific.antibodies.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403563/catherine.thieblemont.case-based.lecture.car-t.patient.selection.and.bridging.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403562/tom.van.meerten.interactive.case.diffuse.large.b-cell.lymphoma.and.radiotherapy.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/2nd-car-t-therapies/403561/jeremy.abramson.car.t-cell.therapy.something.old.something.new.%28novel.targets.html 2023-10-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391225/dennis.schewe.combining.daratumumab.with.cd47.blockade.in.t-all.html 2023-05-25 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391224/guillaume.andrieu.precision.medicine.for.t-all.html 2023-06-02 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391223/sarah.k.tasian.precision.medicine.for.b-cell.precursor.all.html 2023-06-02 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391222/paul.maciocia.targeting.t-all.via.ccr9.html 2023-06-02 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391221/jae.h.park.role.of.sct.in.the.era.of.car-t.html 2023-06-02 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391220/andr.baruchel.how.to.prioritize.immune.interaction.in.b-acute.lymphoblastic.html 2023-06-02 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391219/federico.lussana.new.antibody-based.all.therapies.html 2023-06-02 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391218/philippe.rousselot.front.line.therapy.with.inotuzumab.ozogamicin.html 2023-06-02 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391216/jun.j.yang.comprehensive.profiling.of.leukemia.drug.sensitivity.in.pediatric.html 2023-06-02 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391215/stephen.p.hunger.minimal.chemotherapy.for.good-risk.childhood.all.html 2023-06-02 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391214/nitin.jain.early.t-cell.precursor.%28etp%29-all.html 2023-06-02 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391211/nicholas.short.the.evolution.of.tki.therapy.in.ph%2B.all.html 2023-05-29 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391209/marie.passet.cdx2.deregulation.and.ubtf.atxn7l3.define.a.novel.b-all.high-risk.html 2023-05-29 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391208/ronald.stam.characterizing.relapse.initiating.cells.by.single-cell.html 2023-05-29 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391207/jules.meijerink.new.insights.in.tlx3.rearranged.t-all.html 2023-05-29 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391206/rathana.kim.adult.low-hypodiploid.acute.lymphoblastic.leukemia.emerges.from.html 2023-05-29 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391205/charles.mullighan.acute.leukaemia.of.ambiguous.lineage.html 2023-05-29 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391204/stephen.p.hunger.clinical.use.of.tkis.in.ph-like.all.patients.html 2023-05-29 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391203/takahiro.maeda.identifying.novel.combination.therapies.for.b-all.harboring.the.html 2023-05-29 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391198/eytan.stein.menin.inhibitors.html 2023-05-29 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391197/janine.stutterheim.current.therapy.for.kmt2a-rearranged.all.html 2023-05-30 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391196/katrin.ottersbach.the.biology.of.kmt2a-rearranged.leukaemia.html 2023-05-30 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-acute-lymph/391194/faculty.presenters.conference.book.%28pdf%29.html 2023-05-16 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382687/faculty.presenters.panel.discussion.html 2023-05-01 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382685/elizabeth.odonnell.case-based.lecture.bone.disease.in.multiple.myeloma.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382684/fredrik.schjesvold.case-based.lecture.is.this.myeloma.kidney.a.case.of.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382683/mario.nuvolone.case-based.lecture.how.i.treat.amyloidosis.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382682/jorge.castillo.interactive.case.how.i.treat.waldenstrom.s.macroglobulinemia.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382681/kenneth.c.anderson.mm.treatment.in.2030.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382680/faculty.presenters.panel.discussion.html 2023-05-01 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382679/adam.sperling.case-based.lecture.role.of.antigen.loss.in.car.t.cell.engaging.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382678/paola.neri.case-based.lecture.how.to.predict.outcome.of.car.t.cell.and.t.cell.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382677/hermann.einsele.case-based.lecture.bi-.and.trispecific.antibodies.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382676/maik.luu.case-based.lecture.novel.targets.for.car.t.cells.in.multiple.myeloma.html 2023-04-28 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382675/omar.nadeem.case-based.lecture.cart.in.multiple.myeloma.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382674/hermann.einsele.interactive.case.how.to.use.novel.immunotherapies.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382673/faculty.presenters.discussion.html 2023-05-01 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382672/omar.nadeem.no.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382671/noemi.puig.yes.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382670/k.martin.kortm.introduction.html 2023-04-28 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382667/enrique.maria.ocio.san.miguel.interactive.case.optimal.sequence.at.relapse.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382666/michel.delforge.case-based.lecture.novel.agents.in.relapsed.multiple.myeloma.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382665/mara-victoria.mateos.case-based.lecture.how.to.use.t.cell.engagers.in.relapse.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382664/katja.weisel.case-based.lecture.how.i.treat.first.relapse.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382663/xavier.leleu.interactive.case.relapsed.multiple.myeloma.html 2023-04-18 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382661/faculty.presenters.discussion.html 2023-05-01 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382660/francesca.gay.no.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382659/salomon.manier.yes.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382658/hermann.einsele.introduction.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382657/faculty.presenters.discussion.html 2023-05-01 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382656/heinz.ludwig.no.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382655/noemi.puig.yes.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382654/mara-victoria.mateos.introduction.html 2023-05-01 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382653/faculty.presenters.panel.discussion.html 2023-05-01 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382652/stefan.knop.interactive.case.how.i.treat.a.high-risk.mm.patient.in.the.first.html 2023-05-03 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382651/marc.raab.case-based.lecture.precision.medicine.in.multiple.myeloma.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382650/leo.rasche.case-based.lecture.should.we.add.immunotherapy.in.high-risk.patients.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382649/faith.davies.case-based.lecture.should.the.high-risk.patient.be.treated.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382648/faith.davies.interactive.case.how.i.diagnose.the.high-risk.patient.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382647/faculty.presenters.panel.discussion.html 2023-05-01 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382646/siobhan.glavey.interactive.case.newly.diagnosed.transplant-ineligible.patient.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382645/alessandra.larocca.case-based.lecture.novel.therapeutic.approaches.for.frail.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382644/sonja.zweegman.case-based.lecture.how.to.treat.the.frail.patient.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382643/omar.nadeem.case-based.lecture.do.we.still.need.transplant.in.the.first-line.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382642/charlotte.pawlyn.interactive.case.newly.diagnosed.transplant.eligible.multiple.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382641/faculty.presenters.panel.discussion.html 2023-05-01 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382639/elena.zamagni.case-based.lecture.imaging.with.pet-ct.in.smm.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382638/madhav.dhodapkar.case-based.lecture.understanding.the.immune.html 2023-04-25 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382637/elizabeth.odonnell.case-based.lecture.high.risk.smoldering.myeloma.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382636/mara-victoria.mateos.interactive.case.smoldering.myeloma.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382635/hermann.einsele.maria-victoria.mateos.welcome.words.html 2023-04-24 monthly 0.5 https://elearning.esh.org/esh/2023/4th-how-to-diagnose-and-treat-multiple-myeloma/382619/faculty.presenters.conference.book.%28pdf%29.html 2023-04-13 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376466/faculty.presenters.conference.book.%28pdf%29.html 2023-03-02 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376448/kevin.kuo.rbc.metabolism.manipulation.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376443/mitchell.j.weiss.base.editing.for.hemoglobin.disorders.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376442/selim.corbacioglu.crispr.vertex.scd.and.thal.trial.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376441/daniel.bauer.hematopoietic.stem.cell.gene.editing.html 2023-03-13 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376439/oscar.quintana.bustamante.selected.brief.oral.communication.modeling.of.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376438/achille.iolascon.congenital.dyserythropoietic.anemia.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376437/wilma.barcellini.methemoglobinaemia.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376436/noemi.roy.how.to.do.the.molecular.diagnosis.for.rare.anaemias.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376433/catherine.lavazec.p.falciparum.infection.of.erythroid.cells.html 2023-04-25 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376431/immacolata.andolfo.piezo1.in.xerocytosis.dehydrated.hereditary.stomatocytosis.html 2023-03-13 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376428/cristian.bellodi.alterations.of.translation.control.by.rna.modification.in.mds.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376423/giuliana.ferrari.gene.therapy.for.beta-thalassemia.what.do.we.know.about.html 2023-03-13 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376419/megane.brusson.selected.brief.oral.communication.novel.lentiviral.vectors.for.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376413/mohandas.narla.erythroblast.enucleation.and.reticulocyte.biology.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376411/leonard.i.zon.m6a.epitranscriptome-mediated.rna.stress.granule.assembly.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376409/diletta.maira.selected.brief.oral.communication.the.role.of.hypoxia.and.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376408/marlies.rossmann.coenzyme.q.ferroptosis.tif1g.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376356/faculty.presenters.panel.discussion.html 2023-03-17 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376355/ning-chun.chen.brief.oral.communication.outcomes.of.discontinuation.of.html 2023-03-15 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376354/andreas.reiter.interactive.case.is.treatment.free.remission.feasible.in.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376353/francesca.palandri.case-based.lecture.is.treatment.free.remission.the.goal.in.html 2023-03-15 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376352/tim.brmmendorf.case-based.lecture.how.to.target.stem.cell.persistence.in.cml.html 2023-03-23 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376351/giuseppe.saglio.case-based.lecture.how.to.increase.eligibility.for.treatment.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376350/satu.mustjoki.interactive.case.are.all.bcr.abl1.alike.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376349/faculty.presenters.panel.discussion.html 2023-03-17 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376348/jessie.medeiros.brief.oral.communication.stem.cell-derived.gene.expression.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376347/jonah.rakoff.brief.oral.communication.values.and.preferences.towards.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376346/carl.crodel.case-based.lecture.infections.in.mpn.cml.patients.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376344/tiziano.barbui.case-based.lecture.ruxolitinib.and.hyperinflammation.html 2023-03-17 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376343/francesca.palandri.case-based.lecture.second.malignancies.and.tk.inhibition.html 2023-03-15 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376342/breccia.massimo.interactive.case.comorbidity.in.cml.mpn.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376341/faculty.presenters.discussion.html 2023-03-15 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376340/susanne.saussele.con.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376339/mhairi.copland.pro.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376338/thomas.ernst.introduction.html 2023-05-01 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376337/faculty.presenters.discussion.html 2023-03-15 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376336/vikas.gupta.advanced.mpn.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376334/martin.bornhuser.cml.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376332/faculty.presenters.panel.discussion.html 2023-03-17 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376331/marta.sobas.brief.oral.communication.a.retrospective.comparison.of.patient.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376329/valentin.garcia-gutierrez.case-based.lecture.new.drugs.and.patient.reported.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376327/delphine.rea.case-based.lecture.asciminib.third.line.-.which.patients.will.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376326/philipp.le.coutre.interactive.case.allogeneic.stem.cell.transplantation.or.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376325/faculty.presenters.discussion.html 2023-03-14 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376324/carlo.gambacorti-passerini.atypical.cml.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376322/daniel.wiseman.chronic.myelomonocytic.leukaemia.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376321/faculty.presenters.discussion.html 2023-03-15 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376320/john.mascarenhas.individualized.therapy.best.for.myelofibrosis.html 2023-03-15 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376319/adam.mead.disease.modification.is.the.universal.goal.in.myelofibrosis.html 2023-03-15 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376318/ruben.mesa.introduction.html 2023-03-15 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376317/faculty.presenters.panel.discussion.html 2023-03-14 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376316/philipp.ernst.interactive.case.bcr.abl1.independent.mutation.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376315/katerina.machova.case-based.lecture.cml.cytogenetic.and.molecular.evolution.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376314/jane.apperley.case-based.lecture.accelerated.phase.vs.high-risk.disease.-.the.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376313/annamaria.brioli.case-based.lecture.cml.blast.crisis.-.the.european.registry.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376312/fausto.castagnetti.interactive.case.advanced.cml.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376311/faculty.presenters.panel.discussion.html 2023-03-14 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376310/daniela.kov.interactive.case.autoimmune.disease.caused.by.ifn.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376309/paul.la.rose.case-based.lecture.dose.optimization.dasatinib.-.the.dasahit.trial.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376308/andreas.hochhaus.case-based.lecture.interferon.alpha.in.combination.-.the.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376306/raanani.pia.sophia.interactive.case.tumour.lysis.syndrome.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376305/faculty.presenters.panel.discussion.html 2023-04-26 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376303/marta.sobas.brief.oral.communication.transfusion.independence.potential.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376302/mary.frances.mcmullin.interactive.case.secondary.or.other.erythrocytosis.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376301/naveen.pemmaraju.case-based.lecture.combination.approaches.for.myelofibrosis.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376300/ruben.mesa.case-based.lecture.moving.beyond.hydroxyurea.in.essential.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-how-to-diagnose-and-treat-cmlmpn/376299/marina.kremyanskaya.case-based.lecture.targeting.hepcidin.pathway.in.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/4th-scientific-workshop-the-haematological-tumour/376264/michael.andreeff.combinatorial.cxcr4.e-selectin.inhibition.is.required.to.html 2023-02-15 monthly 0.5 https://elearning.esh.org/esh/2023/4th-scientific-workshop-the-haematological-tumour/376261/john.dipersio.immune.escape.and.immune.editing.post.stem.cell.transplant.html 2023-02-15 monthly 0.5 https://elearning.esh.org/esh/2023/4th-scientific-workshop-the-haematological-tumour/376255/shahram.kordasti.the.immunome.in.mds.html 2023-02-15 monthly 0.5 https://elearning.esh.org/esh/2023/4th-scientific-workshop-the-haematological-tumour/376252/karin.tarte.follicular.lymphoma.and.stroma.cells.html 2023-02-15 monthly 0.5 https://elearning.esh.org/esh/2023/4th-scientific-workshop-the-haematological-tumour/376251/stephane.mancini.the.bm.niche.in.lymphoid.disorders.html 2023-02-15 monthly 0.5 https://elearning.esh.org/esh/2023/4th-scientific-workshop-the-haematological-tumour/376250/claire.edwards.adipocytes.in.the.multiple.myeloma.microenvironment.html 2023-02-15 monthly 0.5 https://elearning.esh.org/esh/2023/4th-scientific-workshop-the-haematological-tumour/376247/aaron.schimmer.venetoclax.t.cells.and.ros.in.aml.html 2023-02-15 monthly 0.5 https://elearning.esh.org/esh/2023/4th-scientific-workshop-the-haematological-tumour/376246/toshio.suda.self-renewal.capacity.in.hematopoietic.stem.cells.html 2023-02-15 monthly 0.5 https://elearning.esh.org/esh/2023/4th-scientific-workshop-the-haematological-tumour/376241/bhatia.ravi.the.bone.marrow.niche.in.cml.html 2023-02-15 monthly 0.5 https://elearning.esh.org/esh/2023/4th-scientific-workshop-the-haematological-tumour/376238/markus.manz.bone.marrow.inflamm-ageing.and.chip.html 2023-02-15 monthly 0.5 https://elearning.esh.org/esh/2023/4th-scientific-workshop-the-haematological-tumour/376237/liran.shlush.extrinsic.regulation.of.clonal.hematopoiesis.during.aging.html 2023-02-15 monthly 0.5 https://elearning.esh.org/esh/2023/4th-scientific-workshop-the-haematological-tumour/376234/jennifer.trowbridge.ageing.and.the.bone.marrow.microenvironment.html 2023-02-15 monthly 0.5 https://elearning.esh.org/esh/2023/4th-scientific-workshop-the-haematological-tumour/376233/ralf.adams.the.bone.marrow.niche.in.aging.and.regeneration.html 2023-02-15 monthly 0.5 https://elearning.esh.org/esh/2023/3rd-translational-research-conference-erythropoie/376119/faculty.presenters.conference.book.%28pdf%29.html 2023-03-09 monthly 0.5 https://elearning.esh.org/esh/2023/4th-scientific-workshop-the-haematological-tumour/376102/faculty.presenters.conference.book.%28pdf%29.html 2023-02-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374877/faculty.presenters.panel.discussion.html 2022-12-13 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374876/louis.terriou.selected.brief.oral.communication.clinical.humanistic.and.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374875/rodrigo.calado.role.of.complement.in.covid-19.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374874/shahram.kordasti.immunederangement.in.aa.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374872/marc.raaijmakers.inflammation.linking.tissue.failure.to.clonal.evolution.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374871/faculty.presenters.panel.discussion.html 2022-12-13 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374870/rgis.peffault.de.latour.selected.brief.oral.communication.evaluation.of.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374869/antonio.risitano.proximal.complement.inhibitors.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374867/rgis.peffault.de.latour.classical.treatment.of.pnh.terminal.inhibitors.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374866/faculty.presenters.panel.discussion.html 2022-12-13 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374864/sujith.samarasinghe.saa.in.pediatric.patients.transplant.or.ist.html 2022-12-02 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374863/andrea.bacigalupo.transplantation.for.acquired.saa.when.and.how.html 2022-12-02 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374862/rgis.peffault.de.latour.the.revolution.of.tpo.agonists.html 2022-12-02 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374861/faculty.presenters.panel.discussion.html 2022-12-13 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374860/sofie.lundgren.selected.brief.oral.communication.immune.cell.landscape.of.html 2022-12-02 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374858/philip.scheinberg.malignant.clonal.evolutions.in.aa.any.predictors.html 2022-12-02 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374857/austin.kulasekararaj.somatic.mutations.in.aa.what.we.learned.from.race.html 2022-12-02 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374855/jaroslaw.maciejewski.innate.immunity.and.clonal.evolution.in.bone.marrow.failure.html 2022-12-02 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374853/emma.pool.selected.brief.oral.communication.high-dimensional.mass.cytometric.html 2022-12-02 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374851/lucio.luzzatto.pnh.a.model.of.adaptation.html 2022-12-02 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374850/simona.pagliuca.human.leucocyte.antigen.in.aplastic.anemia.cause.or.consequence.html 2022-12-02 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374848/neal.young.keynote.lecture.new.clues.in.aa.pathophysiology.html 2022-12-02 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374846/marcin.wlodarski.clinical.and.biological.aspects.of.samd9.%26.samd9l.syndromes.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374845/thierry.leblanc.new.ibmfs.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374843/sharon.savage.disease.progression.and.clinical.outcomes.in.tbd.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374842/tim.brmmendorf.telomeres.biology.in.hematopoietic.stem.cell.disorders.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374841/faculty.presenters.panel.discussion.html 2022-12-13 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374840/nathan.gray.selected.brief.oral.communication.results.of.prospective.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374839/deena.iskander.management.of.diamond-blackfan.anaemia.%28dba%29.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374838/akiko.shimamura.management.of.sds.html 2022-11-28 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374837/alan.warren.ribosomes.and.hematopoiesis.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374836/robert.meyer.selected.brief.oral.communication.germline.variants.in.mdm4.cause.html 2022-11-28 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374835/juan.bueren.roncero.gene.therapy.for.fanconi.anaemia.and.other.ibmf.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374834/carlo.dufour.classical.and.new.treatment.of.fanconi.anaemia.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374829/peter.campbell.clonal.tracking.of.hematopoietic.stem.cells.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374828/coleman.lindsley.clonal.hematopoiesis.in.inherited.bmfd.html 2022-11-24 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374827/markus.manz.inflamm-ageing.of.the.hematopoietic.system.html 2022-12-07 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374826/faculty.presenters.welcome.address.html 2022-12-07 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-esh-ebmt-translational-research-conference-bo/374825/faculty.presenters.conference.book.%28pdf%29.html 2022-11-17 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374709/faculty.presenters.panel.discussion.html 2022-11-15 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374705/faculty.presenters.conference.book.%28pdf%29.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374701/faculty.presenters.panel.discussion.html 2022-11-18 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374700/catherine.thieblemont.interactive.case.gastric.malt.lymphoma.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374699/judith.trotman.case-based.lecture.waldenstrom.macroglobulinemia.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374698/stefano.luminari.case-based.lecture.systemic.marginal.zone.lymphoma.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374695/faculty.presenters.panel.discussion.html 2022-11-18 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374694/roberta.di.blasi.case-based.lecture.what.are.the.treatment.options.after.car-t.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374692/frederick.locke.case-based.lecture.aes.in.car.t.and.bite.therapy.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374691/martin.hutchings.interactive.case.integrating.bispecific.antibodies.into.the.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374690/faculty.presenters.final.vote.html 2022-11-18 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374689/matthew.wilson.con.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374688/christopher.fox.pro.html 2022-11-18 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374687/michael.crump.introduction.html 2022-11-18 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374686/faculty.presenters.discussion.html 2022-11-18 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374685/pashna.munshi.cd19.car-t.cell.therapy.for.mantle.cell.lymphoma.and.follicular.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374684/frederick.locke.cd19.car-t.as.second.line.therapy.for.diffuse.large.b-cell.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374683/marco.ruella.cd19.car-t.mechanisms.of.action.and.resistance.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374682/faculty.presenters.panel.discussion.html 2022-11-18 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374681/michael.roost.clausen.selected.brief.oral.communication.subcutaneous.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374680/marek.trneny.case-based.lecture.is.auto-transplant.over.in.diffuse.large.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374679/armando.lopez-guillermo.case-based.lecture.relapsed%28not.autologous.stem.cell.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374678/kim.linton.case-based.lecture.front.line.therapy.%28focus.on.high.risk%29.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374677/viola.pschel.case-based.lecture.consolidation.radiation.therapy.in.diffuse.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374676/faculty.presenters.discussion.html 2022-11-14 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374674/silvia.montoto.autologous.and.allogeneic.stem.cell.transplant.for.t-cell.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374673/faculty.presenters.final.vote.html 2022-11-14 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374672/alison.moskowitz.con.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374671/peter.borchmann.pro.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374670/graham.collins.introduction.html 2022-11-14 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374669/lorenzo.falchi.selected.brief.oral.communication.subcutaneous.epcoritamab.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374668/caron.jacobson.case-based.lecture.relapsed.follicular.lymphoma.which.cellular.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374667/stefano.luminari.case-based.lecture.optimal.front.line.approach.for.high-risk.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374666/kai.hbel.case-based.lecture.understanding.biology.of.high.risk.follicular.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374665/jessica.okosun.interactive.case.recognizing.high.risk.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374664/faculty.presenters.panel.discussion.html 2022-11-14 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374663/alison.moskowitz.case-based.lecture.salvage.therapy.in.peripheral.t-cell.html 2022-11-14 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374662/alison.moskowitz.case-based.lecture.front-line.personalized.therapy.of.common.html 2022-11-15 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374660/faculty.presenters.panel.discussion.html 2022-11-14 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374659/vojin.vukovic.selected.brief.oral.communication.clinicopathological.features.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374657/anca.prica.case-based.lecture.advanced.-.how.to.choose.optimal.therapy.in.the.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374656/marc.andre.case-based.lecture.limited.stage.hodgkin.lymphoma.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374655/graham.collins.interactive.case.elderly.patients.with.hodgkin.lymphoma.chemo.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-lymphoma/374654/faculty.presenters.welcome.address.html 2022-11-04 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374438/faculty.presenters.conference.book.%28pdf%29.html 2022-10-14 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374418/jorge.cortes.selected.abstract.immunological.response.to.sars-cov-2.after.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374417/dennis.kim.selected.abstract.adverse.impact.of.hmgcll1.gene.variant.on.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374416/nirmalya.roy.moulik.selected.abstract.treatment.and.long-term.follow-up.of.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374415/giora.sharf.patients.perspective.on.cure.in.cml.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374414/jan.geissler.20.years.of.evidence-based.patient.advocacy.in.cml.a.story.of.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374410/andrew.innes.selected.abstract.uk.real.world.of.experience.of.asciminib.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374409/camille.c.b.kockerols.selected.abstract.clinical.outcome.of.asciminib.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374408/dragana.milojkovic.keynote.presentation.clinical.trials.and.the.real.world.how.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374406/faculty.presenters.discussion.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374405/delphine.rea.asciminib.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374404/jorge.cortes.ponatinib.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374403/hughes.tim.introduction.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374401/greg.wang.phase.separation-based.mechanisms.underlying.3d.chromatin.structure.html 2023-01-23 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374399/steve.eacker.next-generation.cytogenomics.in.leukemia.opportunities.for.html 2023-01-23 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374397/faculty.presenters.discussion.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374396/mirle.schemionek-reinders.intrinsic.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374395/daniela.krause.extrinsic.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374394/bhatia.ravi.introduction.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374393/hee.jeong.cho.selected.abstract.long-term.treatment.outcome.and.health-related.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374391/franck.emmanuel.nicolini.selected.abstract.tfr.after.nilotinib.or.dasatinib.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374390/dennis.kim.selected.abstract.final.result.of.tki.discontinuation.trial.with.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374389/susanne.saussele.keynote.presentation.tfr.and.pro.where.do.we.stand.where.to.go.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374388/andreas.hochhaus.teamwork.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374387/gianantonio.rosti.selected.abstract.dose.modification.dynamics.of.ponatinib.in.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374386/jorge.cortes.selected.abstract.vodobatinib.in.chronic.phase.ph%2B.cml.-.updated.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374384/andreas.hochhaus.selected.abstract.efficacy.and.safety.results.from.ascembl.a.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374383/valentin.garcia.gutirrez.keynote.presentation.new.drugs.in.cml.which.where.and.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374382/carlo.maley.cancer.evolution.ecosystems.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374379/milad.rouhimoghadam.selected.abstract.deciphering.the.cooperative.mechanism.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374378/andrew.wu.selected.abstract.identification.of.key.micrornas.as.predictive.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374377/anna.d.doleschall.selected.abstract.relationship.between.telomere.length.and.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374372/george.burslem.targeted.protein.degradation.as.a.tool.to.probe.non-kinase.html 2022-10-12 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374371/stefan.knapp.validation.of.protacs.as.chemical.tools.and.expanding.the.tool.html 2022-10-12 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374369/faculty.presenters.general.discussion.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374368/ehab.atallah.the.last.trial.the.value.of.pro.after.treatment.discontinuation.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374367/franois-xavier.mahon.lessons.learnt.from.euro-ski.where.now.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374366/susan.branford.icmlf.genomic.alliance.goals.and.accomplishments.through.a.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374365/simona.soverini.current.understanding.mutation.assessment.and.significance.in.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374363/rdiger.hehlmann.champion.in.cml.cooperative.research.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374362/giuseppe.saglio.introductory.overview.concepts.and.challenges.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374361/ryan.yen.selected.abstract.targeting.a.highly.deregulated.eif4f.translation.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374358/ahmed.khalaf.selected.abstract.lomerizine.blocks.calcium.ion.influx.to.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374356/kudzai.nyamondo.combined.targeting.of.cml.cells.using.tyrosine.kinase.and.bone.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374355/athena.phoa.restoration.of.mir-185.in.combination.with.bcr-abl.downregulation.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374354/burda.pavel.the.rate.of.cellular.energy.production.of.muscle.cells.attenuated.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374353/lukas.hselbarth.synthetic.lethality.in.cml.-.targeting.metabolism.effectively.html 2022-10-31 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374352/toni.ribas.immunology.aspects.of.cancer.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374351/oliver.hantschel.molecular.mechanisms.of.bcr-abl.regulation.and.its.inhibition.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374350/jusuf.imeri.selected.abstract.modeling.progression.of.cml.using.mutagenized.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374348/jerome.artus.selected.abstract.bcr-abl1.-dependent.promotion.of.hematopoietic.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374347/ya-ching.hsieh.selected.abstract.single-cell.multiomics.reveals.the.stem.and.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374344/camille.c.b.kockerols.bcr.abl1.digital.pcr.identifies.chronic.phase.cml.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374343/kevin.rattigan.glucose.anaplerosis.is.a.bcr-abl.independent.metabolic.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374342/fabian.lang.asciminib.provides.durable.molecular.responses.in.patients.with.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374339/helong.zhao.a.shared.molecular.mechanism.among.blastic.transformation.residual.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/24th-annual-john-goldman-conference-on-chronic-mye/374338/jorge.cortes.welcome.address.html 2022-11-21 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/374270/faculty.presenters.conference.book.%28pdf%29.html 2022-10-06 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373855/faculty.presenters.panel.discussion.html 2022-11-16 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373854/prashant.kapoor.waldenstrom.macroglobulinemia.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373853/vaishali.sanchorawala.al.amyloidosis.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373852/vincent.rajkumar.mgus.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373851/faculty.presenters.panel.discussion.html 2022-11-16 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373850/shaji.kumar.endpoints.for.frontline.therapy.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373849/philippe.moreau.strategic.questions.for.investigator.initated.trials.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373848/graham.jackson.control.arms.in.regulatory.trials.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373847/faculty.presenters.discussion.html 2022-11-16 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373846/mohamad.mohty.fiction.html 2022-10-12 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373845/adrian.mosquera.reality.html 2022-10-12 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373844/nizar.j.bahlis.where.when.and.how.to.use.bi-specifics.mabs.in.mm.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373843/salomon.manier.where.when.and.how.to.use.car-.cells.in.mm.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373842/rakesh.popat.where.when.and.how.to.use.adc.in.mm.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373841/faculty.presenters.panel.discussion.html 2022-11-16 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373840/fredrik.schjesvold.current.options.for.3rd.line.of.therapy.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373839/saad.usmani.how.to.rescue.patients.after.the.soc.in.1st.line.in.2022.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373838/enrique.maria.ocio.san.miguel.treatment.at.biochemical.versus.clinical.relapse.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373837/faculty.presenters.panel.discussion.html 2022-11-16 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373836/noemi.puig.mrd.evaluation.in.the.peripheral.blood.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373835/elena.zamagni.mrd.evaluation.by.imaging.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373834/stefania.oliva.mrd.evauation.in.the.bone.marrow.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373833/faculty.presenters.panel.discussion.html 2022-11-16 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373832/martin.kaiser.ultra.high.risk.asct.%2B.immunotherapy.html 2022-10-14 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373831/graham.jackson.maintenance.2.agents.for.all.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373830/cyrille.touzeau.quadruplet.induction.for.all.patients.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373829/faculty.presenters.panel.discussion.html 2022-11-16 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373828/gordon.cook.how.to.assess.frailty.in.2022.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373827/kwee.yong.quadruplet.in.elderly.patients.is.it.manageable.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373826/vincent.rajkumar.vrd.or.drd.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373825/faculty.presenters.panel.discussion.html 2022-11-16 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373824/evangelos.terpos.imaging.at.diagnosis.in.2022.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373823/jill.corre.genetics.and.risk.assessment.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373822/albert.oriol.diagnostic.criteria.and.initial.workup.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373821/faculty.presenters.panel.discussion.html 2022-11-16 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373820/sagar.lonial.clinical.trials.in.smm.past.and.future.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373819/mara-victoria.mateos.definition.of.high-risk.smm.in.2022.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373818/irene.ghobrial.biology.of.smoldering.a.different.disease.html 2022-10-11 monthly 0.5 https://elearning.esh.org/esh/2022/6th-translational-research-conference-multiple-my/373817/graham.jackson.welcome.address.html 2022-11-16 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/372595/matteo.doglio.selected.brief.oral.communication.car-tregs.for.systemic.lupus.html 2022-10-20 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/372511/faculty.presenters.conference.book.%28pdf%29.html 2022-09-08 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371992/faculty.presenters.panel.discussion.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371989/markus.sauer.super-resolution.fluorescence.imaging.of.plasma.membrane.html 2022-09-01 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371988/johannes.huppa.interrogating.tcr.%26.car.function.with.high-end.microscopy.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371987/faculty.presenters.panel.discussion.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371986/maik.luu.selected.brief.oral.communication.joint.forces.-.synergizing.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371985/philippe.bousso.decoding.the.mode.of.action.of.car-t.cells.using.intravital.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371983/chiara.bonini.genome.editing.to.overcome.t-cell.exhaustion.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371982/faculty.presenters.panel.discussion.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371981/igor.slukvin.selected.brief.oral.communication.pluripotent.stem.cell-derived.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371980/maria.themeli.ipsc-derived.car-t.and.car-nk.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371978/daniel.powell.the.big.bang.of.universal.immune.receptors.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371977/faculty.presenters.panel.discussion.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371976/laura.grunewald.selected.brief.oral.communication.pharmacologically.inhibiting.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371974/cliona.rooney.modification.of.gd2.car.t-cells.with.a.constitutively.active.il7.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371971/faculty.presenters.panel.discussion.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371970/marta.biondi.selected.brief.oral.communication.improving.bone.marrow.homing.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371969/marcela.maus.translation.of.new.car-t.cells.into.the.clinic.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371968/michael.jensen.synthetic.solutions.for.improving.car-t.solid.tumor.immunotherapy.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371967/yvonne.chen.engineering.next-generation.car-t.cell.therapy.for.cancer.html 2022-09-21 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371966/faculty.presenters.panel.discussion.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371965/dionysia.kefala.selected.brief.oral.communication.pre-clinical.development.and.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371963/mirjam.heemskerk.optimization.of.tcr.gene.therapy.and.preventing.tumor.escape.html 2022-09-22 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371962/aude.chapuis.tackling.mechanisms.of.immune.escape.to.tcr.therapy.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371961/faculty.presenters.panel.discussion.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371959/evelyn.ullrich.nk.cells.next.generation.cell.therapies.for.cancer.html 2022-09-12 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371957/giulia.casorati.adoptive.immunotherapy.of.acute.leukemia.by.inkt.cells.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371956/faculty.presenters.panel.discussion.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371955/anthea.wirges.selected.brief.oral.communication.ebag9-silencing.links.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371954/dirk.busch.advanced.engineering.of.recombinant.tcr.expressing.t-cells.for.html 2022-09-21 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371953/eliana.ruggiero.engineering.t.lymphocytes.with.newly.identified.tcrs.for.the.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371952/franziska.blaeschke.pooled.crispr.knockin.screens.reprogramming.therapeutic.t.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371951/faculty.presenters.panel.discussion.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371950/philipp.gdel.selected.brief.oral.communication.csf1r.blockade.improves.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371948/luca.gattinoni.harnessing.t.memory.stem.cells.for.adoptive.immunotherapy.of.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371947/michael.hudecek.car.t.cells.a.road.trip.from.the.clinic.back.to.the.lab.html 2022-09-12 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-immune-ce/371946/faculty.presenters.welcome.address.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366606/faculty.presenters.panel.discussion.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366605/marina.kremyanskaya.rusfertide.%28ptg-300%29.treatment.effectively.controls.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366604/catriona.jamieson.targeting.aberrant.self-renewal.in.mpn.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366603/timothy.graubert.targeting.splicing.factors.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366602/faculty.presenters.panel.discussion.html 2022-07-04 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366601/ann.mullally.initiation.and.progression.of.calr.mutant.mpn.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366600/caroline.marty.calr.mutations.in.the.development.of.mpn.using.mouse.modeling.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366599/faculty.presenters.panel.discussion.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366598/ciro.rinaldi.expression.of.cd47.and.calr.in.myeloproliferative.neoplasms.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366597/lionel.ades.therapy.of.overlap.mpn.mds.syndromes.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366596/tiziano.barbui.why.hydroxyurea.must.still.be.the.standard.in.patients.with.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366595/eric.solary.insights.in.diagnosis.and.management.of.cmml.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366594/faculty.presenters.panel.discussion.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366593/alessandro.vannucchi.prognostic.scores.in.mpn.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366592/ruben.mesa.keynote.lecture.combination.therapies.for.myelofibrosis.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366591/faculty.presenters.panel.discussion.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366589/john.mascarenhas.therapeutic.approaches.in.post-mpn.aml.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366588/andreas.reiter.unusual.firms.of.eosinophilias.%28fgfr1.inhibitors.moab.for.other.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366587/faculty.presenters.panel.discussion.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366586/ross.levine.keynote.lecture.new.insights.into.the.role.of.jak2v617f.in.mpn.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366584/faculty.presenters.panel.discussion.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366583/linda.resar.hmga1.chromatin.regulators.induce.transcriptional.networks.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366582/david.kent.non-genetic.mechanisms.of.clonal.expansion.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366581/angela.fleischman.role.of.inflammation.in.mpn.initiation.and.progression.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366580/adam.mead.single.cell.studies.to.uncover.novel.insights.into.mpn.pathogenesis.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366579/faculty.presenters.panel.discussion.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366578/raajit.k.rampal.molecular.pathogenesis.of.progression.from.mpn.to.aml.html 2022-06-20 monthly 0.5 https://elearning.esh.org/esh/2022/9th-translational-research-e-conference-myeloprol/366577/ronald.hoffman.mpn.stem.cell.directed.therapeutics.html 2022-08-31 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366512/faculty.presenters.panel.discussion.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366511/joanna.wilinska-.mackowiak.new.eu.regulations.for.clinical.trials.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366510/thomas.cluzeau.apr.246.magorlimab.and.other.potential.drugs.active.in.mds.aml.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366509/mikkael.a.sekeres.rethinking.clinical.trial.endpoints.in.mds.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366508/faculty.presenters.panel.discussion.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366507/silke.gloaguen.clinical.trials.-.german.mds.study.group.emsco.html 2022-07-01 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366506/pierre.fenaux.gfm.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366505/mara.dez.campelo.gesmd.clinical.trials.and.projects.html 2022-07-01 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366504/valeria.santini.ongoing.mds.studies.in.italy.html 2022-07-01 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366503/raphael.itzykson.introduction.html 2022-07-01 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366502/faculty.presenters.discussion.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366501/elsa.bernard.keynote.lecture.routine.integration.of.molecular.data.in.the.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366500/faculty.presenters.panel.discussion.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366499/uwe.platzbecker.novel.strategies.to.treat.cytopenia.in.low.risk.mds.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366498/thomas.cluzeau.a.renewed.role.for.intensive.chemotherapy.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366497/lionel.ades.higher.risk.mds.lessons.from.elderly.aml.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366496/pierre.fenaux.strategies.to.improve.hma.based.therapy.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366495/faculty.presenters.panel.discussion.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366494/valeria.santini.overview.of.novel.therapeutics.in.mds.lessons.from.the.lab.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366493/raphael.itzykson.current.treatment.guidelines.for.cmml.and.rare.subtypes.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366492/marie.robin.allo.transplantation.when.and.how.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366491/mikkael.a.sekeres.hmas.when.and.how.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366490/faculty.presenters.panel.discussion.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366489/mara.dez.campelo.how.to.best.define.del.%285q%29.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366488/eric.solary.why.and.how.should.we.target.mature.cells.of.the.clone.in.chronic.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366487/faculty.presenters.panel.discussion.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366486/mara.dez.campelo.treatment.patterns.and.overall.survival.in.patients.with.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366485/jaroslaw.maciejewski.the.best.soup.has.many.ingredients.prognosis.in.mds.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366484/rami.s.komrokji.the.best.clinical.prognostic.system.for.mds.is.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366483/torsten.haferlach.the.basics.are.not.enough.how.molecular.genetics.make.the.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366482/faculty.presenters.panel.discussion.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366481/anne.sophie.kubasch.artificial.intelligence.for.treatment.and.prognosis.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366480/faculty.presenters.panel.discussion.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366479/valeria.santini.the.case.of.iron.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366478/katherine.king.impact.of.the.microbiome.on.hematopoiesis.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366477/shahram.kordasti.the.immunome.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366476/faculty.presenters.panel.discussion.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366475/luca.malcovati.clonal.cytopenia.of.undetermined.significance.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/8th-translational-research-conference-myelodyspla/366474/klaus.metzeler.chip.clonal.hematopoiesis.of.not-so-indeterminate.potential.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366473/faculty.presenters.panel.discussion.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366472/vi.lam.brief.oral.communication.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366471/tanya.siddiqi.car-t.cell.therapy.in.cll.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366470/jennifer.brown.mapk.erk.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366469/faculty.presenters.panel.discussion.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366468/arnon.kater.brief.oral.communication.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366467/marco.ruella.car-t.cell.immunotherapy.for.cll.a.chance.for.cure.in.the.era.of.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366466/john.gribben.future.of.pi3ks.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366465/faculty.presenters.panel.discussion.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366464/kristyna.zavacka.brief.oral.communication.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366463/anthony.mato.non-covalent.btk.inhibitors.%28arq531.mk1026.pirtobrutinib%29.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366462/adrian.wiestner.resistance.to.covalent.btk.inhibitors.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366461/faculty.presenters.panel.discussion.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366460/alessandra.tedeschi.zanubrutinib.and.combinations.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366459/richard.furman.acalabrutinib.and.combinations.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366458/faculty.presenters.panel.discussion.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366457/fabrizio.mavilia.brief.oral.communication.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366456/talha.munir.defined.duration.vs.mrd.driven.time-limited.therapy.html 2022-06-15 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366455/john.allan.btk.bcl-2.combinations.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366454/othman.al-sawaf.venetoclax.antibody.combinations.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366453/faculty.presenters.panel.discussion.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366452/emma.kennedy.brief.oral.communication.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366451/arnon.kater.reversed.microenvironmental.stimuli.how.cll.cells.suppress.t.cell.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366449/dimitar.efremov.effects.of.cxcr4-.and.macrophage-derived.signals.on.the.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366448/chris.pepper.cd49d.a.biologically.relevant.molecule.and.important.prognostic.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366447/faculty.presenters.panel.discussion.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366446/anna.andrzejczak.brief.oral.communication.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366445/davide.rossi.prognostic.role.of.rare.gene.mutations.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366444/richard.rosenquist.brandell.ig.mutational.status.and.gene.mutations.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366443/faculty.presenters.panel.discussion.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366442/selena.mimmi.brief.oral.communication.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366441/andrew.rawstron.how.do.we.look.at.mrd.in.2021.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366440/panagiotis.baliakas.complex.karyotype.what.is.relevant.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366439/sarka.pospisilova.low.level.tp53.clones.what.is.the.significance.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366438/faculty.presenters.panel.discussion.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366436/silvia.deaglio.richters.transformation.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366435/kostas.stamatopoulos.what.is.the.definition.of.high.risk.cll.now.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/2nd-translational-research-conference-chronic-lym/366434/alberto.orfao.mbl.low.vs.high.count.html 2022-06-14 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366269/faculty.presenters.panel.discussion.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366268/kimmo.porkka.brief.oral.communication.a.phase.ib.study.exploring.mdm2.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366267/raphael.itzykson.case-based.lecture.which.aml.patients.should.be.transplanted.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366265/rita.assi.case-based.lecture.post-transplant.maintenance.therapies.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366264/pierre.fenaux.interactive.case.is.there.a.place.for.transplantation.in.aml.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366263/faculty.presenters.panel.discussion.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366262/andrew.brunner.brief.oral.communication.efficacy.and.safety.of.sabatolimab.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366261/patrick.a.patrick.a.brown.interactive.case.combining.checkpoints.inhibitors.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366260/fabio.ciceri.case-based.lecture.new.developments.in.car-t.and.nk.cell.therapy.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366258/faculty.presenters.discussion.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366257/claire.roddie.car.t-cell.as.a.bridge.to.transplant.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366256/shannon.maude.car.t-cell.is.a.curative.all.therapy.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366255/herv.dombret.introduction.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366254/faculty.presenters.discussion.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366253/nicholas.short.post-remission.and.maintenance.treatment.for.non-transplanted.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366252/sabina.chiaretti.which.patients.with.ph%2B.all.should.be.transplanted.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366251/yves.chalandon.initial.treatment.for.ph%2B.all.chemo.free.or.not.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366250/nicola.gkbuget.introduction.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366249/faculty.presenters.panel.discussion.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366248/christian.recher.brief.oral.communication.agile.a.global.randomized.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366247/eytan.stein.interactive.case.the.future.of.idh.inhibitors.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366246/jorge.sierra.case-based.lecture.innovative.treatment.for.relapsed.aml.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366245/gail.roboz.case-based.lecture.maintenance.therapy.without.transplant.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366244/alexander.perl.case-based.lecture.how.to.treat.flt3.mutant.aml.at.diagnosis.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366243/eunice.wang.interactive.case.the.future.of.menin.inhibitors.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366242/faculty.presenters.discussion.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366241/sebastian.giebel.the.value.of.pre-transplant.mrd.in.all.and.how.to.use.it.html 2022-06-09 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366240/roland.b.walter.the.value.of.pre-transplant.mrd.in.aml.and.how.to.use.it.html 2022-06-09 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366239/charles.craddock.introduction.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366238/faculty.presenters.discussion.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366237/courtney.dinardo.con.the.reasons.to.favour.venetoclax-azaitidine.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366236/farhad.ravandi-kashani.introduction.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366235/faculty.presenters.panel.discussion.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366233/richard.stone.interactive.case.what.is.refractory.aml.and.what.to.do.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366232/david.sallman.case-based.lecture.p53.mutant.leukaemia.is.there.a.good.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366231/charles.craddock.case-based.lecture.who.should.receive.a.ric.transplant.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366230/paresh.vyas.case-based.lecture.non-intensive.treatment.for.aml.to.target.or.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366229/lionel.ades.interactive.case.how.to.decide.fitness.for.intensive.aml.therapy.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366228/faculty.presenters.panel.discussion.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366227/farhad.ravandi-kashani.interactive.case.evaluation.of.response.in.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366226/adriano.venditti.interactive.case.mrd.negativity.as.therapeutic.goal.in.aml.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366225/jan.trka.case-based.lecture.methods.for.mrd.assessment.in.all.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366224/faculty.presenters.panel.discussion.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366223/wendy.stock.case-based.lecture.early.t-cell.precursor.all.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366222/emily.curran.interactive.case.ph-like.all.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366221/marielle.wondergem.case-based.lecture.mpal.with.t%289.22%29.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366220/lars.bullinger.case-based.lecture.tp53-mutated.aml.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366219/faculty.presenters.discussion.html 2022-06-09 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366218/david.spencer.will.standard.aml.cytogenetics.become.prehistoric.html 2022-06-09 monthly 0.5 https://elearning.esh.org/esh/2022/3rd-how-to-diagnose-and-treat-acute-leukaemias/366217/gert.ossenkoppele.introduction.html 2022-06-08 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349666/faculty.presenters.panel.discussion.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349665/pieternella.%28elly%29.lugtenburg.selected.brief.oral.communication.antitumor.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349664/frederick.locke.car.t-cell.therapies.in.mantle.cell.lymphoma.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349663/caron.jacobson.update.car.t-cells.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349662/faculty.presenters.panel.discussion.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349661/laurie.sehn.tailoring.therapy.in.frontline.dlbcl.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349660/michael.hallek.combining.pathway.inhibitors.in.the.treatment.of.cll.html 2022-01-17 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349659/wyndham.wilson.role.of.bcr.inhibitors.in.the.treatment.of.lymphoma.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349658/faculty.presenters.panel.discussion.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349657/marek.mraz.selected.brief.oral.communication.ibrutinib.blocks.cd40.signalling.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349656/david.weinstock.oncogenic.signaling.in.t-cell.lymphoma.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349655/adrian.wiestner.oncogenic.signaling.in.cll.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349653/faculty.presenters.panel.discussion.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349652/anand.d.selected.brief.oral.communication.clinical.application.of.an.ex-vivo.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349651/andrew.rawstron.role.of.ctdna.mrd.in.the.clinic.html 2022-01-17 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349650/bertrand.nadel.single.cell.analyses.in.lymphoma.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349649/faculty.presenters.panel.discussion.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349648/arief.gunawan.selected.brief.oral.communication.the.myc.miz1.complexes.are.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349647/faculty.presenters.panel.discussion.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349646/daniel.hodson.selected.brief.oral.communication.sequential.inverse.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349645/jos.ignacio.epigenetic.alterations.in.mantle.cell.lymphoma.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349644/ari.melnick.role.of.epigenetic.aberrations.in.dlbcl.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349643/faculty.presenters.panel.discussion.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349642/othman.al-sawaf.selected.brief.oral.communication.outcome.prediction.in.cll.by.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349641/andrew.davies.targeting.genetic.alterations.in.lymphoma.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349640/elias.campo.the.genetic.landscape.of.mantle.cell.lymphoma.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349639/faculty.presenters.panel.discussion.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349638/vronique.baud.selected.brief.oral.communication.the.alternative.relb.nfkb.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/6th-translational-research-conference-lymphoid-mal/349637/david.scott.dissecting.gcb.dlbcl.and.its.therapeutic.implications.html 2022-01-18 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349636/akriti.jain.incidence.of.pleural.effusion.with.dasatinib.and.the.effect.of.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349635/faculty.presenters.discussion.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349634/marcel.lorch.health-related.quality.of.life.%28hrqol%29.in.cml-patients.at.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349633/breccia.massimo.the.effect.of.comorbidities.on.response.outcomes.with.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349632/faculty.presenters.discussion.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349631/fabio.efficace.keynote.presentation.the.role.of.patient.reported.outcomes.in.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349630/susanne.saussele.introduction.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349629/faculty.presenters.discussion.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349628/benjamin.ebert.the.biology.and.implications.of.clonal.hematopoiesis.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349627/tim.brmmendorf.introduction.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349626/faculty.presenters.discussion.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349625/margarita.gurianova.first.interim.results.of.the.russian.prospective.study.of.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349624/vincent.alcazer.molecular.relapse.after.tki.cessation.for.treatment-free.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349623/faculty.presenters.discussion.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349621/jorge.cortes.updated.results.from.phase.1.study.of.vodobatinib.a.novel.oral.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349620/ingo.roeder.mathematical.modelling.of.immune.response.in.cml.patients.suggests.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349619/jorge.cortes.optic.primary.analysis.a.dose-optimization.study.of.3.starting.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349618/faculty.presenters.discussion.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349617/delphine.rea.keynote.presentation.the.future.of.cml.therapy.are.more.tkis.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349616/franck.emmanuel.nicolini.introduction.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349614/faculty.presenters.discussion.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349613/giuseppe.saglio.special.lecture.5.cml.beyond.tki.therapy.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349612/robert.gale.presentation.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349611/faculty.presenters.discussion.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349610/peter.van.multimodal.single-cell.analysis.delineates.the.evolution.of.myeloid.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349609/greg.wang.use.of.cutting-edge.techniques.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349608/faculty.presenters.introduction.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349607/faculty.presenters.general.discussion.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349606/aleksandar.radujkovic.the.role.and.outcome.of.stem.cell.transplant.for.blast.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349605/koji.sasaki.treatment.of.lymphoid.in.blast.phase.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349604/mhairi.copland.treatment.of.myeloid.in.blast.phase.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349603/robert.hasserjian.challenges.and.controversies.in.the.diagnosis.and.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349602/simona.soverini.mutations.genetics.cytogenetics.and.their.prognostic.role.in.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349601/rdiger.hehlmann.introductory.overview.-.concepts.and.challenges.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349600/faculty.presenters.discussion.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349599/susan.branford.janet.rowley.prize.special.lecture.bcr-abl1.dependent.and.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349598/jerry.radich.janet.rowley.prize.presentation.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349597/faculty.presenters.discussion.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349596/virginia.camacho.leukemic.cytokines.co-opt.regulatory.t.cell.and.th17.immunity.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349595/valeriya.kuznetsova.perturbed.function.of.natural.killer.cells.by.inflammatory.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349594/catherine.smith.does.ph%2B.in.aml.exist.or.not.vs.cml.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349593/faculty.presenters.discussion.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349592/kazuhito.naka.the.lysophospholipid.metabolism.enzyme.gdpd3.maintains.chronic.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349591/faculty.presenters.discussion.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349590/bhatia.ravi.keynote.presentation.evolution.of.our.learning.in.stem.cell.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349589/bing.carter.introduction.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349588/faculty.presenters.discussion.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349587/craig.jordan.bcl2-mediated.metabolic.properties.of.leukemia.stem.cells.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349586/brian.huntly.introduction.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349585/martha.zarou.impact.of.inhibition.of.folate.metabolism.in.leukaemic.stem.cells.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349584/faculty.presenters.discussion.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349583/catriona.jamieson.detection.and.targeting.of.malignant.deaminase.activation.in.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349582/tomasz.skorski.introduction.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/23rd-annual-john-goldman-conference-on-chronic-mye/349581/hughes.tim.icmlf.-.a.review.html 2022-01-19 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348430/faculty.presenters.panel.discussion.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348429/sarah.tasian.ph-like.all.patient.management.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348428/nicholas.short.next.generation.tkis.for.ph%2B.all.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348427/yves.chalandon.which.tki-chemo-transplant.cocktail.for.ph%2B.all.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348426/faculty.presenters.panel.discussion.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348425/anjali.advani.novel.therapies.for.t-all.ll.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348424/elisabeth.macintyre.should.t-ll.and.t-alls.be.treated.on.the.same.protocols.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348423/elizabeth.raetz.risk.factors.in.t-all.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348422/dieter.hoelzer.keynote.management.of.t-ll.patients.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348421/faculty.presenters.panel.discussion.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348420/sabina.chiaretti.frontline.chemo-free.regimens.in.ph%2B.all.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348419/faculty.presenters.panel.discussion.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348418/david.marks.post-transplant.interventions.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348417/claire.roddie.new.cars.for.b-cell.precursor.all.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348416/faculty.presenters.panel.discussion.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348415/quentin.van.selected.brief.oral.communication.oncogenic.cooperation.between.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348414/christian.hurtz.selected.brief.oral.communication.pharmacologic.inhibition.of.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348413/matthew.j.wieduwilt.new.all.drugs.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348412/stephen.p.hunger.tki.use.in.ph%2B.ph-like.diseases.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348411/adele.k.fielding.the.critical.role.of.microenvironment.in.all.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348410/faculty.presenters.panel.discussion.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348409/jordi.ribera.selected.brief.oral.communication.t%281.19%29%28q23.p13%29.tcf3-pbx1.may.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348408/elias.jabbour.management.of.relapsed.all.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348407/rachael.hough.treatment.issues.in.teenagers.and.young.adults.all.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348406/faculty.presenters.panel.discussion.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348405/jan.zuna.ig-tcr.versus.bcr-abl1.mrd.in.ph%2B.all.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348404/faculty.presenters.panel.discussion.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348403/jacques.ghysdael.targeting.cd3.in.t-all.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348402/jan.cools.aberrant.signaling.in.t-cell.all.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348401/adolfo.ferrando.molecular.mechanisms.of.t-all.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348400/faculty.presenters.panel.discussion.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348399/lai.chan.selected.brief.oral.communication.mechanistic.basis.for.targeting.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348398/charles.mullighan.targeting.novel.b-cell.progenitor.all.subtypes.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348397/ester.mejstrikova.myeloid.switch.of.b-cell.precursor.all.subtypes.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348396/henrik.lilljebjrn.transcriptional.landscape.of.b-cell.precursor.all.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-acute-lympho/348395/scott.armstrong.keynote.hox.gene.deregulation.in.all.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348394/faculty.presenters.discussion.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348393/carl.june.the.role.of.car.t-cell.therapy.in.cancer.in.2030.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348392/faculty.presenters.introduction.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348391/faculty.presenters.panel.discussion.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348390/paul.maciocia.perspectives.t-cell.non-hodgkins.lymphoma.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348389/marie.jos.kersten.perspectives.mantle.cell.lymphoma.and.follicular.lymphoma.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348388/faculty.presenters.panel.discussion.html 2022-07-05 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348387/sara.ghorashian.case-based.lecture.car-t.for.bridging.to.allogeneic.transplant.html 2022-07-05 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348386/andr.baruchel.case-based.lecture.car-t.after.allogeneic.transplant.html 2022-07-05 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348385/peter.bader.case-based.lecture.car.t-cell.therapy.in.childhood.all.what.can.we.html 2022-07-05 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348384/faculty.presenters.discussion.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348383/marie.jos.kersten.car.t-cells.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348382/martin.hutchings.bispecific.antibodies.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348381/bertram.glass.allo-transplant.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348380/john.gribben.introduction.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348379/faculty.presenters.panel.discussion.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348378/richard.greil.case-based.lecture.bispecifics.in.first.line.dlbcl.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348377/stephan.schuster.case-based.lecture.bispecifics.in.relapsed.dlbcl.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348376/pieternella.%28elly%29.lugtenburg.short.oral.presentation.antitumor.activity.and.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348375/marion.subklewe.interactive.case.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348374/faculty.presenters.live.discussion.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348373/faculty.presenters.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348372/faculty.presenters.discussion.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348371/sham.mailankody.cars.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348370/hermann.einsele.bispecific.antibodies.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348369/mara-victoria.mateos.introduction.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348368/faculty.presenters.panel.discussion.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348367/mara-victoria.mateos.interactive.case.multiple.myeloma.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348366/suzette.girgis.short.oral.presentation.teclistamab.and.talquetamab.modulate.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348365/saad.z.usmani.short.oral.presentation.ciltacabtagene.autoleucel.a.b-cell.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348364/sham.mailankody.case-based.lecture.bcma.targeted.car.t-cell.therapy.for.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348363/niels.van.de.donk.short.oral.presentation.talquetamab.a.g.protein-coupled.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348362/mara-victoria.mateos.interactive.case.multiple.myeloma.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348361/faculty.presenters.panel.discussion.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348360/christian.chabannon.perspectives.learning.from.doing.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348359/marion.subklewe.case-based.lecture.hematotoxicity.early.%26.late.cytopenia.and.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348358/stephan.grupp.case-based.lecture.novel.strategies.to.prevent.treat.crs.icans.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348357/peter.schellongowski.interactive.case.icans.grading.and.management.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348356/ulrich.jger.interactive.case.crs.grading.and.management.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348355/faculty.presenters.panel.discussion.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348354/gilles.salles.perspectives.ongoing.clinical.trials.and.developments.in.dlbcl.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348353/adrian.minson.short.oral.presentation.longitudinal.car.t-cell.detection.and.html 2021-12-20 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348352/peter.borchmann.interactive.case.monitoring.car.expansion.and.persistence.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/how-i-manage-car-t-therapies-and-bispecific-antibo/348351/catherine.thieblemont.case-based.lecture.real.world.data.patient.selection.and.html 2022-01-06 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348350/faculty.presenters.panel.discussion.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348349/danuta.jarocha.inclusion.of.a.shrna.targeting.bcl11a.into.a.-globin.expressing.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348348/lucia.de.franceschi.new.approcahes.for.managing.scd.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348347/uwe.platzbecker.new.approaches.to.anemia.of.mds.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348346/tomas.ganz.iron.restrictided.erythropoiesis.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348345/faculty.presenters.panel.discussion.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348344/rafael.bejar.focus.on.immunotherapy.and.car-t.in.mds.dream.or.reality.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348343/mitchell.j.weiss.gene.therapy.in.hemoglobinophaties.vs.gene.editing.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348342/vip.viprakasit.who.is.the.best.patient.candidate.to.gene.therapy.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348341/faculty.presenters.panel.discussion.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348340/du.a.darabsheh.haploidentical.stem.cell.transplantation.for.high.risk.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348339/lydie.da.dba.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348338/faculty.presenters.panel.discussion.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348337/graa.porto.atypical.microcytic.anemias.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348336/martina.muckenthaler.macrophage.and.iron.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348335/faculty.presenters.panel.discussion.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348334/alessandra.balduini.bm.3d.modelling.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348333/faculty.presenters.eryptosis.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348332/lionel.blanc.erythroid.progenitors.though.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348331/faculty.presenters.panel.discussion.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348330/prashant.sharma.acquired.-thalassemia.%28hbh.disease%29.in.a.patient.with.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348329/mark.fleming.congenital.sideroblastic.anemias.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348328/faculty.presenters.panel.discussion.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348327/ismael.boussaid.why.is.the.translation.selectivity.of.low.ribosome.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348326/michaela.fontenay.into.the.mechanisms.of.dyserythopoiesis.the.sf3b1.mutation.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348325/faculty.presenters.panel.discussion.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348324/eric.solary.hematopoiesis.in.mds.and.covid.19.infection.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348323/giancarlo.liumbruno.focus.on.blood.management.during.covid.outbreak.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348322/alexander.drakesmith.iron.and.viral.infection.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348321/faculty.presenters.panel.discussion.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-translational-research-conference-erythropoies/348320/antonella.nai.targeting.tfr2.a.novel.erythropoiesis-stimulating.approach.html 2021-12-23 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348318/faculty.presenters.panel.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348317/elena.vuelta.ramos.brief.oral.communication.the.crispr.cas9.system.abolishes.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348316/naveen.pemmaraju.interactive.case.blastic.plasmacytoid.dendritic.cell.neoplasms.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348315/franck.emmanuel.nicolini.interactive.case.treatment-free.remission.strategy.in.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348314/andreas.buchert.case-based.lecture.interferon.alpha.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348313/nick.cross.case-based.lecture.new.technologies.in.monitoring.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348312/susanne.saussele.interactive.case.prognostic.factors.for.successful.tfr.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348311/faculty.presenters.panel.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348310/francesco.passamonti.brief.oral.communication.cpi-0610.a.bromodomain.and.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348309/srdan.verstovsek.interactive.case.venetoclax.data.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348308/donal.mclornan.interactive.case.cmml.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348307/dragana.milojkovic.case-based.lecture.blast.crisis.in.cml.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348305/andreas.reiter.case-based.lecture.management.of.rare.translocations.mpn.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348304/faculty.presenters.panel.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348303/damien.luque.paz.brief.oral.communication.genomic.analysis.of.primary.and.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348302/haifa.kathrin.al-ali.interactive.case.when.to.switch.from.ruxolitinib.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348301/john.mascarenhas.case-based.lecture.evolving.therapies.for.myelofibrosis.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348300/srdan.verstovsek.case-based.lecture.jak.inhibitors.in.combination.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348299/adam.mead.case-based.lecture.other.jak.inhibitors.%28momelotinib.pacritinib%29.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348298/ruben.mesa.interactive.case.therapy.of.myelofibrosis.with.approved.agents.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348297/faculty.presenters.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348296/delphine.rea.no.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348295/jane.apperley.yes.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348294/andreas.hochhaus.introduction.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348293/faculty.presenters.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348292/martin.griesshammer.interferon.alpha.in.pregnancies.of.myeloproliferative.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348291/ekaterina.chelysheva.russian.recommendations.to.manage.pregnancy.in.cml.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348290/elisabetta.abruzzese.pregnancy.and.tki.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348289/jane.apperley.introduction.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348288/faculty.presenters.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348287/florian.heidel.infections.in.mpn.-.patients.survey.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348286/delphine.rea.covid-19.and.cml.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348285/ruben.mesa.introduction.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348284/faculty.presenters.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348283/claire.harrison.no.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348282/florian.heidel.yes.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348281/ruben.mesa.introduction.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348280/faculty.presenters.panel.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348279/emmanuel.messas.case-based.lecture.vascular.risk.assessment.in.mpn.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348278/paola.guglielmelli.case-based.lecture.pre-myelofibrosis.%26.myelofibrosis.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348277/naseema.gangat.case-based.lecture.polycythemia.vera.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348276/alberto.alvarez-larrn.case-based.lecture.essential.thrombocythemia.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348275/francesco.passamonti.interactive.case.mpn.risk.stratification.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348274/faculty.presenters.panel.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348273/peter.westerweel.interactive.cml.case.double.trouble.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348272/gianantonio.rosti.case-based.lecture.salvage.treatment.and.other.lines.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348271/tomasz.sacha.case-based.lecture.the.use.of.imatinib.generics.in.the.cml.therapy.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348270/giuseppe.saglio.case-based.lecture.first.line.tkis.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348269/franois-xavier.mahon.interactive.case.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348268/faculty.presenters.panel.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348267/abdulraheem.yacoub.brief.oral.communication.addition.of.parsaclisib.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348266/marina.kremyanskaya.interactive.case.hepcidin.agonists.in.polycythemia.vera.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348265/brady.l.stein.case-based.lecture.use.of.ruxolitinib.in.essential.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348263/alessandro.vannucchi.case-based.lecture.hydroxyurea.resistance.to.hydroxyurea.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/2nd-how-to-diagnose-and-treat-cml-mpn/348262/jean-jacques.kiladjian.interactive.case.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348261/faculty.presenters.panel.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348260/lin-pierre.zhao.mds.cmml.with.tet2.or.idh.mutations.are.associated.with.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348259/faculty.presenters.panel.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348258/klaus.metzeler.how.to.target.chip.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348255/valeria.santini.current.mds.cmml.clinical.trials.in.europe.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348254/faculty.presenters.panel.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348253/andrew.brunner.efficacy.and.safety.of.sabatolimab.%28mbg453%29.in.combination.with.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348252/uwe.platzbecker.novel.strategies.to.treat.cytopenia.in.low.risk.mds.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348251/valeria.santini.management.of.hma.failure.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348250/pierre.fenaux.strategies.to.improve.hma.based.therapy.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348249/lionel.ades.higher.risk.mds.lessons.from.elderly.amla.renewed.role.for.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348248/faculty.presenters.panel.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348247/raphael.itzykson.current.treatment.guidelines.for.cmml.and.rare.subtypes.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348246/mikkael.a.sekeres.hmas.when.and.how.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348245/valeria.santini.esa.and.other.growth.factors.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348244/eva.hellstrm-.lindberg.overview.of.mds.treatment.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348243/faculty.presenters.specific.subtypes.of.mds.based.on.morphology.and.molecular.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348242/klaus.geissler.specific.subtypes.of.mds.based.on.morphology.and.molecular.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348241/aristoteles.giagounidis.specific.subtypes.of.mds.based.on.morphology.and.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348240/eric.solary.specific.subtypes.of.mds.based.on.morphology.and.molecular.biology.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348239/faculty.presenters.panel.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348238/guillermo.sanz.debate.is.ngs.useful.in.mds.-.no.html 2021-12-29 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348237/pierre.fenaux.roundtable.response.criteria.%28with.recent.proposed.changes.iwg.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348236/reinhard.stauder.role.of.comorbidities.and.quality.of.life.in.prognosis.new.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348235/michael.pfeilstcker.examining.prognostic.indicators.in.mds.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348232/uwe.platzbecker.controversial.debate.genetics.versus.epigenetics.in.myeloid.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348231/faculty.presenters.panel.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348230/shahram.kordasti.immunological.mess.in.mds.is.there.a.target.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348229/ulrike.baschant.bone.biology.and.the.osteo-hematopoietic.niche.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348228/faculty.presenters.panel.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348227/torsten.haferlach.druggable.molecular.targets.in.mds.and.elderly.aml%29.%28idh.tp53%29.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348226/oliver.kosmider.multiple.acquired.clonal.steps.to.mds.molecular.architecture.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348225/faculty.presenters.panel.discussion.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348224/jaroslaw.maciejewski.relationships.between.inherited.and.acquired.predisposition.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2021/7th-translational-research-conference-myelodysplas/348223/maria.teresa.voso.therapy.related.mds.and.other.environmental.factors.in.mds.html 2021-12-22 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347828/georg.he.con.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347827/faculty.presenters.general.discussion.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347826/barbara.eichhorst.time.limited.vs.continuous.treatments.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347825/william.wierda.sequential.vs.combination.treatments.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347824/peter.hillmen.mrd.as.a.dynamic.endpoint.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347823/faculty.presenters.general.discussion.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347821/j.f.seymour.venetoclax.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347820/jennifer.brown.pi3k.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347819/davide.rossi.clonal.evolution.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347818/faculty.presenters.general.discussion.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347817/stefano.fagiuoli.gastroenterology.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347816/michele.bartoletti.infectious.diseases.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347815/nicole.le.dermatologist.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347814/javid.moslehi.cardiologist.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347813/faculty.presenters.general.discussion.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347812/stephan.schuster.car-t.cells.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347811/alexey.danilov.novel.inhibitors.at.preclinical.level.%28mcl1.%26cdk.inhibitors%29.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347810/peter.hillmen.next.generation.pi3k.inhibitors.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347809/faculty.presenters.general.discussion.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347808/adrian.wiestner.immunomodulatory.effects.of.kinase.inhibitors.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347807/arnon.kater.role.of.t.cells.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347806/faculty.presenters.general.discussion.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347805/julia.von.short.oral.communicationsequential.treatment.with.bendamustine.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347804/lindsey.roeker.venetoclax.pi3k.real.world.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347803/loc.ysebaert.ibrutinib.real.world.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347802/alessandra.tedeschi.ibrutinib.trials.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347801/faculty.presenters.general.discussion.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347799/j.f.seymour.murano.and.mrd.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347798/florence.cymbalista.ibrutinib.for.a.small.subgroup.only.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347797/jennifer.woyach.ibrutinib.for.everybody.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347796/faculty.presenters.general.discussion.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347795/anthony.mato.next.generation.btk.inhibitors.%28covalent.non-covalent.%29.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347794/kostas.stamatopoulos.the.latest.news.of.stereotypes.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347793/faculty.presenters.general.discussion.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347792/antonio.cuneo.risk.stratification.in.cll.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347791/jennifer.woyach.ibrutinib.resistance.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/1st-translational-research-conference-chronic-lymp/347790/jennifer.brown.genetic.predisposition.html 2021-12-16 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347789/faculty.presenters.discussion.q.%26.a.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347788/laura.korin.bone.marrow.microenvironment.lymphocytes.measured.by.flow.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347787/stephen.ansell.checkpoint.inhibitors.and.bispecifics.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347786/renier.brentjens.next.generation.car-t.cells.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347785/faculty.presenters.discussion.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347784/marco.ladetto.pro.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347783/faculty.presenters.discussion.q.%26.a.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347782/miguel.cid.lpez.improved.personalized.survival.prediction.of.patients.with.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347781/stephen.schuster.car-t.cells.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347780/jason.westin.relapse.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347779/thierry.molina.diagnostics.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347778/faculty.presenters.discussion.q.%26.a.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347777/ezzat.elhassadi.tp53.status.in.mantle.cell.lymphoma.%28mcl%29.-.a.10-year.single.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347776/martin.dreyling.salvage.treatment.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347775/steven.le.first.line.treatment.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347774/elias.campo.diagnostics.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347773/faculty.presenters.discussion.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347772/izidore.s.lossos.what.we.can.learn.from.a.single.case.of.enmzl.with.multiple.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347771/faculty.presenters.discussion.q.%26.a.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347770/catia.reis.macroglobulinemia.waldenstrm.a.single.centre.experience.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347769/jorge.castillo.waldenstrom.macroglobulinemia.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347768/maurilio.ponzoni.diagnostics.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347767/faculty.presenters.discussion.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347766/umberto.vitolo.con.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347765/nathan.fowler.pro.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347764/gilles.salles.introduction.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347763/faculty.presenters.discussion.q.%26.a.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347762/emmanuel.bachy.challenges.in.fl.pod24.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347761/stefano.luminari.first.line.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347758/gandhi.laurent.damaj.allogeneic.stem.cell.transplantation.for.ptcl.patients.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347757/camille.laurent.introduction.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347756/faculty.presenters.discussion.q.%26.a.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347755/pier.luigi.zinzani.salvage.treatment.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347754/owen.a.oconnor.first.line.treatment.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347753/faculty.presenters.discussion.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347752/peter.johnson.con.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347751/joachim.yahalom.pro.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347750/marc.andre.introduction.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347749/faculty.presenters.discussion.q.%26.a.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347748/maria.eduarda.couto.refractory.relapsed.hodgkin.lymphoma.the.profile.of.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347747/pier.luigi.zinzani.relapsed.disease.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347746/andreas.engert.first.line.treatment.-.intermediate.advanced.stages.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347745/marc.andre.first.line.treatment.-.early.stages.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/how-to-diagnose-and-treat-lymphoma/347744/stefano.pileri.diagnostics.-.the.boundaries.of.hodgkin.lymphoma.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336807/faculty.presenters.discussion.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336806/lucy.godley.genetic.predisposition.for.myeloid.malignancies.clinical.management.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336805/matthew.porteus.genetic.editing.of.haematopoietic.stem.cells.are.we.getting.html 2021-09-24 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336804/faculty.presenters.discussion.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336803/antonio.risitano.novel.complement.inhibitors.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336802/faculty.presenters.discussion.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336801/britta.hchsmann.how.to.handle.moderate.aplastic.anaemia.html 2021-09-24 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336800/andrea.bacigalupo.transplantation.for.acquired.saa.are.we.making.progress.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336799/faculty.presenters.discussion.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336798/aikaterini.poulaki.selected.brief.oral.communication.the.metabolomic.status.of.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336797/jens.panse.health-related.quality.of.life.and.its.assessment.in.aplastic.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336796/jaroslaw.maciejewski.impact.of.clonal.haematopoiesis.in.aplastic.anaemia.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336795/alan.list.innate.immunity.and.clonal.evolution.in.bone.marrow.failure.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336794/lucio.luzzatto.keynote.discussion.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336793/lucio.luzzatto.keynote.presentation.pnh.as.paradigm.of.the.mutability.of.bone.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336792/faculty.presenters.discussion.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336791/kirsten.fairfax.selected.brief.oral.communication.single.cell.eqtl.mapping.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336790/austin.kulasekararaj.modern.diagnosis.of.aplastic.anaemia.and.pnh.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336789/rosario.notaro.pathophysiology.of.pnh.html 2021-09-24 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336788/neal.young.pathophysiology.of.immune.aplastic.anaemia.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336786/faculty.presenters.discussion.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336785/abhishek.mangaonkar.selected.brief.oral.communication.natural.history.and.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336784/inderjeet.dokal.dyskeratosis.congenita.and.related.haematological.diseases.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336783/faculty.presenters.discussion.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336782/yigal.dror.management.of.ribosomopathies.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336781/vijay.sankaran.diamond-blackfan.anaemia.%28dba%29.ribosomes.and.haematopoiesis.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336780/faculty.presenters.discussion.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336779/carlo.dufour.classical.and.new.treatment.of.fanconi.anaemia.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/translational-research-conference-bone-marrow-fail/336778/ashvind.prabahran.selected.brief.oral.communication.immunologic.basis.to.poor.html 2021-09-22 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336776/breccia.massimo.selected.abstract.high.body.mass.index.%28bmi%29.and.treatment.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336775/james.januzzi.selected.abstract.retrospective.independent.review.of.arterial.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336773/sabira.kurtovic.cml.management.in.war.and.peace.lessons.that.shaped.future.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336771/faculty.presenters.voting.and.discussion.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336770/giuseppe.saglio.for.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336768/faculty.presenters.discussion.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336767/andrew.janowczyk.computational.pathology.towards.precision.medicine.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336766/giovanni.martinelli.discussion.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336765/melissa.ilardo.human.evolutionary.genomic.medicine.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336764/faculty.presenters.discussion.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336763/robert.gale.selected.abstract.best.duration.of.deep.molecular.remission.to.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336762/giora.sharf.selected.abstract.chronic.myeloid.leukemia.patients.concerns.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336761/delphine.agnes.discussion.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336760/agnes.yong.keynote.presentationsuccessful.tfr.in.cml.is.it.predictable.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336759/faculty.presenters.discussion.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336758/katia.pagnano.selected.abstract.efficacy.and.safety.of.pioglitazone.in.a.phase.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336757/johan.richter.selected.abstract.high.level.of.successful.tki.discontinuation.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336755/vaidehi.krishnan.high.dimensional.single-cell.analysis.to.predict.tfr.at.the.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336753/faculty.presenters.discussion.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336752/sung-hyun.kim.selected.abstract.radotinib.treatment.for.patients.with.chronic.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336751/jorge.cortes.selected.abstract.activity.of.vodobatinib.a.novel.oral.bcr-abl1.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336750/giantonio.rosti.discussion.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336749/andreas.hochhaus.keynote.presentation.citius.altius.fortius.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336748/faculty.presenters.discussion.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336747/oliver.schilling.investigating.secretome.and.sheddome.composition.with.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336746/sara.zanivan.ms-proteomics.to.uncover.the.complexity.and.function.of.the.cell.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336745/faculty.presenters.discussion.html 2021-12-08 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336744/roland.b.walter.bispecific.antibodies.in.leukemia.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336743/justin.kline.checkpoint.inhibitors.html 2021-11-29 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336741/david.scheinberg.leukemia.vaccines.html 2021-11-26 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336740/faculty.presenters.discussion.html 2021-12-09 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336739/eleonora.mkel.selected.abstract.discovery.of.novel.cip2a.variant.%28nociva%29.and.html 2021-11-26 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336738/shady.adnan.awad.selected.abstract.unx1.mutations.in.blast.phase.chronic.html 2021-11-26 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336736/daniel.bolon.keynote.presentationcrispr.predictions.about.relaps.in.cml.html 2021-11-26 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336735/rob.welner.discussion.html 2021-11-26 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336734/bhatia.ravi.special.lecturethe.seed.and.the.soil.-.the.leukemia.stem.cell.in.html 2021-11-26 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336732/daniela.krause.discussion.html 2021-11-26 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336731/ralf.adams.keynote.presentationregulation.of.hematopoietic.stem.and.progenitor.html 2021-11-26 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336730/faculty.presenters.discussion.html 2021-11-26 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336729/johan.richter.selected.abstract.molecular.status.36.months.after.html 2021-11-26 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336728/jorge.cortes.selected.abstract.interim.analysis.from.the.optic.trial.a.html 2021-11-26 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336727/bac.viet.le.selected.abstract.tgfr.-.smad3.signaling.protects.cml.and.other.html 2021-11-26 monthly 0.5 https://elearning.esh.org/esh/2020/22nd-annual-john-goldman-conference-on-chronic-mye/336726/susan.branford.selected.abstract.targeted.rna-based.gene.sequencing.identifies.html 2021-11-26 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336538/faculty.presenters.discussion.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336537/francesca.gay.the.future.is.now.science.fiction.thereafter.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336536/kenneth.c.anderson.there.is.no.future.without.past.html 2021-12-10 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336535/faculty.presenters.panel.discussion.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336534/faculty.presenters.brief.oral.communication.-.reductions.in.absolute.iflc.and.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336533/elena.zamagni.case-based.lecture.how.to.treat.bone.disease.in.multiple.myeloma.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336532/stefan.knop.case-based.lecture.how.i.treat.mgrs.and.mgus.with.neuropathy.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336531/giampaolo.merlini.case-based.lecture.how.i.treat.amyloidosis.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336530/faculty.presenters.panel.discussion.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336529/faculty.presenters.brief.oral.communication.-.teclistamab.a.b-cell.maturation.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336528/deepu.madduri.brief.oral.communication.-.cartitude-1.a.phase.1b.2.study.of.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336527/eric.smith.case-based.lecture.future.immunotherapies.in.multiple.myeloma.html 2021-12-10 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336526/niels.van.de.donk.case-based.lecture.antibody.based.immunotherapy.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336525/nina.shah.case-based.lecture.cart.in.multiple.myeloma.html 2021-12-10 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336524/hermann.einsele.interactive.case.bi-.and.trispecific.antibodies.in.multiple.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336523/jean-luc.harousseau.access.to.drugs.in.europe.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336522/daniel.auclair.multiple.myeloma.research.foundation.html 2021-12-10 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336521/bindu.kanapuru.food.and.drug.administration.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336520/faculty.presenters.discussion.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336519/fredrik.schjesvold.no.html 2021-12-10 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336518/philippe.moreau.yes.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336517/paul.richardson.brief.oral.communication.-.horizon.%28op-106%29.melflufen.plus.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336516/faculty.presenters.brief.oral.communication.-talquetamab.a.g.protein-coupled.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336515/enrique.ocio.case-based.lecture.novel.agents.in.relapsed.multiple.myeloma.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336514/stefan.knop.case-based.lecture.how.i.treat.later.relapses.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336513/paula.rodrguez-otero.case-based.lecture.how.i.treat.first.relapse.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336512/xavier.leleu.interactive.case.relapsed.multiple.myeloma.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336511/faculty.presenters.discussion.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336510/ola.landgren.no.html 2021-12-10 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336509/salomon.manier.yes.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336508/faculty.presenters.discussion.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336507/angela.dispenzieri.no.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336506/nikhil.munshi.yes.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336505/faculty.presenters.panel.discussion.html 2021-12-10 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336504/daniel.auclair.case-based.lecture.my.drug.-.precision.interception.in.multiple.html 2021-12-10 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336503/samir.parekh.case-based.lecture.ngs.guided.targeted.and.immune.therapies.in.html 2021-12-10 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336502/faith.davies.interactive.case.how.i.treat.a.high.risk.patient.html 2021-12-10 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336501/faculty.presenters.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336500/faculty.presenters.panel.discussion.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336499/faculty.presenters.brief.oral.communication.-.daratumumab.plus.lenalidomide.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336498/sonja.zweegman.case-based.lecture.are.all.frail.patients.frail.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336497/charlotte.pawlyn.case-based.lecture.tandem.transplant.in.the.dara-era.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336496/karthik.ramasamy.interactive.case.newly.diagnosed.transplant.eligible.multiple.html 2021-12-10 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336495/faculty.presenters.panel.discussion.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336494/faculty.presenters.brief.oral.communication.early.diagnosis.of.multiple.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336493/cristina.nanni.case-based.lecture.imaging.with.pet-ct.in.smm.html 2021-12-15 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336492/madhav.dhodapkar.case-based.lecture.understanding.the.immune.me.of.smm.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336491/irene.ghobrial.case-based.lecture.understanding.genomics.of.smm.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2021/3rd-how-to-diagnose-and-treat-multiple-myeloma/336490/mara-victoria.mateos.interactive.case.smoldering.myeloma.html 2021-07-20 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314113/faculty.presenters.panel.discussion.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314112/giampaolo.merlini.amyloidosis.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314111/arnaud.jaccard.poems.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314110/jorge.castillo.waldenstroms.disease.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314109/faculty.presenters.panel.discussion.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314108/steven.le.gouill.bureaucracy.is.strangling.clinical.research.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314107/sigurdur.kristinsson.istopmm-a.nationwide.screening.for.mgus.and.myeloma.and.html 2021-01-29 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314106/faculty.presenters.panel.discussion.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314105/sagar.lonial.novel.immunotherapies.%28part.2%29.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314104/hermann.einsele.novel.immunotherapies.%28part.1%29.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314103/shaji.kumar.novel.targeted.therapies.%28not.immune%29.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314102/faculty.presenters.panel.discussion.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314101/deepu.madduri.update.of.cartitude-1.a.phase.1b.2.study.of.jnj-68284528.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314100/noopur.raje.overview.immune.therapies.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314099/saad.usmani.beyond.2nd.relapse.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314098/meletios.dimopoulos.how.to.sequence.in.1st.and.2nd.relapse.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314097/faculty.presenters.panel.discussion.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314096/noemi.puig.how.mrd.assessment.will.impact.clinical.management.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314095/bruno.paiva.mrd.and.immune.profiling.%28differences.in.terms.of.response%29.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314094/elena.zamagni.mrd.and.imaging.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314093/faculty.presenters.panel.discussion.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314092/graham.jackson.maintenance.therapy.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314091/paul.richardson.us.point.of.view.on.new.trials.%28including.explanation.of.why.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314090/faculty.presenters.panel.discussion.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314089/hira.mian.fit.vs.frail.the.point.of.view.of.north.america.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314088/sonja.zweegman.fit.vs.frail.the.european.point.of.view.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314087/xavier.leleu.overview.phase.3.trials.and.newly.approved.treatments.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314086/faculty.presenters.panel.discussion.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314085/alessandra.larocca.frailty.assessment.at.diagnosis.html 2021-01-29 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314084/herv.avet-loiseau.genetics.and.risk.assessment.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314083/shaji.kumar.diagnostic.criteria.and.initial.workup.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314082/faculty.presenters.panel.discussion.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314081/mara-victoria.mateos.clinical.trials.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/esh-5th-translational/314080/irene.ghobrial.high-risk.smoldering.what.is.the.exact.definition.html 2021-01-12 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312793/faculty.presenters.discussion.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312792/david.t.teachey.standard.and.new.options.for.t-all.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312791/faculty.presenters.panel.discussion.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312790/naval.daver.case-based.lecture.immune.check-point.inhibitors.in.acute.leukaemia.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312789/franoise.mchinaud.case-based.lecture.car.t-cells.for.precursor.b-cell.all.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312788/anita.rijneveld.case-based.lecture.use.of.blinatumomab.in.all.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312787/faculty.presenters.panel.discussion.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312786/claudia.nunez-torron.stock.detectable.minimal.measurable.disease.by.flow.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312785/sergio.giralt.case-based.lecture.prevention.and.treatment.of.vod.-.100.years.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312784/jorge.sierra.case-based.lecture.haplo-identical.hsct.with.acute.leukaemia.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312783/jean-hugues.dalle.case-based.lecture.new.gvhd.prophylactic.curative.treatment.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312782/faculty.presenters.discussion.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312781/ali.bazarbachi.targeted.agents.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312779/faculty.presenters.discussion.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312778/andrew.wei.defining.the.role.of.venetoclax.in.older.patients.with.aml.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312777/jorge.cortes.liposomal.daunorubicin.cytarabine.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312776/thomas.braun.current.intensive.therapy.of.older.aml.patients.in.2020.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312775/faculty.presenters.panel.discussion.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312774/alexander.perl.updated.results.from.a.phase.1.study.of.gilteritinib.in.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312773/nigel.russell.case-based.lecture.nucleoside.analogues.in.high-risk.aml.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312772/juliette.lambert.case-based.lecture.addition.of.gemtuzumab.ozogamicin.to.front.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312771/jorge.sierra.case-based.lecture.midostaurin.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312770/faculty.presenters.poster.walk.html 2020-11-24 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312769/faculty.presenters.discussion.html 2020-11-23 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312768/courtney.dinardo.the.role.of.idh1.2.inhibitors.as.monotherapy.html 2020-11-23 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312767/alexander.perl.next-generation.flt3.inhibitors.html 2020-11-23 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312766/nicolas.boissel.mutation-based.therapy.off-label.-.go.for.aml.salvage.therapy.html 2020-11-23 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312765/sarah.tasian.targeted.therapy.for.ph-like.all.html 2020-11-23 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312764/faculty.presenters.discussion.html 2020-11-23 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312763/gail.roboz.no.html 2020-11-23 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312762/charles.craddock.yes.html 2020-11-20 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312761/faculty.presenters.panel.discussion.html 2020-11-20 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312760/lars.bullinger.case-based.lecture.minimal.optimal.gene.panel.in.aml.html 2020-11-20 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312759/josep-maria.ribera.case-based.lecture.minimal.optimal.gene.panel.in.all.html 2020-11-20 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312758/sabina.chiaretti.case-based.lecture.ph-like.all.diagnosis.html 2020-11-20 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312757/faculty.presenters.panel.discussion.html 2020-11-20 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312756/daniel.janos.erdlyi.circulating.micrornas.behaving.as.minimal.residual.disease.html 2020-11-20 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312755/emmanuelle.clappier.case-based.lecture.mrd.monitoring.in.ph-positive.all.html 2020-11-20 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312754/jacqueline.cloos.case-based.lecture.flow.identification.and.monitoring.of.html 2020-11-19 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312753/faculty.presenters.panel.discussion.html 2020-11-19 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312752/nathali.kaushanski.dasatinib.inhibits.flt3.itd.and.ptpn11.mutated.acute.html 2020-11-19 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312751/lucy.godley.case-based.lecture.germline.predisposition.to.aml.html 2020-11-19 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312750/jonathan.bond.case-based.lecture.interface.acute.leukaemias.%28t.m%29.html 2020-11-19 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312749/charles.mullighan.case-based.lecture.mixed.phenotype.acute.leukaemias.%28b.m%29.html 2020-11-19 monthly 0.5 https://elearning.esh.org/esh/2020/2nd-acute-leukaemia/312748/jorge.sierra.keynote.lecture.covid.19.and.aml.html 2020-11-18 monthly 0.5 https://elearning.esh.org/esh/2019/yb_book/286514/yves.beuzard.les.dfis.des.maladies.du.globule.rouge.html 2019-11-14 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286485/andrew.pettitt.innovative.adaptive.trial.design.for.cll.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286484/david.weinstock.lymphoma.xenografts.how.to.get.back.to.the.bench.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286483/sarah.tasian.ph-like.b-all.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286482/christian.buske.waldenstrm.macroglobulinemia.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286481/gerald.illerhaus.cns.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286480/simon.rule.mantle.cell.lymphoma.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286479/david.maloney.preparatory.regimen.for.efficient.car-t.cell.therapy.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286478/andrei.thomas-tikhonenko.mechanisms.of.resistance.against.car-t.cell.therapy.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286477/jae.h.park.longterm.follow-up.of.cd19.car.therapy.in.acute.lymphoblastic.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286476/stephen.j.schuster.car-t.cell.update.in.dlbcl.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286475/hinrich.abken.cars.trucks.and.beyond.novel.strategies.and.constructs.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286474/markus.muschen.metabolic.gatekeepers.in.b-lymphoid.malignancies.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286473/hien.nguyen.targeting.of.kinases.to.modify.the.lymphoma.microenvironment.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286472/silvia.deaglio.modulation.of.the.tumour.microenvironment.in.cll.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286471/karin.tarte.the.role.of.the.microenvironment.in.lymphoma.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286470/christian.reinhardt.novel.mouse.models.of.aggressive.lymphoma.reveal.distinct.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286469/jude.fitzgibbon.transformation.and.genomics.in.follicular.lymphoma.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286468/ari.melnick.epigenetics.in.lymphoma.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286467/christian.steidl.pathogenesis.of.hodgkin.lymphoma.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286466/thomas.oellerich.signaling.components.in.lymphoma.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/286465/ulf.klein.mechanisms.of.b-cell.development.with.relevance.to.lymphomagenesis.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/discussion_john-goldman-award/286464/faculty.presenters.panel.discussion.on.the.esh.john.goldman.international.html 2019-11-08 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/285235/doctor.a.melnick.%28moderator%29.doctor.r.dalla-favera.doctor.j.fitzgibbon.doctor.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/285233/doctor.a.melnick.%28moderator%29.doctor.r.dalla-favera.doctor.j.fitzgibbon.doctor.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/285231/doctor.a.melnick.%28moderator%29.doctor.r.dalla-favera.doctor.j.fitzgibbon.doctor.html 2019-11-11 monthly 0.5 https://elearning.esh.org/esh/2019/21st/285155/tim.brmmendorf.efficacy.and.safety.of.bosutinib.by.charlson.comorbidity.index.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/21st/285154/jeffrey.miller.novel.ways.to.activate.and.target.nk.cells.with.specificity.to.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/21st/285153/max.petersen.loss.of.abelson.interactor-1.is.linked.to.inflammatory.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/21st/285152/franois-xavier.mahon.the.long-term.impact.of.tfr.on.economics.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/21st/285151/franois-xavier.mahon.curing.cml.to.be.or.not.to.be.that.is.the.question.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/21st/285150/carolina.pavlovsky.awardee.2019.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/21st/285149/marieke.essers.homeostatic.interferon.priming.in.haematopoietic.stem.cells.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/21st/285148/charles.schiffer.keynote.presentation.20.years.of.tki.therapy.in.cml.what.have.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/21st/285147/james.de.gregori.adaptive.oncogenesis.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/21st/285146/johan.richter.late.relapses.after.tki-discontinuation.are.not.uncommon.and.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/21st/285145/anna.eiring.nf-kappa.b-dependent.proteasome.activation.as.a.mechanism.of.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/21st/285144/peter.valent.keynote.presentation.deciphering.the.molecular.and.functional.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/21st/285143/ingo.roeder.individual.response.of.cml.patients.to.tki.dose.reduction.can.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/21st/285142/amy.dawson.the.dysregulated.cml.stem.progenitor.cell.secretome.alters.the.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/ict/284341/johannes.dll.is.tafasitamab.an.alternative.to.car-t.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/ict/284340/megan.levings.application.of.car.technology.to.regulatory.t.cells.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/ict/284339/olle.ringden.placenta.derived.decidua.stromal.cells.for.severe.acute.gvhd.and.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/ict/284338/aude.chapuis.clinical.trials.with.tcr.engineered.t.cells.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/ict/284337/francesco.dazzi.immunosuppressive.activity.of.msc.resolving.the.mechanism.of.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/ict/284336/cecilia.garlanda.il-1r8.a.checkpoint.molecule.in.nk.cell-mediated.anti-tumoral.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/ict/284335/john.godwin.bispecific.antibodies.for.acute.myeloid.leukaemia.early.results.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/ict/284334/renier.brentjens.next.generation.car.t-cell.for.therapy.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/ict/284333/michael.jensen.overcoming.antigen.escape.in.the.setting.of.car.t.cell.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/ict/284332/david.barrett.modeling.cytokine.release.syndrome.challenges.of.defining.the.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/ict/284331/fabio.ciceri.cd44v6.car.t.cells.for.aml.and.mm.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/ict/284330/kelvin.lee.blocking.co-stimulation.as.anti-myeloma.immunotherapy.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/ict/284329/cameron.turtle.all.and.dlbcl.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/283476/doctor.l.sehn.%28moderator%29.doctor.c.buske.and.doctor.b.falini.faculty.panel.html 2019-10-28 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/283475/anas.younes.how.to.ensure.that.breakthroughs.will.happen.for.nhl.cll.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/283474/brunangelo.falini.targeted.therapy.in.hairy.cell.leukaemia.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/283473/barbara.eichhorst.strategies.to.integrate.genomics.novel.agents.and.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/283472/andreas.strasser.targeting.the.signaling.pathways.of.lymphoid.malignancies.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/283471/david.maloney.preparatory.regimen.for.efficient.car-t.cell.therapy.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/283470/doctor.m.hallek.%28moderator%29.doctor.s.schuster.and.doctor.k.tarte.faculty.html 2019-10-28 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/283469/markus.muschen.metabolic.gatekeepers.in.b-lymphoid.malignancies.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/283468/doctor.a.melnick.%28moderator%29.doctor.r.dalla-favera.doctor.j.fitzgibbon.doctor.html 2019-10-28 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/283467/ash.alizadeh.insights.from.single.cell.or.proteome.analysis.in.lymphoma.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/283466/dan.landau.evolution.of.the.genomic.landscape.in.cll.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/5th-annual/283465/thomas.oellerich.molecular.mechanisms.of.b-cell.neoplasms.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/all/279753/mark.r.litzow.indications.for.allogeneic.hsct.for.adult.acute.lymphoblastic.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/all/279752/anthony.moorman.should.mrd.overcome.baseline.factors.in.risk.assessment.adult.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/all/279751/hagop.kantarjian.antibody.conjugates.in.all.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/all/279750/mary.v.relling.metabolism.disposition.and.toxicity.of.all.drugs.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/all/279749/pieter.van.vlierberghe.jak.stat.signaling.in.t-all.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/all/279748/jan.cools.targeting.oncogenic.notch1.signaling.in.t-cell.acute.lymphoblastic.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/all/279747/charles.mullighan.the.new.taxonomy.of.b-all.html 2019-10-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272263/delphine.rea.asciminib.results.from.the.phase.i.study.and.perspectives.of.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272262/claire.harrison.finding.the.right.time.to.start.systemic.therapy.in.pv.after.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272261/jane.apperley.cml.diagnosed.in.a.pregnant.woman.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272260/jane.apperley.pregnancy.in.cml.and.mpn.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272259/andreas.buchert.case-based.lecture.ifn.tki.combination.and.ifn.maintenance.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272258/breccia.massimo.case-based.lecture.cml.in.blast.crisis.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272256/jeffrey.tyner.and.jason.gotlib.tki.therapy.in.a.patient.with.csfr3.mutated.mpn.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272255/andreas.buchert.to.continue.or.to.discontinue.treatment.in.a.cml.patient.in.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272254/jeroen.janssen.case-based.lecture.milestones.-.management.of.suboptimal.response.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272253/delphine.rea.case-based.lecture.role.of.concomitant.disease.and.drug.therapy.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272252/dragana.milojkovic.case-based.lecture.role.of.baseline.cytogenetics.and.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272251/andreas.hochhaus.case-based.lecture.cml.as.an.emergency.initial.management.of.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272250/claire.harrison.the.young.patient.with.myelofibrosis.to.transplant.or.not.to.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272249/jean-christophe.ianotto.familial.mpn.diagnosis.and.treatment.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272248/jeffrey.tyner.case-based.lecture.diagnosis.and.management.of.a.cml.and.cnl.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272247/john.mascarenhas.case-based.lecture.management.of.blast.phase.mpn.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272246/ruben.mesa.case-based.lecture.management.of.myelofibrosis.excluding.stem.cell.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272245/alessandro.vannucchi.case-based.lecture.diagnosis.and.risk.stratification.of.mf.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272244/ruben.mesa.myelofibrosis.progression.vs.drug.failure.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272243/andreas.hochhaus.diagnosis.and.treatment.initiation.of.cml.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272242/john.mascarenhas.no.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272241/alessandro.vannucchi.yes.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272240/jyoti.nangalia.molecular.predictors.of.outcome.in.mpn.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272239/claire.harrison.case-based.lecture.management.of.essential.thrombocythaemia.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/cml-mpn/272238/mary.frances.mcmullin.case-based.lecture.diagnosis.and.management.of.non-pv.html 2019-05-17 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265289/marcin.wlodarski.diamond-blackfan.anaemia.genetic.and.clinical.complexity.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265288/alexis.a.thompson.gene.therapy.for.thalassaemia.sickle.cell.disease.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265287/daniel.bauer.gene.editing.for.thalassemia.and.sickle.cell.disease.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265286/janis.abkowitz.heme.regulation.and.gata1.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265285/david.rees.new.approches.to.managing.sickle.cell.disease.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265284/valeria.santini.tgf-b.pathway.inhibitors.in.low.risk.mds.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265283/alan.list.inflammation.as.a.determinant.of.ineffective.erythropoiesis.in.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265282/wilma.barcellini.autoimmune.haemolytic.anaemias.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265281/carlo.dufour.fanconi.anaemia.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265280/daniel.bauer.rational.targeting.of.the.nurd.complex.for.fetal.hemoglobin.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265279/merlin.crossley.promoter.mutations.associated.with.hereditary.persistence.of.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265278/douglas.higgs.the.relationship.between.genome.structure.and.function.lessons.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265277/lucia.de.franceschi.acute.sickling.crisis.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265276/marianne.de.montalembert.sickle.cell.disease.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265275/immacolata.andolfo.hereditary.haemolytic.anaemias.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265274/aristoteles.giagounidis.clinical.consequences.of.ineffective.erythropoiesis.in.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265273/roberta.russo.congenital.dyserythropoietic.anaemias.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265272/achille.iolascon.congenital.dyserythropoietic.anaemias.%28cdas%29.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265271/john.strouboulis.transcription.factors.in.erythropoiesis.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/b2b/265270/claus.nerlov.origin.of.mega.erythroid.progenitors.in.haematopoiesis.html 2019-04-12 monthly 0.5 https://elearning.esh.org/esh/2019/3rd/263172/hartmut.geiger.the.hsc.niche.in.aging.html 2019-04-04 monthly 0.5 https://elearning.esh.org/esh/2019/3rd/261707/xiang.h.f.zhang.new.insights.into.the.early-stage.bone.colonization.of.html 2019-03-26 monthly 0.5 https://elearning.esh.org/esh/2019/3rd/261706/elisa.laurenti.molecular.regulation.and.heterogeneity.in.quiescence.exit.of.html 2019-03-26 monthly 0.5 https://elearning.esh.org/esh/2019/3rd/261705/haobin.ye.subversion.of.systemic.glucose.metabolism.as.a.mechanism.to.support.html 2019-03-26 monthly 0.5 https://elearning.esh.org/esh/2019/3rd/261704/yoko.tabe.fatty.acid.metabolism.and.bone.marrow.adipocytes.in.aml.html 2019-03-26 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261691/sonja.zweegman.what.is.old.-.from.biology.of.the.disease.to.patient.html 2019-04-15 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261690/elena.zamagni.functional.imaging.characteristics.of.myeloma.-.promising.now.html 2019-04-15 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261689/niels.van.de.donk.antibody.based.immune.therapy.html 2019-07-22 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261688/evangelos.terpos.bone.disease.-.personalized.limited.treatment.html 2019-04-29 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261687/paula.rodrguez-otero.a.transplant-eligible.patient.with.an.aggressive.relapse.html 2019-06-21 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261686/karthik.ramasamy.first.relapse.in.transplant.non.eligible.html 2019-05-27 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261685/charlotte.pawlyn.bone.disease.-.continuous.treatment.html 2019-04-29 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261684/inger.nijhof.a.transplant-.ineligible.patient.with.partial.response.after.12.html 2019-06-21 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261683/inger.nijhof.how.to.manage.side.effects.html 2019-06-10 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261682/gareth.morgan.double.hit.also.in.myeloma.the.role.of.genome.sequencing.html 2019-04-15 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261681/stefan.knop.late.relapse.html 2019-05-27 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261680/giovanni.palladini.amyloidosis.from.diagnosis.to.treatment.html 2019-05-13 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261679/salomon.manier.a.patient.with.proteasome.inhibitors-.and.immunomodulatory.html 2019-06-21 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261678/sagar.lonial.first.relapse.in.transplant.eligible.html 2019-05-27 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261677/nelson.leung.no.html 2019-08-05 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261676/stefan.knop.is.this.multiple.myeloma.a.patient.with.high.serum.light.chains.html 2019-06-21 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261675/jonathan.keats.high.risk.disease.-.from.definition.to.treatment.html 2019-04-15 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261673/robert.hills.meta-analyses.-.how.to.interpret.and.to.translate.to.clinical.html 2019-07-08 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261672/salomon.manier.smouldering.disease.-.from.definition.to.treatment.html 2019-06-10 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261671/francesca.gay.a.transplant-eligible.patient.with.a.non-aggressive.relapse.24.html 2019-06-21 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261670/thierry.facon.transplant.non-eligible.html 2019-05-13 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261669/hermann.einsele.bispecific.antibodies.in.the.treatment.of.multiple.myeloma.html 2019-07-22 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261668/hermann.einsele.car-t.cell.in.clinical.practice.html 2019-07-22 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261667/angela.dispenzieri.monoclonal.gammopathy.of.clinical.significance.html 2019-05-13 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261665/michele.cavo.transplant.eligible.html 2019-05-13 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261664/jorge.castillo.waldenstrom.macroglobulinemia.html 2019-05-13 monthly 0.5 https://elearning.esh.org/esh/2019/berlin/261663/bertrand.arnulf.yes.html 2019-08-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/257032/susanne.saussele.treatment-free.remission.in.patients.with.chronic.phase.html 2019-01-22 monthly 0.5 https://elearning.esh.org/esh/2018/20th/257031/lucia.masarova.long-term.results.of.a.phase.2.trial.of.nilotinib.400.mg.twice.html 2019-01-22 monthly 0.5 https://elearning.esh.org/esh/2018/20th/257030/gemlyn.george.patients.perspectives.on.the.definition.of.cure.in.chronic.html 2019-01-22 monthly 0.5 https://elearning.esh.org/esh/2018/20th/257029/david.vetrie.modulation.of.p53.with.the.mdm2.antagonist.idasanutlin.in.html 2019-01-22 monthly 0.5 https://elearning.esh.org/esh/2018/20th/257028/matthieu.lewis.a.genome-scale.crispr.knock-out.screen.in.chronic.myeloid.html 2019-01-22 monthly 0.5 https://elearning.esh.org/esh/2018/20th/257027/christophe.ferrand.cml.hematopoietic.stem.cells.expressing.il-1rap.may.be.html 2019-01-22 monthly 0.5 https://elearning.esh.org/esh/2018/20th/257026/michael.w.deininger.mds.mpn.senectus.ipsa.est.morbus.html 2019-01-22 monthly 0.5 https://elearning.esh.org/esh/2018/20th/257025/manuela.mancini.loss.of.function.of.the.setd2.tumor.suppressor.is.a.recurrent.html 2019-01-22 monthly 0.5 https://elearning.esh.org/esh/2018/20th/257024/nick.cross.minimal.measurable.atypical.html 2019-01-22 monthly 0.5 https://elearning.esh.org/esh/2018/20th/257023/zuzana.brabcova.identification.of.metabolic.vulnerabilities.in.leukemic.stem.html 2019-01-22 monthly 0.5 https://elearning.esh.org/esh/2018/20th/257022/puneet.agarwal.tnf-induced.bone.marrow.stromal.niche.alterations.enhance.html 2019-01-22 monthly 0.5 https://elearning.esh.org/esh/2018/20th/257021/stephen.obrien.spirit.2.final.analysis.of.an.ncri.randomised.study.comparing.html 2019-01-22 monthly 0.5 https://elearning.esh.org/esh/2018/20th/257020/andreas.hochhaus.nilotinib.vs.nilotinib.plus.interferon.induction.and.html 2019-01-22 monthly 0.5 https://elearning.esh.org/esh/2018/20th/257019/elias.jabbour.aim.for.the.cure.tki-based.chemotherapy.for.ph%2B.all.html 2019-01-22 monthly 0.5 https://elearning.esh.org/esh/2018/20th/257018/jiang.qian.prevalence.and.outcomes.of.uncommon.bcr-abl.fusion.transcripts.in.html 2019-01-22 monthly 0.5 https://elearning.esh.org/esh/2018/20th/257017/marc.delord.the.technical.decline.in.the.rate.of.cml.treatment-free.remission.html 2019-01-22 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234803/satu.mustjoki.what.prevents.the.disease.from.relapsing.after.tki.discontinuation.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234802/justin.pritchard.single-molecule.sequencing.reveals.patterns.of.pre-existing.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234801/mauricette.michallet.long-term.survival.of.patients.with.chronic.phase.chronic.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234800/jerry.radich.resistance.and.progression.to.tki.not.just.mutations.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234799/jerry.radich.novel.approaches.to.monitor.mpn.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234798/sarah.tasian.how.to.identify.and.manage.ph-like.all.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234797/federico.lussana.stem.cell.transplant.for.ph%2B.all.who.when.how.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234664/malhotra.hermant.managing.cml.in.emerging.regions.some.problems.and.perspectives.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234637/marina.y.konopleva.bcl-2.and.its.inhibition.in.leukemia.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234573/dennis.kim.molecular.milestones.using.the.bcr-abl1.qpcr.level.and.doubling.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234572/dennis.kim.hmgcll1.is.a.predictive.germline.biomarker.for.deep.molecular.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234571/young.rok.do.long-term.impact.of.early.and.deeper.molecular.response.in.newly.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234570/carlo.gambacorti-passerini.are.tki.really.safe.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234569/shinto.francis.thekkudan.impact.of.kinase.domain.mutations.on.second.line.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234568/herv.dombret.low-intensity.tki-based.therapy.for.ph%2B.all.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234567/jitka.koblihova.the.association.of.transposable.elements.with.chronic.myeloid.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234566/giuseppe.saglio.eln.and.real-word.treatment.algorithms.for.mpns.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/20th/234565/robert.gale.why.the.fuss.over.cml.stem.cells.html 2018-12-05 monthly 0.5 https://elearning.esh.org/esh/2018/lymphoid-malignancies/234063/andrew.j.davies.design.of.innovative.clinical.trials.still.a.role.for.phase.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/lymphoid-malignancies/234062/david.weinstock.how.to.predict.response.in.silico.and.in.vitro.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/lymphoid-malignancies/234061/lisa.rimsza.minimal.biological.measurement.requirements.for.dlbcl.what.do.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/lymphoid-malignancies/234060/norbert.schmitz.t-nhl.novel.targets.and.therapies.-.how.can.we.move.forward.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/lymphoid-malignancies/234059/eias.campo.the.genetic.landscape.of.mcl.more.than.cyclind1.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/lymphoid-malignancies/234058/daniel.krapmann.targeting.malt1.signaling.preclinical.data.and.perspectives.in.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/lymphoid-malignancies/234057/andreas.strasser.which.pro-survival.bcl-2.family.member.should.be.targeted.for.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234055/steven.treon.mapping.the.genomic.landscape.of.waldenstrms.macroglobulinemia.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234054/steven.treon.exploring.treatment.options.against.different.waldenstrms.mutations.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234053/steven.treon.whole.genome.sequencing.opens.door.for.targeted.waldenstrms.therapy.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234052/saad.usmani.updated.pollux.results.for.early.relapsed.myeloma.patients.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234051/saad.usmani.targeting.bcma.with.bispecific.antibodies.in.r.r.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234050/saad.usmani.monoclonal.antibodies.current.and.future.potential.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234049/robert.hills.uk.ncri.aml17.trial.update.everolimus.addition.for.consolidation.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234048/robert.hills.opinion.value.of.mrd.as.an.endpoint.in.hem-onc.clinical.trials.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234047/robert.hills.judging.the.value.of.a.clinical.trial.in.hem-onc.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234046/noopur.raje.precision.medicine.in.multiple.myeloma.braf.nras.krad.t%2811.14%29.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234045/noopur.raje.pvx-410.vaccine.for.smoldering.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234044/noopur.raje.car.t-cells.for.myeloma.an.update.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234043/noopur.raje.quadruplet.regimens.and.antibodies.for.newly.diagnosed.multiple.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234042/noopur.raje.frontline.treatment.of.transplant-ineligible.mm.a.changing.landscape.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234041/nikhil.munshi.genomics.shed.light.on.targeted.treatment.for.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234040/nikhil.munshi.mrd.sequencing.test.approved.for.mm.in.the.us.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234039/nikhil.munshi.mrd.negativity.using.deep.sequencing.is.a.major.prognostic.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234038/niels.van.de.donk.cd38.antibodies.under.investigation.for.myeloma.isatuximab.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234037/niels.van.de.donk.a.novel.mechanism.of.action.for.daratumumab.in.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234036/niels.van.de.donk.daratumumab.in.myeloma.update.expanding.indications.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234035/niels.van.de.donk.plasma.cell.leukemia.and.extramedullary.disease.in.multiple.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234034/mara-victoria.mateos.opinion.eu.approval.of.daratumumab.plus.vmp.for.frontline.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234033/mara-victoria.mateos.updated.castor.analysis.daratumumab.plus.vd.for.r.r.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234032/mara-victoria.mateos.update.on.recent.smoldering.multiple.myeloma.trials.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234031/mara-victoria.mateos.how.should.smoldering.multiple.myeloma.be.monitored.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234030/kwee.yong.real.world.evidence.what.is.it.and.what.can.it.tell.us.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234029/kwee.yong.combining.bortezomib.and.lenalidomide-based.regimens.for.frontline.mm.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234028/kwee.yong.frontline.transplant-ineligible.mm.treatment.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234027/kenneth.anderson.mrd.detection.in.myeloma.approval.of.ngs.assay.%26.questions.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234026/kenneth.anderson.future.treatment.combinations.for.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234025/jess.san.miguel.continuous.vs.fixed.duration.therapy.for.multiple.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234024/jess.san.miguel.early.detection.and.intervention.in.myeloma.a.critical.point.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234023/jess.san.miguel.mrd.and.disease.eradication.in.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234022/jesus.berdeja.toxicity.profile.for.car.t-cells.in.multiple.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234021/jesus.berdeja.car.t-cells.for.multiple.myeloma.update.%26.what.s.in.store.for.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234020/irene.ghobrial.opinion.mrd.sequencing.test.approval.in.multiple.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234019/irene.ghobrial.smoldering.multiple.myeloma.what.is.the.current.definition.%26.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234018/heinz.ludwig.emerging.treatments.for.myeloma.quadruplets.bispecific.antibodies.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234017/heinz.ludwig.treatment.sequencing.in.multiple.myeloma.a.multitude.of.options.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234016/evangelos.terpos.double-blind.trial.of.denosumab.vs.zoledronic.acid.for.bone.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234015/evangelos.terpos.real.world.data.for.len.dex.in.second-line.myeloma.what.does.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234014/evangelos.terpos.real.world.data.bortezomib-based.therapy.for.r.r.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234013/evangelos.terpos.the.evolving.imaging.of.multiple.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234012/enrique.ocio.are.bcl2.and.mcl1.inhibitors.the.key.against.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234011/enrique.ocio.immunotherapeutics.against.multiple.myeloma.it.s.all.about.bcma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234010/enrique.ocio.a.host.of.promising.agents.for.myeloma.melflufen.filanesib.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234009/elena.zamagni.where.will.we.be.in.mm.management.5.years.from.now.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234008/elena.zamagni.what.is.the.role.of.pet.ct.in.myeloma.management.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234007/david.avigan.investigating.vaccines.for.hem-onc.key.questions.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234006/david.avigan.dendritic.cell.vaccine.for.mm.trial.updates.with.maintenance.%26.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234005/annemiek.broijl.smoldering.myeloma.treatment.landscape.%26.mrd.negativity.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234004/annemiek.broijl.treatment.options.for.high-risk.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234003/annemiek.broijl.how.do.we.define.a.cure.in.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234002/ann.van.de.velde.vaccines.to.prevent.progression.or.relapse.in.multiple.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234001/alessandra.larocca.mrd.as.a.response.assessment.in.elderly.multiple.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/234000/alessandra.larocca.geriatric.assessment.in.multiple.myeloma.is.it.required.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233982/jean-luc.harousseau.optimal.cost.safety.efficacy.qol.ration.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233981/kwee.yong.real-world.evidence.what.is.it.and.what.can.it.tell.us.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233980/robert.hills.how.to.judge.the.value.of.a.clinical.trial.hr.median.pfs.p-value.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233979/arnaud.jaccard.poems.syndromes.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233978/steven.treon.genomic.landscape.of.waldenstrms.macroglobulinemia.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233977/kenneth.c.anderson.future.combinations.for.the.treatment.of.mm.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233976/jesus.berdeja.adoptive.cell.therapy.in.multiple.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233975/enrique.ocio.new.drugs.new.immune.therapies.new.targeted.therapies.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233973/nikhil.munshi.new.generation.sequencing.in.multiple.myeloma.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233972/philippe.moreau.induction.therapy.triplet.quadruplet.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233971/kwee.yong.ongoing.trials.for.newly.diagnosed.patients.not.eligible.for.stem.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233970/sonja.zweegman.european.guidelines.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233969/alessandra.larocca.geriatric.assessment.is.it.required.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233968/niels.van.de.donk.primary.plasma.cell.leukaemia.and.extramedullary.disease.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233967/herv.avet-loiseau.genetics.and.risk.assessment.%28including.clonal.evolution.and.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233966/mara-victoria.mateos.leukemic.stem.cells.modulate.the.bone.marrow.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/multiple-myeloma/233965/madhav.dhodapkar.from.mgus.to.mm.do.all.clones.take.the.same.road.html 2018-10-15 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226286/wendy.stock.support.systems.are.a.crucial.factor.in.all.treatment.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226285/wendy.stock.emerging.novel.approaches.for.all.inotuzumab.ozogamicin.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226284/wendy.stock.next-generation.methodologies.the.future.for.mrd.monitoring.in.all.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226283/noelle.frey.the.importance.of.mrd.assessment.in.all.phases.of.all.treatment.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226282/noelle.frey.the.car.t-cell.therapy.race.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226281/noelle.frey.car.t-cell.therapy.and.all.the.current.landscape.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226280/mark.levis.involving.the.patient.is.a.key.part.of.cancer.treatment.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226279/marion.subklewe.immunotherapy.clinical.trial.participation.in.r.r.aml.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226278/marion.subklewe.how.can.we.improve.car.t-cell.therapy.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226277/marion.subklewe.exciting.immunotherapy.clinical.trials.for.the.management.of.aml.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226276/marion.subklewe.the.challenges.of.choosing.the.right.target.antigen.in.aml.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226275/gail.roboz.increasing.aml.clinical.trial.participation.rates.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226274/gail.roboz.combining.existing.drugs.for.the.creation.of.novel.aml.therapies.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226273/gail.roboz.managing.relapse.in.aml.the.role.of.mrd.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226272/gail.roboz.the.complications.of.treating.elderly.patients.with.aml.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226271/eytan.stein.the.latest.clinical.trials.into.novel.aml.therapies.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226270/eytan.stein.encouraging.patients.to.participate.in.aml.trials.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226269/eytan.stein.primary.and.secondary.resistance.in.aml.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226268/eytan.stein.toxicity.profiles.of.idh.inhibitors.are.they.as.intimidating.as.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226267/eytan.stein.targeting.idh.mutations.for.the.treatment.of.aml.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226266/christoph.rllig.biological.rationales.when.determining.aml.therapies.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226265/christoph.rllig.managing.aml.in.elderly.patients.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226264/christoph.rllig.immunotherapies.for.the.treatment.of.aml.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226263/christoph.rllig.mrd.detection.techniques.in.aml.pros.and.cons.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226262/christoph.rllig.applying.the.right.therapies.to.the.right.aml.patient.population.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226261/christoph.rllig.combination.therapy.for.the.treatment.of.aml.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226260/charles.craddock.increasing.the.effectiveness.of.all.therapies.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226259/charles.craddock.minimal.residual.disease.a.key.determinant.of.all.treatment.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226258/charles.craddock.improving.response.to.all.therapies.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226257/charles.craddock.challenges.with.the.identification.of.all.subtypes.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226256/charles.craddock.current.understandings.of.all.approaches.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226255/charles.craddock.transplantation.clinical.trial.network.to.build.available.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226254/arnold.ganser.overcoming.the.issues.with.clinical.trial.recruitment.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226253/arnold.ganser.midostaurin.the.first.drug.to.receive.approval.for.aml.since.2000.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226252/arnold.ganser.finding.the.right.targets.for.car.t-cell.therapy.in.aml.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226251/arnold.ganser.from.bench.to.the.bedside.understanding.the.genetic.changes.in.aml.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226250/arnold.ganser.the.devastating.effects.of.relapsed.or.refractory.aml.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226249/arnold.ganser.an.overview.of.2018.european.school.of.hematology.%28esh%29.clinical.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226248/andrew.wei.clinical.trials.investigating.venetoclax.combinations.for.aml.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226247/andrew.wei.improving.the.activity.of.bh3.mimetic.venetoclax.a.case.study.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/226246/andrew.wei.understanding.gene-gene.interactions.via.machine.learning.pandoras.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/8th-international-conference-on-mpn/219417/jason.gotlib.mastocytosis.html 2018-06-13 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/219268/nolle.frey.car.t-cells.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/219267/wendy.stock.antibodies.%26.antibody.conjugates.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/219266/marion.subklewe.tumor.target.antigens.in.aml.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/219265/herv.dombret.low-intensity.treatments.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/219264/charles.craddock.maintenance.therapy.after.transplantation.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/219263/alan.burnett.gemtuzumab.ozogamicin.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/219262/lionel.ades.therapy.of.acute.promyelocytic.leukemia.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/219261/eytan.stein.idh.inhibitors.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/219260/mark.levis.flt3.inhibitors.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/219259/arnold.ganser.salvage.therapy.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/219258/richard.schlenk.treatment.of.poor.eln.risk.aml.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/219257/farhad.ravandi-kashani.is.transplant.needed.to.cure.ph%2B.all.in.patients.who.html 2018-07-24 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/219256/dominique.bonnet.leukemic.stem.cells.modulate.the.bone.marrow.microenvironment.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/clinical-updates-on-acute-leukemias/219255/charles.mullighan.diagnosis.of.ph-like.all.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/8th-international-conference-on-mpn/219254/alessandro.vannucchi.are.we.using.personalized.treatment.for.patients.with.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/8th-international-conference-on-mpn/219253/ronald.hoffman.stem.cell.depletion.therapy.is.needed.to.change.the.natural.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/8th-international-conference-on-mpn/219252/ann.mullally.dissecting.the.molecular.genetics.of.mpn.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/8th-international-conference-on-mpn/219251/mary.frances.mcmullin.epigenetics.in.myeloproliferative.neoplasms.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/8th-international-conference-on-mpn/219250/john.d.crispino.megakaryocyte.differentiation.therapy.in.the.mpns.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/8th-international-conference-on-mpn/219249/ross.levine.role.of.epigenetic.dysregulation.in.mpn.pathogenesis.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/8th-international-conference-on-mpn/219248/stefan.n.constantinescu.mpn.drivers.from.active.jak2.and.tpor.mutants.to.rogue.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/8th-international-conference-on-mpn/219247/peter.campbell.somatic.mutations.and.clonal.relationships.html 2018-06-06 monthly 0.5 https://elearning.esh.org/esh/2018/2nd-int-symposium/219043/eliane.gluckman.bone.marrow.transplant.in.red.cell.disorders.html 2018-06-04 monthly 0.5 https://elearning.esh.org/esh/2018/2nd-int-symposium/219042/giel.bosman.red.cell.senescence.and.storage.lesions.html 2018-06-04 monthly 0.5 https://elearning.esh.org/esh/2018/2nd-int-symposium/219041/fred.piel.epidemiology.of.red.cell.disorders.html 2018-06-04 monthly 0.5 https://elearning.esh.org/esh/2018/2nd-int-symposium/219040/michael.lanzer.malaria.and.red.cell.disorders.html 2018-06-04 monthly 0.5 https://elearning.esh.org/esh/2018/2nd-int-symposium/219039/maria.domenica.cappellini.thalassaemias.html 2018-06-04 monthly 0.5 https://elearning.esh.org/esh/2018/2nd-int-symposium/219038/jacques.elion.sickle.cell.disease.pathophysiology.html 2018-06-04 monthly 0.5 https://elearning.esh.org/esh/2018/2nd-int-symposium/219037/lucia.de.franceschi.red.cells.and.oxidative.stress.html 2018-06-04 monthly 0.5 https://elearning.esh.org/esh/2018/2nd-int-symposium/219036/laurent.gouya.heme.synthesis.and.iron.metabolism.html 2018-06-04 monthly 0.5 https://elearning.esh.org/esh/2018/2nd-int-symposium/219035/gordon.d.ginder.epigenetics.in.erythropoiesis.html 2018-06-04 monthly 0.5 https://elearning.esh.org/esh/2018/2nd-int-symposium/219034/mohandas.narla.erythroid.niche.and.erythroblast.maturation.html 2018-06-04 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212199/paul.hamlin.double.hit.and.other.types.of.high-risk.lymphoma.molecular.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212198/christian.reinhardt.targeting.the.dna.damage.response.in.high-risk.lymphoma.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212197/davide.rossi.richter.transformation.in.the.elderly.patient.molecular.origin.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212196/loretta.nastoupil.management.strategies.and.outcomes.for.very.elderly.patients.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212195/farrukh.awan.management.of.comorbidity.and.specific.adverse.events.in.the.era.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212194/loretta.nastoupil.management.of.indolent.lymphoma.in.the.elderly.patient.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212193/jude.fitzgibbon.clonal.evolution.in.malignant.lymphoma.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212192/jess.san.miguel.multiple.myeloma.in.the.elderly.a.particular.challenge.in.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212191/irene.ghobrial.mgus.and.mgus.transition.to.myeloma.what.do.we.need.to.do.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212190/nikhil.munshi.clonal.evolution.of.multiple.myeloma.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212189/nicolaus.krger.alloegeneic.stem.cell.transplantation.at.older.age.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212188/herv.dombret.the.older.patient.with.all.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212187/gert.ossenkoppele.management.of.the.unfit.patient.with.aml.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212186/bob.lwenberg.therapeutic.management.of.the.so-called.fit.older.patient.with.aml.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212185/terrence.n.wong.biology.of.aml.at.older.age.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212184/tanya.wildes.assessing.the.aging.individual.with.hematologic.disorders.how.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212183/raphael.itzykson.management.of.cmml.and.other.mds.mpn.entities.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212182/pierre.fenaux.management.of.high.grade.mds.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212181/benjamin.ebert.biology.of.mds.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212180/rebekka.schneider.microenvironment.and.mds.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212179/nancy.berliner.anemia.at.older.age.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212178/michael.milsom.aging.stem.cells.and.stress.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212177/terrence.n.wong.selection.of.tp53.mutant.clones.following.chemotherapy.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212176/george.vassiliou.clonal.hematopoiesis.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212175/benjamin.ebert.clonal.hematopoiesis.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/hematologic_malignancies_older_age/212174/bjrn.schumacher.dna.damage.a.driving.force.of.aging.html 2018-04-05 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210040/emanuele.zucca.treatment.of.malt.lymphoma.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210039/catherine.thieblemont.treatment.of.nodal.marginal.zone.lymphoma.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210038/barbara.kiesewetter.treatment.of.splenic.marginal.zone.lymphoma.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210036/carlos.montalban.marginal.zone.lymphoma.prognostic.models.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210034/german.ott.the.pathology.of.marginal.zone.lymphomas.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210033/gilles.salles.new.agents.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210032/vincent.ribrag.treatment.of.follicular.lymphoma.%28fl%29.salvage.therapy.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210031/christian.buske.advanced.stage.patient.first.line.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210030/oliver.weigert.integrating.molecular.diagnostics.for.improved.patient.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210029/michael.green.clonal.evolution.of.follicular.lymphoma.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210028/riccardo.dalla-favera.follicular.lymphoma.from.genetics.to.pathogenesis.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210026/michael.j.keating.idelalisib.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210025/john.gribben.novel.targeted.therapies.in.cl.-.ibrutinib.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210024/valentin.goede.chlorambucil.plus.anti-cd20.moab.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210022/michael.j.keating.fcr.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210021/davide.rossi.predictive.biomarkers.in.cll.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210020/catherine.wu.genetic.portrait.of.cll.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2018/cll_indolent_lymphoma/210019/carlo.m.croce.micro.rna.dysregulation.to.identify.targets.for.therapy.in.html 2018-03-13 monthly 0.5 https://elearning.esh.org/esh/2017/19_john_goldman_conference/205142/mhairi.copland.janet.rowley.prize.talk.html 2017-10-12 monthly 0.5 https://elearning.esh.org/esh/2017/19_john_goldman_conference/205141/jerry.radich.icmlf.prize.talk.html 2017-10-12 monthly 0.5 https://elearning.esh.org/esh/2017/19_john_goldman_conference/205140/tim.hughes.john.goldman.prize.talk.html 2017-10-12 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204715/stphane.de.botton.the.future.of.aml.and.mds.diagnosis.and.treatment.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204714/stphane.de.botton.working.with.smaller.research.companies.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204713/stphane.de.botton.the.next.steps.for.the.idh2.inhibitor.drug.enasidenib.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204712/stphane.de.botton.the.potential.of.differentiation.therapies.for.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204711/saar.gill.price.vs.performance.car.t-cells.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204710/saar.gill.transferring.lessons.learnt.from.treating.all.to.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204709/saar.gill.the.development.of.novel.treatment.modalities.regulations.and.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204708/saar.gill.car.t-cells.and.crispr.the.future.of.aml.treatment.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204707/ravindra.majeti.game-changing.treatments.for.leukemia.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204706/ravindra.majeti.pre-leukemic.stem.cells.a.telltale.sign.of.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204705/ravindra.majeti.tackling.cd47-positive.malignancies.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204704/ravindra.majeti.an.overview.of.immunotherapies.for.leukemia.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204703/marina.konopleva.promising.results.for.venetoclax.combination.therapies.in.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204702/marina.konopleva.selecting.aml.patients.for.intensive.treatment.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204701/lars.bullinger.reassuring.patients.with.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204700/lars.bullinger.translational.research.in.berlin.to.improve.aml.treatment.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204699/lars.bullinger.adapting.aml.treatment.for.elderly.patients.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204698/lars.bullinger.the.challenges.facing.elderly.aml.treatment.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204697/john.dipersio.expanding.trials.using.bispecifics.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204696/john.dipersio.when.to.use.bispecifics.for.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204695/john.dipersio.the.future.of.leukemia.treatment.in.the.elderly.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204694/francesco.lo-coco.new.treatments.for.aml.using.inhibitors.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204693/francesco.lo-coco.the.standardization.of.molecular.diagnostics.for.myeloid.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204692/francesco.lo-coco.the.use.of.second.generation.flt3.inhibitors.for.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204691/emery.bresnick.collaboration.and.cooperation.in.hematology-oncology.research.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204690/emery.bresnick.gata2.and.its.influence.on.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204689/christoph.plass.the.potential.benefits.of.epigenetic.therapy.research.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204688/christoph.plass.the.molecular.mechanisms.of.epigenetic.therapies.ltrs.and.tinats.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204687/andrew.wei.current.research.into.pro-apoptosis.medication.for.leukemia.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204686/andrew.wei.combating.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204685/andrew.wei.highly.targeted.medication.for.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204684/andrew.wei.mimetics.the.future.of.aml.treatment.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204683/john.dipersio.the.problem.of.treating.aml.with.cd123-targeting.drugs.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204682/john.dipersio.bispecific.agents.the.future.of.aml.and.mds.treatment.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204681/john.dipersio.cytokine.release.syndrome.a.limiting.factor.for.aml.treatment.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204680/jorge.sierra.what.are.the.alternative.treatment.options.for.relapsed.or.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204679/jorge.sierra.providing.the.relevant.information.to.patients.a.changing.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204678/marina.konopleva.upcoming.clinical.trials.for.venetoclax.chemotherapy.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204677/marion.subklewe.t-cell.engaging.antibodies.what.lessons.have.we.learnt.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204676/marion.subklewe.aml.clinical.trials.early.stage.vs.relapse.refractory.patients.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204675/marion.subklewe.aml.immunotherapy.pre-clinical.data.to.look.forward.to.at.ash.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204674/mark.levis.one.size.does.not.fit.all.aml.subtype.treatment.approaches.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204673/marina.konopleva.advising.aml.patients.to.participate.in.clinical.trials.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204672/stphane.the.rapid.progression.of.idh1.2.mutant.enzyme.inhibitors.through.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204671/marion.subklewe.aml.immunotherapy.patients.need.to.be.well.informed.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204670/mark.levis.the.drugs.being.used.to.treat.newly.diagnosed.aml.patients.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204669/mark.levis.venetoclax.for.elderly.aml.patients.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204668/mark.levis.the.challenges.of.using.kinase.inhibitors.for.aml.treatment.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204667/mark.levis.combination.therapies.and.improving.overall.survival.in.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204666/jane.churpek.balancing.hereditary.research.with.patient.care.in.leukemia.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204665/jane.churpek.developing.an.understanding.of.disease.progression.in.mds.and.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204664/jane.churpek.the.benefits.of.patient.advocacy.groups.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204663/omar.abdel-wahab.what.are.the.drivers.of.leukemia.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204662/omar.abdel-wahab.therapeutics.targeting.splicing.in.hematological.malignancies.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204661/omar.abdel-wahab.neomorphic.mutations.driving.hematological.cancers.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204660/omar.abdel-wahab.the.importance.of.collaboration.in.aml.research.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204659/jorge.sierra.finding.novel.treatment.options.for.relapsed.progressing.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204658/jorge.sierra.infrastructure.for.aml.treatment.in.spain.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204657/katherine.smith.resistance.mechanisms.to.flt3.inhibitors.in.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204656/katherine.smith.combinations.with.flt3.inhibitors.the.way.forward.for.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204655/jane.churpek.role.of.genetics.in.hematological.malignancies.expanding.our.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204654/miguel.sanz.integrating.midostaurin.into.flt3.positive.aml.treatment.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204653/miguel.sanz.why.are.new.molecules.typically.combined.with.standard.chemotherapy.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204652/miguel.sanz.the.need.for.collaboration.amongst.hospitals.learning.from.ratify.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204651/miguel.sanz.efficacy.of.first.generation.flt3.inhibitors.for.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204650/omar.abdel-wahab.the.spliceosome.mutations.that.can.cause.hematological.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204649/ramiro.garzon.novel.targets.for.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204648/ramiro.garzon.exportin.%28xpo1%29.inhibitors.for.the.treatment.of.aml.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/interviews/204647/ramiro.garzon.targeting.non-coding.rnas.in.leukemia.html 2018-01-08 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202164/graham.collins.activities.of.the.ncri.and.uk.lymphoma.studies.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202163/martin.dreyling.european.mantle.cell.network.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202162/little.richard.new.generation.studies.in.follicular.and.mantle.cell.lymphoma.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202161/carsten.niemann.novel.inhibitors.in.lymphoma.an.outlook.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202160/maddocks.kami.j.targeting.btk.in.current.therapy.of.indolent.nhl.and.cll.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202159/anthony.letai.bcl2.%26.regulation.of.the.apoptotic.response.in.lymphoid.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202158/stephen.ansell.immune.checkpoint.inhibitors.in.indolent.lymphomas.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202157/david.maloney.status.of.allogeneic.transplant.immunotherapy.compared.to.car.t.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202156/martin.dreyling.initial.diagnostic.work.up.of.mcl.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202155/rawstron.andy.mrd.in.cll.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202154/michael.hallek.potential.disparities.in.europe.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202153/gabus.raul.disparity.of.lymphoma.treatment.insouthamerica.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202152/ari.melnick.epigenetic.basis.of.germinal.center.derived.b.cell.lymphomas.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202151/adrian.wiestner.modulation.of.the.tme.in.nhl.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202150/jan.burger.cll.microenvironment.as.a.drug.target.for.kinase.inhibitors.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202149/christian.reinhardt.next.generation.sequencing.data.analysis.critical.issues.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202148/jude.fitzgibbon.routes.of.transformation.of.follicular.lymphoma.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/indolent_lymphoma/202147/catherine.wu.genomic.landscape.of.cll.and.other.indolent.lymphoma.html 2017-10-13 monthly 0.5 https://elearning.esh.org/esh/2017/multiple_myeloma/188660/philippe.moreau.later.on.html 2017-06-30 monthly 0.5 https://elearning.esh.org/esh/2017/multiple_myeloma/188659/bart.barlogie.from.the.start.html 2017-06-30 monthly 0.5 https://elearning.esh.org/esh/2017/multiple_myeloma/188658/giampaolo.merlini.amyloidosis.from.proteomics.to.resolving.proteins.html 2017-06-30 monthly 0.5 https://elearning.esh.org/esh/2017/multiple_myeloma/188657/angela.dispenzieri.treatment.of.castleman.monoclonal.antibodies.or.chemotherapy.html 2017-06-30 monthly 0.5 https://elearning.esh.org/esh/2017/multiple_myeloma/188656/niels.van.de.donk.no.treatment.is.no.option.for.plasma.cell.leukaemia.html 2017-06-30 monthly 0.5 https://elearning.esh.org/esh/2017/multiple_myeloma/188655/shaji.kumar.allogeneic.stem.cell.transplantation.when.and.who.html 2017-06-30 monthly 0.5 https://elearning.esh.org/esh/2017/multiple_myeloma/188654/meletios.dimopoulos.treatment.of.refractory.disease.html 2017-06-30 monthly 0.5 https://elearning.esh.org/esh/2017/multiple_myeloma/188653/philippe.moreau.treatment.of.high.risk.multiple.myeloma.should.we.treat.them.html 2017-06-30 monthly 0.5 https://elearning.esh.org/esh/2017/multiple_myeloma/188652/sonja.zweegman.first.line.treatment.of.tx.non-eligible.patients.from.fit.to.html 2017-06-30 monthly 0.5 https://elearning.esh.org/esh/2017/multiple_myeloma/188651/bart.barlogie.from.limited.to.total.a.back.in.the.time.of.precision.medicine.html 2017-06-30 monthly 0.5 https://elearning.esh.org/esh/2017/multiple_myeloma/188650/elena.zamagni.ct.html 2017-06-30 monthly 0.5 https://elearning.esh.org/esh/2017/multiple_myeloma/188649/angela.dispenzieri.mrd-based.treatment.paradigms.in.minimal.time.html 2017-06-30 monthly 0.5 https://elearning.esh.org/esh/2017/multiple_myeloma/188648/herv.avet-loiseau.risk.profiling.in.multiple.myeloma.from.cytogenetics.to.html 2017-06-30 monthly 0.5 https://elearning.esh.org/esh/2017/multiple_myeloma/188647/shaji.kumar.newly.diagnosed.multiple.myeloma.the.role.of.looking.different.html 2017-06-30 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174310/gianluca.gaidano.mutations.in.cll.and.how.they.affect.therapy.choice.%28focus.on.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174309/stephan.stilgenbauer.therapeutic.targeting.of.biology.in.cll.focus.on.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174308/eva.hellstrm-.lindberg.treating.anaemia.according.to.patient.genome.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174307/matteo.giovanni.della.porta.personalized.transplantation.procedures.in.myeloid.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174306/michaela.fontenay.implications.of.patient.genome.on.clinical.decision.making.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174303/charles.mullighan.new.subtypes.of.all.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174302/christine.harrison.the.genomic.landscape.of.all.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174301/simona.soverini.clinical.significance.of.ngs.in.second-line.treatment.and.beyond.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174300/nick.cross.current.status.of.standardization.efforts.for.pcr.in.cml.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174299/andreas.hochhaus.cml.monitoring.why.which.where.and.when.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174298/alessandro.vannucchi.the.future.of.jak.inhibition.in.mpn.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174297/francesco.passamonti.genotype-based.clinical.decision.making.in.mpn.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174295/robert.gale.precision.medicine.in.aml.hope.hype.or.both.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174294/bob.lwenberg.towards.personalized.medicine.in.aml.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174293/hartmut.dhner.genotype-tailored.therapy.of.aml.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174292/torsten.haferlach.translational.implications.of.the.medical.genomics.in.aml.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174289/torsten.haferlach.next.generation.sequencing.data.analysis.critical.issues.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174288/andreas.hochhaus.genomic.applications.in.the.clinic.are.we.ready.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2017/training_course_who_classification/174287/nick.cross.abcs.of.genomics.html 2017-03-28 monthly 0.5 https://elearning.esh.org/esh/2016/esh.mm/173926/faculty.presenters.panel.discussion.html 2016-11-08 monthly 0.5 https://elearning.esh.org/esh/2016/esh.mm/173925/kwee.yong.targeting.epigenetics.in.multidrug.combinations.for.relapsed.html 2016-11-08 monthly 0.5 https://elearning.esh.org/esh/2016/esh.mm/173924/enrique.ocio.hdac.inhibitors.in.combination.with.immunomodulatory.drugs.and.html 2016-11-08 monthly 0.5 https://elearning.esh.org/esh/2016/esh.mm/173923/hermann.einsele.novel.combinations.of.hdac.and.proteasome.inhibitors.html 2016-11-08 monthly 0.5 https://elearning.esh.org/esh/2016/esh.mm/173922/hermann.einsele.experience.with.pan-hdac.inhibitors.in.multiple.myeloma.html 2016-11-08 monthly 0.5 https://elearning.esh.org/esh/2016/esh.mm/173921/hermann.einsele.welcome.and.introduction.html 2016-11-08 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173820/martin.dreyling.salvage.treatment.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173819/simon.rule.elderly.patient.first.line.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173818/wolfram.klapper.pathology.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173817/lorenz.trmper.elderly.patient.first.line.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173816/f.d.amore.young.patient.first.line.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173815/philippe.gaulard.pathology.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173814/andrs.ferreri.cns.lymphoma.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173813/miguel.a.piris.plasmoblastic.lymphoma.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173812/h.tilly.double.hit.lymphoma.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173811/vincent.ribrag.burkitt.lymphoma.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173810/michael.pfreundschuh.salvage.therapies.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173809/wolfram.klapper.transformed.lymphoma.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173808/olivier.casasnovas.role.of.pet.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173807/michael.pfreundschuh.debate.in.dlbcl.is.cell.of.origin.ready.for.prime.time.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173806/catherine.thieblemont.r-chop.and.maintenance.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173805/andrew.j.davies.r-chop.%2B.targeted.therapy.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173804/umberto.vitolo.optimized.immunotherapy.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2017/clinical_updates_aggressive_lymphoma/173803/philippe.gaulard.pathology.abc-gcb.html 2017-03-21 monthly 0.5 https://elearning.esh.org/esh/2016/esh.bcm/170308/jf.seymour.closing.comments.html 2016-11-03 monthly 0.5 https://elearning.esh.org/esh/2016/esh.bcm/170307/faculty.presenters.q%26a.panel.session.html 2016-11-03 monthly 0.5 https://elearning.esh.org/esh/2016/esh.bcm/170306/jf.seymour.tomorrows.innovations.emerging.novel.therapeutic.approaches.html 2016-11-03 monthly 0.5 https://elearning.esh.org/esh/2016/esh.bcm/170305/julio.delgado.deeper.remissions.the.future.of.cll.treatment.html 2016-11-03 monthly 0.5 https://elearning.esh.org/esh/2016/esh.bcm/170304/anna.schuh.an.update.what.patients.can.expect.today.html 2016-11-03 monthly 0.5 https://elearning.esh.org/esh/2016/esh.bcm/170303/jos.eduardo.guimares.a.historical.perspective.on.cll.html 2016-11-03 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/166044/nicolaus.krger.benefits.and.problems.of.allogeneic.stem.cell.transplantation.html 2017-01-05 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/166043/paolo.corradini.new.drugs.and.combinations.in.haematological.cancers.improve.html 2017-01-05 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/166042/torben.plesner.overview.of.the.cd38.antibody.in.multiple.myeloma.html 2017-01-05 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/166041/niels.van.de.donk.drug.combos.with.daratumumab.likely.to.become.standard.of.html 2017-01-05 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/166040/mara-victoria.mateos.preemptively.treating.patients.most.at.risk.of.html 2017-01-05 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/166039/andrea.manca.how.can.we.make.the.best.decisions.for.health.whilst.considering.html 2017-01-05 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/166038/phillippe.moreau.monoclonal.antibodies.in.multiple.myeloma.html 2017-01-05 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/166037/giovanni.palladini.cancer.or.amyloidosis.html 2017-01-05 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/166036/heinz.ludwig.elderly.patients.should.be.treated.based.on.biological.age.not.html 2017-01-05 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/166035/jens.hillenga.history.of.antiangiogenic.drugs.in.multiple.myeloma.starting.html 2017-01-05 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/166034/karthik.ramasamy.better.doctor-patient.communication.needed.to.improve.myeloma.html 2017-01-05 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/166033/mohamad.mohty.maintenance.therapy.in.young.myeloma.patients.beneficial.after.html 2017-01-05 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/166032/fabio.malavasi.history.and.progress.of.cd38.in.myeloma.html 2017-01-05 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/166031/nicola.giuliani.overcoming.painful.bone.disease.in.myeloma.html 2017-01-05 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165994/tamas.masszi.chronic.gvhd.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165993/jane.apperley.acute.gvhd.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165992/francesco.dazzi.prevention.and.treatment.of.relapse.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165991/francesco.dazzi.immune.reconstitution.and.tolerance.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165990/sebastian.giebel.adults.acute.leukaemia.%28aml.and.all%29.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165989/peter.dreger.aggressive.non.hodgkin.lymphoma.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165988/nicolaus.krger.myeloproliferative.disorders.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165987/fabio.ciceri.is.gene.therapy.an.option.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165986/dominique.farge.new.indications.in.autoimmune.diseases.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165985/franco.locatelli.paediatric.non-malignant.diseases.related.haplo.mismatched.t.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165984/peter.bader.paediatric.malignant.diseases.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165983/montserrat.rovira.diagnosis.and.treatment.of.viral.infection.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165982/janos.sink.diagnosis.and.treatment.of.fungal.infection.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165981/montserrat.rovira.diagnosis.and.treatment.of.bacterial.infection.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165980/myriam.labopin.richard.szydlo.understanding.transplant.statistics.for.clinicians.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165979/andre.tichelli.long.term.follow-up.and.late.complications.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165978/enric.carreras.early.non-infectious.complications.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165977/tamas.masszi.supportive.care.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165976/andrea.bacigalupo.related.haplo.mismatched.with.post-transplant.cyclophosphamide.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165975/eliane.gluckman.unrelated.cord.blood.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165974/andrea.bacigalupo.matched.unrelated.donors.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165973/annalisa.ruggeri.conditioning.regimens.reduced.intensity.versus.myeloablative.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165972/robert.gale.lessons.on.haemopoietic.stem.cell.transplantation.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165971/anna.sureda.the.role.of.transplantation.for.hodgkin.disease.in.the.light.of.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165970/enric.carreras.principles.of.hla.typing.for.the.clinician.and.criteria.of.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165969/faculty.presenters.stem.cell.source.bone.marrow.peripheral.blood.cord.blood.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165968/christian.chabannon.the.stem.cell.product.collection.and.delivery.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165967/francesco.dazzi.mesenchymal.stromal.cells.biology.production.and.clinical.use.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/haemopoietic_stem_cell_transplantation/165966/marie.caroline.le.bousse-kerdiles.the.stem.cell.from.embryo.to.adult.html 2017-01-04 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165709/cliff.chaplin.chapter.24.-.ethics.of.research.and.clinical.practice.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165708/eliane.gluckman.marie.caroline.le.bousse-kerdi.chapter.23.-.cell.therapy.for.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165707/mohamad.mohty.chapter.22.-.methodology.of.conducting.academic.clinical.trials.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165706/richard.richard.chapter.21.-.statistical.evaluation.of.hsct.data.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165705/ruth.ladenstein.and.ulrike.ptschger.chapter.20.10.-.high-dose.chemotherapy.and.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165704/emanuele.angelucci.and.donatella.baronciani.chapter.20.9.-.haemoglobinopathies.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165703/eliane.gluckman.chapter.20.8.-.hereditary.bone.marrow.failure.syndromes.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165702/jaap.j.boelens.marc.bierings.robert.wynn.chapter.20.7.-.hsct.in.inborn.errors.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165701/paul.veys.and.h.bobby.gaspar.chapter.20.6.-.primary.immunodeficiency.diseases.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165700/franco.claviez.chapter.20.5.-.hsct.for.lymphomas.in.children.and.adolescents.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165699/franco.locatelli.and.charlotte.m.niemeyer.chapter.20.4.-.chronic.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165698/franco.locatelli.alice.bertaina.giuseppe.palum.chapter.20.3.-.hsct.in.children.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165697/christina.peters.chapter.20.2.-acute.lymphoblastic.leukaemia.in.children.and.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165696/giorgio.dini.and.stefano.giardino.chapter.20.1.-.acute.myeloid.leukaemia.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165695/judith.marsh.chapter.19.12.-.aplastic.anaemia.and.paroxysmal.nocturnal.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165694/john.a.snowden.riccardo.sacc.dominique.farge.chapter.19.11.-.autoimmune.diseases.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165693/marco.bregni.chapter.19.10.-.solid.tumours.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165692/anna.sureda.and.harry.c.schouten.chapter.19.9.-.hsct.for.hodgkins.lymphoma.in.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165691/harry.c.schouten.and.anna.sureda.chapter.19.8.-.hsct.for.non-hodgkins.lymphoma.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165690/m.teresa.cibeira.and.jordi.esteve.chapter.19.7.-.role.of.hsct.in.primary.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165689/jess.san-miguel.jos.a.pre.m.victoria.mateos.chapter.19.6.-.multiple.myeloma.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165688/peter.dreger.and.johannes.schetelig.chapter.19.5.-.chronic.lymphocytic.leukaemia.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165687/jiri.pavlu.and.jane.apperley.chapter.19.4.-.chronic.myeloid.leukaemia.and.the.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165686/nicolaus.krger.chapter.19.3.-.hsct.for.myelodysplastic.syndromes.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165685/mohamad.mohty.chapter.19.2.-.acute.lymphoblastic.leukaemia.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165684/mohamad.mohty.chapter.19.1.-.acute.myeloid.leukaemia.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165683/alois.gratwohl.helen.baldomer.anna.sureda.chapter.18.-.indications.for.and.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165682/inge.jedema.and.j.h.frederik.falkenburg.chapter.17.immunotherapy.post-transplant.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165681/thomas.lion.chapter.16.2.-.chimerism.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165680/jean-michel.cayuela.chapter.16.1.-.molecular.monitoring.of.minimal.residual.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165679/andre.tichelli.chapter.15.-.late.effects.in.patients.treated.with.hsct.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165678/antoine.toubert.chapter.14.-.immune.reconstitution.after.allogeneic.hsct.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165677/jane.apperley.and.tamas.masszi.chapter.13.-.graft-versus-host.disease.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165676/montserrat.rovira.josep.mensa.enric.carreras.chapter.12.-.infections.after.hsct.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165675/enric.carreras.chapter.11.-.early.complications.after.hsct.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165674/tamas.masszi.and.arno.mank.chapter.10.-.supportive.care.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165673/rachel.pawson.and.derwood.pamphilon.chapter.9.-.transfusion.support.in.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165672/alois.gratwohl.and.enric.carreras.chapter.8.-.principles.of.conditioning.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165671/carlheinz.mueller.and.sergio.querol.chapter.7.-.bone.marrow.donor.registries.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165670/eliane.gluckman.chapter.6.-.choice.of.the.donor.according.to.hla.typing.and.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165669/bronwen.e.shaw.alejandro.madrigal.chapter.5.-.immunogenetics.of.allogeneic.hsct.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165668/aleksandra.wodnar-filipowicz.chapter.4.-.biological.properties.of.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165667/christian.chabannon.eoin.mcgrath.chapter.3.-.jacie.%26.quality.management.in.hsct.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/ebmt_handbook/165666/alejandro.madrigal.anna.sureda.chapter.2.-.present.and.future.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/tumour_microenvironment/165664/jianguo.tao.microenvironment.in.b.cell.lymphoma.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/tumour_microenvironment/165663/daniela.krause.modulation.of.the.bone.marrow.microenvironment.by.pth.for.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/tumour_microenvironment/165662/amnon.peled.moving.lsc.out.of.the.niche.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/tumour_microenvironment/165661/ingo.roeder.a.systems.biological.perspective.on.stem.cell.niche.interactions.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/tumour_microenvironment/165660/cristina.lo.celso.dynamic.interactions.between.normal.and.malignant.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/tumour_microenvironment/165659/hartmut.geiger.effect.of.aging.on.tumor.microenvironment.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/tumour_microenvironment/165658/toshio.suda.the.niche.concept.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/red_blood_cells/165657/j.elion.modifier.genes.in.sickle.cell.disease.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/red_blood_cells/165656/a.merckx.malaria.pathology.and.cytoadherence.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/red_blood_cells/165655/i.macdougall.novel.erythropoiesis-stimulating.agents.a.new.era.in.anaemia.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/red_blood_cells/165654/c.n.roy.not.so.benign.haematology.anaemia.of.the.elderly.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/red_blood_cells/165653/l.douay.large-scale.erythroid.differentiation.using.ips.cells.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/red_blood_cells/165652/j.p.richalet.epidemiology.pathophysiology.and.treatment.of.high.altitude.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/red_blood_cells/165651/v.betin.autophagy.and.erythroblast.maturation.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/red_blood_cells/165650/g.courtois.apoptosis.and.erythroid.differentiation.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165649/faculty.presenters.websites.of.interest.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165648/faculty.presenters.abbreviations.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165647/j.-ch.deybach.l.gouya.h.puy.haem.biosynthesis.and.the.porphyrias.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165646/e.a.price.anaemia.in.the.elderly.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165645/a.piga.s.roggero.f.longo.o.ernst.ch.rose.evaluation.and.treatment.of.secondary.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165644/c.camaschella.diagnosis.and.treatment.of.non-hfe-haemochromatosis.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165643/p.brissot.c.le.lan.m.-b.t.f.gaboriau.g.lescoat.a.-m.diagnosis.and.treatment.of.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165642/n.gattermann.ph.beris.sideroblastic.anaemias.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165641/c.brugnara.ph.beris.iron.therapy.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165640/c.beaumont.s.vaulont.iron.homeostasis.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165639/s.millot.l.de.falco.c.beaumont.iron.and.erythropoiesis.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165638/n.mohandas.x.an.red.blood.cells.and.malaria.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165637/j.-l.vives.corrons.red.blood.cell.enzyme.defects.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165636/j.delaunay.j.-p.cartron.disorders.of.the.red.cell.membrane.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165635/e.payen.o.ngre.b.gillet-.y.beuzard.e.gluckman.ph.l.first.human.gene.therapy.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165634/f.bernaudin.e.gluckman.in.patients.with.sickle.cell.anaemia.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165633/f.locatelli.m.e.bernardo.for.patients.with.thalassaemia.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165632/f.galactros.m.de.montalembert.a.short.guide.to.management.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165631/l.de.franceschi.c.brugnara.pathophysiology.and.target.pathways.for.novel.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165630/m.d.cappellini.k.m.musallam.c.cesaretti.a.taher.thalassaemia.intermedia.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165629/r.galanello.r.origa.management.of.thalassaemia.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165628/b.wood.d.higgs.molecular.basis.of.thalassaemia.syndromes.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165627/n.casadevall.treatment.with.erythropoiesis.stimulating.agents.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165626/ch.james.w.vainchenker.acquired.polycythaemia.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165625/j.prchal.v.gordeuk.familial.polycythaemia.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165624/h.heimpel.a.iolascon.congenital.dyserythropoietic.anaemias.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165623/ph.scheinberg.n.s.young.aplastic.anaemia.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165622/l.da.costa.g.tchernia.th.leblanc.diamond-blackfan.anaemia.a.constitutional.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165621/j.-f.lambert.ph.beris.pathophysiology.and.differential.diagnosis.of.anaemia.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165620/e.m.pasini.a.w.thomas.m.mann.red.blood.cells.proteomics.physiology.and.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165619/j.vandekerckhove.g.courtois.j.-a.ribeil.o.hermine.regulation.of.erythropoiesis.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2009/handbook/165618/p.h.maxwell.c.w.pugh.regulation.of.oxygen.sensing.and.erythropoietin.production.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165617/faculty.presenters.appendix.ebmt.officers.coordination.offices.committees.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165616/faculty.presenters.abbreviations.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165615/i.a.g.roberts.j.de.la.fuente.hsct.in.the.haemoglobinopathies.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165614/e.gluckman.j.e.wagner.hsct.for.hereditary.bone.marrow.failure.syndromes.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165613/j.j.boelens.r.f.wynn.m.bierings.hsct.for.inborn.errors.of.metabolism.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165612/m.cavazzana-calvo.w.friedri.a.fischer.hsct.for.children.with.severe.combined.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165611/m.miano.g.dini.hsct.for.lymphomas.in.children.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165610/f.locatelli.p.merli.hsct.for.chronic.myeloproliferate.disorders.in.children.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165609/f.locatelli.c.m.niemeyer.hsct.for.myelodysplastic.syndromes.in.children.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165608/t.klingebiel.p.bader.hsct.for.acute.lymphoblastic.leukaemia.in.children.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165607/g.dini.m.miano.hsct.for.acute.myeloid.leukaemia.in.children.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165606/f.prosper.hsct.for.tissue.regeneration.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165605/j.passweg.a.bacigalupo.a.locasciulli.hsct.for.aplastic.anaemia.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165604/r.saccardi.d.farge.hsct.for.autoimmune.diseases.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165603/m.bregni.hsct.for.solid.tumours.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165602/a.sureda.hsct.for.hodgkins.lymphoma.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165601/j.g.cribben.hsct.for.low-grade.non-hodgkins.lymphoma.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165600/a.johnston.b.coiffier.hsct.for.high-grade.non-hodgkins.lymphoma.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165599/j.esteve.hsct.for.primary.amyloidosis.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165598/j.a.prez-simon.j.san.miguel.hsct.for.multiple.myeloma.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165597/p.dreger.hsct.for.chronic.lymphocytic.leukaemia.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165596/p.guardiola.hsct.for.myeloproliferate.disorders.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165595/d.niederweiser.hsct.for.chronic.myeloid.leukaemia.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165594/t.de.witte.g.sanz.hsct.for.myelodysplasia.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165593/n.gkbuget.d.hoelzer.hsct.for.acute.lymphoblastic.leukaemia.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165592/r.varaldo.f.frassoni.hsct.for.acute.myeloid.leukaemia.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165591/z.doran.methodology.of.conducting.academic.clinical.trialsin.europe.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165590/r.m.szydlo.statistical.evaluation.of.hsct.data.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165589/a.gratwohl.p.ljungman.indications.and.current.practice.for.allogeneic.and.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165588/a.kiss.psychosocial.aspects.of.hsct.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165587/a.toubert.immune.reconstitution.after.allogeneic.hsct.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165586/e.nadal.adoptive.cellular.immunotherapy.to.harness.post-transplant.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165585/m.kapp.g.u.grigoleit.h.einsele.immunotherapy.post-transplant.for.infections.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165584/s.r.mccann.m.lawler.the.value.of.molecular.monitoring.in.haematological.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165583/a.tichelli.c-p.schwarze.g.soci.long.term.survivorship.general.health.status.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165582/a.devergie.graft.versus.host.disease.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165581/c.cordonnier.infections.after.hsct.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165580/e.carreras.early.complications.after.hsct.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165579/t.masszi.supportive.care.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165578/d.h.pamphilon.transfusion.policy.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165577/a.gratwohl.principles.of.conditioning.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165576/j.larghero.j.garca.e.gluckman.sources.and.procurement.of.stem.cells.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165575/d.samson.jacie.accreditation.of.transplant.centres.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165574/a.m.dickinson.non-hla.immunogenetics.and.role.in.transplant.outcome.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165573/a.velardi.a.mancusi.f.aversa.m.f.martelli.kir.beneficial.effects.of.natural.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165572/j.m.tiercy.the.role.of.hla.in.hsct.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165571/faculty.presenters.immunogenetics.of.allogeneic.hsct.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165570/a.wodnar-filopowicz.biological.properties.of.haematopoietic.stem.cells.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2008/ebmt_handbook/165569/j.apperley.a.keating.stem.cell.transplant.organisations.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165568/m.ndiaye.senegalese.association.for.the.struggle.against.sickle.cell.disease.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165567/m.wane.support.association.for.scd.in.mauritania.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165566/p.jeannot.struggle.against.sickle.cell.disease.madagascar-france.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165565/f.hima.association.for.the.struggle.against.sickle.cell.disease.in.niger.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165564/e.kafando.problems.related.to.the.availability.of.opioids.in.africa.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165563/l.tshilolo.networks.research.tools.and.cooperation.the.example.of.network.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165562/w.arcese.the.rtn.policy.a.comprehensive.algorythm.of.the.allogeneic.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165561/k.ballen.algorythm.of.donor.choice.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165560/j.wagner.haplo.versus.cord.blood.pros.cord.blood.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165559/s.kharbanda.allogeneic.hematopoietic.stem.cell.transplantation.%28hsct%29.for.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165558/y.h.lee.outcome.analysis.of.unrelated.cord.blood.transplantation.in.korea.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165557/a.abraham.unrelated.donor.umbilical.cord.blood.transplantation.%28ucbt%29.for.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165556/d.weisdorf.cord.blood.transplantation.for.adults.what.have.we.learned.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165555/e.gluckman.cord.blood.transplant.in.children.with.non.malignant.disease.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165554/g.sanz.conditioning.for.cord.blood.transplant.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165553/a.ruggeri.results.of.single.and.double.cord.blood.in.adult.malignancies.cost.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165552/j.wagner.state.of.the.art.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165551/i.diagne.epidemiology.and.treatment.of.sickle.cell.in.senegal.including.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165550/r.jones.haplo-identical.related.hematopoietic.stem.cell.transplant.for.sickle.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165549/t.coates.is.sickle.cell.disease.an.autonomic.nervous.system.disorder.what.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165548/e.gluckman.sickle.cell.disease.global.perspective.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165547/v.rocha.role.of.registries.to.analyze.outcomes.data.eurocord.netcord.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165546/s.querol.updating.the.cord.blood.unit.inventory.to.meet.current.needs.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165545/e.baudoux.state.of.the.art.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165544/r.tamouza.role.of.non.hla.markers.for.donor.selection.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165543/m.oudshoorn.increasing.use.of.hematopoietic.stem.cell.transplantation.for.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165542/p.rebulla.the.italian.cord.blood.platelet.gel.project.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165541/j.girdlestone.treatment.of.mesenchymal.stromal.cells.with.immunosuppressive.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165540/s.watt.crosstalk.between.umbilical.cord.cord.blood.endothelial.precursors.and.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165539/m.cairo.human.cord.blood.%28cb%29.derived.unrestricted.somatic.stem.cells.%28usscs%29.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165538/c.chabannon.assesment.of.hla.diversity.in.marseille.cord.blood.bank.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165537/j.wagner.tregs.for.immune.modulation.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165536/s.paczesny.biomarker.based.personalized.medicine.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165535/f.mavilio.the.present.and.future.challenges.of.gene.therapy.for.sickle.cell.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165534/j.wagner.hematopoietic.stem.cell.expansion.to.overcome.non-engraftment.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165533/e.j.shpall.state.of.the.art.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165532/g.koegler.cord.blood.subpopulations.and.reprogrammed.cells.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2013/world_cord_blood/165531/h.e.broxmeyer.state.of.the.art.including.methods.for.graft.facilitation.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165530/g.koegler.indications.and.results.of.the.use.of.stem.cells.for.regenerative.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165529/j.a.ribeil.gene.therapy.for.hereditary.disorders.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165528/m.walters.a.potential.treatment.for.beta-thalassemia.and.sickle.cell.disease.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165527/s.narayan.establishing.a.cost-effective.national.cord.blood.registry.in.a.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165526/b.cappelli.international.survey.of.haematopoietic.stem.cell.transplant.from.an.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165525/f.bernaudin.indication.of.bone.marrow.transplantation.in.sickle.cell.disease.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165524/m.de.montalembert.treatment.of.sickle.cell.disease.in.emerging.countries.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165523/h.elmoazzen.umbilical.cord.blood.collection.first.year.operations.at.the.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165522/p.dhot.substantially.reduced.red.cell.contamination.with.comparative.nucleated.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165521/l.m.rhsig.comparison.of.the.results.of.haemoglobin.pattern.screened.in.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165520/m.abecasis.clinical.utility.of.family-directed.cord.blood.storage.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165519/m.abecasis.clinical.utility.of.family-directed.cord.blood.storage.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165518/l.ponce-verdugo.inventory.depuration.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165517/m.n.zarif.comparison.of.hla-g.expression.in.mesenchymal.stromal.cells.derived.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165516/m.n.zarif.assessment.of.adhesion.and.homing.molecules.alteration.in.ex.vivo.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165515/w.arcese.prospective.study.on.allogeneic.transplant.in.acute.myeloid.leukaemia.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165514/j.wagner.prevention.of.gvhd.by.umbilical.cord.blood.derived.t-.regulatory.cells.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165513/j.sanz.how.to.improve.cord.blood.transplant.results.in.adults.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165512/j.boelens.towards.individualized.conditioning.regimens.to.improve.the.outcomes.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165511/p.veys.importance.of.cd4%2B.lymphocyte.reconstitution.following.cord.blood.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165510/j.girdlestone.ires.an.immune.reconstitution.study.of.umbilical.cord.blood.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165509/r.tamouza.analysis.of.classical.hla.haplotypes.can.predict.outcomes.of.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165508/e.petersdorf.state.of.the.art.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165507/i.ionescu.contribution.of.eurocord.registry.to.the.improvement.of.cord.blood.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165506/s.querol.cost.efficiency.of.cord.blood.banks.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165505/e.baudoux.introduction.of.the.cord.blood.bank.technology.survey.%28wmda-netcord%29.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165504/j.wagner.single.versus.double.cord.blood.transplant.in.children.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165503/e.gluckman.history.and.future.of.cord.blood.transplantation.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165502/m.cairo.rescue.of.the.mucocutaneous.manifestations.in.a.mouse.model.of.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165501/j.kurtzberg.nicord.expands.haematopoietic.stem.cells.and.shortens.time.to.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165500/f.frassoni.cord.blood.stem.cells.acquire.the.signature.of.induced.pluripotent.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165499/s.e.jacobsen.emergence.of.fetal.immune-restricted.lympho-myeloid.progenitors.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/world_cord_blood/165498/g.koegler.do.we.need.a.different.niche.for.fast.haematopoietic.reconstitution.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165497/giampaolo.merlini.amyloidosis.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165496/steven.treon.waldenstrm.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165495/philippe.moreau.how.to.sequence.agents.in.rrmm.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165494/torben.plesner.monoclonal.antibodies.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165493/heinz.ludwig.supportive.care.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165492/alessandra.larocca.front.line.therapy.for.frail.patients.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165491/michele.cavo.consolidation.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165490/hermann.einsele.induction.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165489/sagar.lonial.drug.development.in.myeloma.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165488/mara-victoria.mateos.mgus.and.smoldering.myeloma.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165487/elena.zamagni.imaging.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165486/sonja.zweegman.when.to.treat.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165485/tuna.mutis.signalling.pathways.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165484/fabio.malavasi.immunity.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165483/nikhil.munshi.clonality.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165482/nicola.giuliani.bone.disease.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165481/bruno.paiva.minimal.residual.disease.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/multiple_myeloma/165480/herv.avet-loiseau.cytogenetics.and.ngs.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/lymphoid_neoplasms_and_myeloma/165479/g.merlini.treatment.options.including.clinical.cases.controversies.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/lymphoid_neoplasms_and_myeloma/165478/m.v.mateos.treatment.options.including.clinical.cases.controversies.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/lymphoid_neoplasms_and_myeloma/165477/h.avet-loiseau.stratification.and.response.evaluation.including.demonstration.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/lymphoid_neoplasms_and_myeloma/165476/h.goldschmidt.current.diagnostics.and.staging.of.mm.including.demonstration.of.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/lymphoid_neoplasms_and_myeloma/165475/m.dreyling.treatment.options.including.clinical.cases.controversies.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/lymphoid_neoplasms_and_myeloma/165474/a.hagenbeek.treatment.options.including.clinical.cases.controversies.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/lymphoid_neoplasms_and_myeloma/165473/m.hutchings.staging.and.response.evaluation.including.the.role.of.pet.ct.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/lymphoid_neoplasms_and_myeloma/165472/a.rosenwald.current.diagnostics.in-.and.classification.of.nhl.including.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165471/karen.van.rassel.the.expectations.of.european.patients.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165470/brian.koffman.the.expectations.of.american.patients.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165469/clemens.suter-crazzolara.tools.for.the.analysis.of.big.data.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165468/gilles.salles.eha.research.roadmap.for.lymphoma.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165467/steven.treon.treatment.of.waldenstrm.macroglobulinemia.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165466/andres.ferreri.treatment.of.cns.lymphoma.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165465/catherine.patte.treatment.of.paediatric.lymphoma.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165464/peter.hillmen.the.uk.trials.on.cll.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165463/michael.hallek.the.gcllsg.trials.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165462/richard.little.the.us.trials.on.nhl.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165461/gilles.salles.new.agents.in.the.management.of.nhl.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165460/charles.mullighan.development.of.targeted.agents.in.all.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165459/anthony.letai.mechanisms.of.bcl2.inhibitors.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165458/david.maloney.allogeneic.stem.cell.transplantation.for.lymphoid.malignancies.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165457/ronald.levy.history.and.future.role.of.immune.therapy.in.lymphoma.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165456/wyndham.wilson.imaging.and.circulating.tumour.dna.in.lymphoma.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165455/lena.specht.pet.and.ct.imaging.in.hodgkin.lymphoma.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165454/christoph.plass.epigenetics.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165453/catherine.wu.genomic.profiling.and.clonal.evolution.under.treatment.of.cll.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165452/peter.borchmann.drugs.targeting.the.tme.of.hodgkin.lymphoma.the.clinical.story.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165451/hans-guido.wendel.functional.interactions.between.malignant.and.non-malignant.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165450/jasmin.bahlo.integration.of.genetic.and.clinical.information.into.one.score.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/lymphoma/165449/david.weinstock.inducing.non-cell.autonomous.killing.of.double-hit.lymphoma.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/practical_problems/165448/pierre.fenaux.molecularly.defined.mds.and.mds.mpn.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/practical_problems/165447/pierre.fenaux.overview.of.new.drugs.clinical.trials.and.international.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/practical_problems/165446/nicolaus.krger.allogeneic.sct.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/practical_problems/165445/eva.hellstrom-lindberg.treatment.of.lower.risk.mds.%28non.del.5q%29.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/practical_problems/165444/raphal.itzykson.prognosis.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2015/practical_problems/165443/anna.v.diagnosis.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/myeloproliferative_neoplasms/165442/ruben.mesa.next.generation.mpn.management.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/myeloproliferative_neoplasms/165441/tiziano.barbui.rethinking.the.treatment.recommendations.in.low-risk.pv.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/myeloproliferative_neoplasms/165440/giovanni.barosi.natural.history.and.risk.stratification.of.prefibrotic.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/myeloproliferative_neoplasms/165439/ronald.hoffman.the.effects.of.specialized.microenvironments.on.haematopoiesis.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/myeloproliferative_neoplasms/165438/david.kent.using.single.cell.biology.to.identify.stem.cell.fate.regulators.in.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/myeloproliferative_neoplasms/165437/isabelle.plo.modeling.predisposition.to.familial.mpn.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/myeloproliferative_neoplasms/165436/josef.prchal.cellular.and.molecular.response.to.interferon.therapy.in.pv.and.et.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/myeloproliferative_neoplasms/165435/thomas.radimerski.targeting.jak2.have.we.arrived.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/myeloproliferative_neoplasms/165434/olli.silvennoinen.molecular.insights.into.regulation.of.jak2.in.mpn.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/myeloproliferative_neoplasms/165433/john.crispino.role.of.megakaryocytes.in.the.mpns.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/myeloproliferative_neoplasms/165432/ross.levine.epigenetic.alterations.and.therapeutic.targeting.in.mpn.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/myeloproliferative_neoplasms/165431/peter.campbell.the.genomics.of.mpns.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/myeloproliferative_neoplasms/165430/charles.mullighan.the.genomic.basis.of.acute.lymphoblastic.leukaemia.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/myeloproliferative_neoplasms/165429/mary-frances.mcmullin.causes.of.myeloproliferative.disorders.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/myelodysplastic_syndromes/165428/n.krger.experimental.transplantation.approaches.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/myelodysplastic_syndromes/165427/t.de.witte.allogeneic.hsct.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/myelodysplastic_syndromes/165426/l.ades.high.risk.mds.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/myelodysplastic_syndromes/165425/m.jdersten.management.of.mds.with.del%285q%29.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/myelodysplastic_syndromes/165424/e.hellstrm-lindberg.pathophysiology.and.treatment.of.anaemia.in.mds.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/myelodysplastic_syndromes/165423/r.itzykson.predictive.factors.for.response.to.treatment.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/myelodysplastic_syndromes/165421/l.malcovati.prognosis.and.risk.assessment.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/myelodysplastic_syndromes/165419/t.haferlach.molecular.biology.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/myelodysplastic_syndromes/165417/t.westers.flow.cytometry.in.the.diagnostic.work-up.of.myelodysplastic.syndromes.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/myelodysplastic_syndromes/165415/g.ghring.cytogenetics.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/myelodysplastic_syndromes/165413/p.woll.myelodysplastic.stem.cells.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/myelodysplastic_syndromes/165410/brigitte.schlegelberger.germline.mutations.predisposing.to.mds.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2014/myelodysplastic_syndromes/165409/d.bowen.epidemiology.of.mds.and.environmental.factors.html 2016-12-20 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119645/joan-lluis.vives-corrons.closing.remarks.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119644/jean-benoit.arlet.new.treatments.of.dyserythropoiesis.html 2016-03-11 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119643/ann.barbier.new.treatments.of.pkd.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119642/jose.segovia.gene.therapy.for.pkd.and.other.rare.disorders.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119641/antonio.risitano.paroxysmal.nocturnal.haemoglobinuriaclinical.picture.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119640/flora.peyvandi.microangiopathic.haemolytic.anemias.ttp.hus.%28haemolytic.uraemic.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119639/sigbjorn.berentsen.transient.and.chronic.cold-antibody.mediated.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119638/wilma.barcellini.autoimmune.haemolytic.anaemias.by.warm.antibodies.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119637/paola.bianchi.red.blood.cell.enzymes.abnormalities.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119636/maria.domenica.cappellini.erythropoietic.porphyrias.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119635/loic.garcon.hereditary.stomatocytosis.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119634/tabita.maia.hereditary.elliptocytosis.pyropoikilocytosis.and.south-east.asian.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119633/paola.bianchi.disorders.of.rbc.cytoskeleton.hereditary.spherocytosis.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119632/reinier.raymakers.hereditary.sideroblastic.anaemiaspathophysiology.genetics.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119631/achille.iolascon.hereditary.microcytic.anaemia.-.molecular.basis.clinical.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119630/laura.silvestri.crosstalk.between.iron.and.erythropoiesis.a.lesson.from.irida.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119629/antonio.risitano.aplastic.anaemia.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119628/lydie.da.diamond.blackfan.anaemia.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119627/achille.iolascon.congenital.dyserythropoietic.anaemias.%28cda%29.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119626/michael.angastiniotis.an.overwiew.on.the.epidemiology.of.very.rare.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2016/enerca/119625/patricia.aguilar.martinez.introduction.html 2016-03-08 monthly 0.5 https://elearning.esh.org/esh/2011/video/98853/faculty.presenters.esh.corporate.video.html 2011-06-14 monthly 0.5 https://elearning.esh.org/esh/2011/video/98455/faculty.presenters.communication.skills.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2011/video/96869/faculty.presenters.interactive.session.for.haematologists.and.patients.at.the.html 2011-06-14 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95402/doctor.martin.colard.and.doctor.corentin.orvain.closing.debate.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95254/olivier.hermine.the.red.cell.from.genesis.to.death.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95253/olivier.hermine.laboratory.of.cellular.and.molecular.mechanisms.of.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95252/patricia.aguilar.martinez.introduction.to.the.course.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95017/dimitris.loukopoulos.closing.debate.the.future.of.red.cell.pathologies.among.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95016/frederic.cotton.laboratory.diagnosis.of.abnormal.haemoglobins.an.update.-.from.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95015/maria.domenica.cappellini.iron.overload.in.thalassaemia.and.sickle.cell.disease.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95014/yves.beuzard.gene.therapy.in.thalassaemia.and.sickle.cell.disease.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95013/alina.ferster.bone.marrow.transplantation.in.thalassaemia.and.sickle.cell.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95012/cornelis.l.harteveld.guidelines.for.the.biological.diagnosis.of.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95011/patricia.aguilar.martinez.unstable.haemoglobins.physiopathology.clinical.and.html 2015-03-30 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95010/lucia.de.franceschi.sickle.cell.disease.in.adults.and.elderly.patients.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95009/mariane.de.montalembert.sickle.cell.disease.%28scd%29.in.children.and.adolescents.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95008/cornelis.l.harteveld.alpha-thalassaemia.new.fast.test.for.the.molecular.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95007/patricia.aguilar.martinez.beta-thalassaemia.from.cbc.to.dna.methodologies.and.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95005/maria.domenica.cappellini.beta-thalassaemia.clinical.findings.molecular.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95004/joan-lluis.vives-corrons.recommendations.for.the.recognition.of.centres.of.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95003/michael.angastiniotis.prevention.programmes.for.thalassaemia.and.sickle.cell.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95001/marina.kleanthous.prevention.of.severe.forms.of.haemoglobinopathies.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/95000/beatrice.gulbis.neonatal.screening.for.sickle.cell.disease.in.european.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2015/enerca/94999/maria.del.mar.manu.%28ma%29.migrations.and.haemoglobin.disorders.current.status.in.html 2015-03-27 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/39325/paul.browne.welcome.address.html 2013-12-06 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38723/evangelos.terpos.imaging.html 2014-01-16 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38722/evangelos.terpos.bone.disease.html 2014-01-29 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38721/keith.stewart.carfilzomib.html 2014-02-12 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38720/pieter.sonneveld.treatment.of.younger.patients.html 2014-02-26 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38719/alberto.rocci.gene.expression.profiling.and.mirna.html 2013-12-06 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38718/antonio.palumbo.treatment.of.fit.elderly.patients.html 2014-02-26 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38717/bruno.paiva.new.tools.for.response.assessment.and.prognostic.value.of.cr.html 2014-01-16 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38716/enrique.ocio.histone.deacetylase.html 2014-02-12 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38715/nikhil.munshi.whole.genome.sequence.html 2013-12-06 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38714/enrica.morra.waldenstrom.macroglobulinemia.html 2014-03-12 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38712/philippe.moreau.crab.and.staging.html 2014-01-16 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38710/mara-victoria.mateos.smouldering.myeloma.html 2014-03-12 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38709/heinz.ludwig.clinical.conditions.-.side.effects.html 2014-01-29 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38708/sagar.lonial.monoclonal.antibodies.html 2014-02-12 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38707/henk.lokhorst.role.of.allo.html 2014-02-26 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38706/alessandra.larocca.frailty.html 2014-01-29 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38705/shaji.kumar.mgus.html 2014-03-12 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38704/stefan.knop.renal.insufficiency.html 2014-01-29 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38703/roman.hajek.mln9708.html 2014-02-12 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38702/thierry.facon.pomalidomide.html 2014-02-12 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38701/michel.delforge.treatment.of.relapse.html 2014-02-26 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38700/faith.davies.snip.and.cgh.arrays.html 2013-12-06 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38699/michele.cavo.stratification.for.risk.or.age.html 2014-02-26 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38698/herv.avet-loiseau.prognostic.of.cytogenetic.abnormalities.html 2014-01-16 monthly 0.5 https://elearning.esh.org/esh/2013/cmm/38697/mohamad.mohty.role.of.consolidation.maintenance.html 2014-02-26 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21319/ghulam.mufti.discussion.html 2012-05-30 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21313/mario.cazzola.wrap-up.of.new.molecular.findings.in.mds.-.time.for.a.new.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21312/l.ades.sct.-.decision-making.for.very.high-risk.and.elderly.patients.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21310/l.ades.hypomethylating.agents.in.best.clinical.practice.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21308/a.ganser.how.to.treat.thrombocytopenia.and.autoimmune.features.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21307/guillermo.garcia-manero.combination.drug.therapy.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21306/guillermo.garcia-manero.new.experimental.drugs.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21305/alan.list.new.molecular.and.biological.targets.for.treatment.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21304/pierre.fenaux.risk.evaluation.and.treatment.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21303/charlotte.niemeyer.juvenile.myelomonocytic.leunited.kingdomemia.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21302/dt.bowen.adult.cmml.clinical.features.and.treatment.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21300/seishi.ogawa.spliceosome.mutations.in.different.subtypes.of.mds.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21299/eva.hellstrom-lindberg.clinical.features.and.prognosis.html 2012-05-26 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21298/mario.cazzola.sf3b1.mutations.in.mds.with.ring.sideroblasts.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21295/jacqueline.boultwood.biology.of.anaemia.and.disease.progression.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21293/theo.de.witte.therapeutic.recommendations.in.low-.and.high-risk.mds.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21291/nicolaus.krger.allogeneic.stem.cell.transplantation.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21290/pierre.fenaux.hypomethylating.agents.and.chemotherapy.html 2012-08-29 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21289/a.ganser.immunosuppressive.therapy.and.immunoregulatory.drugs.%28imids%29.html 2012-05-25 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21288/arjan.van.de.loosdrecht.transfusion.therapy.and.erythropoiesis-stimulating.html 2012-05-25 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21287/charlotte.niemeyer.clinical.evaluation.and.risk.assessment.in.children.and.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21285/eva.hellstrom-lindberg.less.common.clinical.features.in.mds.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21284/theo.de.witte.clinical.presentation.including.data.from.the.eumds.registry.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21282/brigitte.schlegelberger.cytogenetics.and.molecular.genetics.in.clinical.practice.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21281/arjan.van.de.loosdrecht.immunophenotyping.html 2012-05-25 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21280/anna.porwit.role.of.morphology.in.2012.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21279/petter.s.woll.mds.stem.and.progenitor.cell.biology.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21276/joop.jansen.deciphering.myelodysplastic.genome.html 2012-06-07 monthly 0.5 https://elearning.esh.org/esh/2012/mds/21274/dt.bowen.incidence.of.mds.and.environmental.factors.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/19900/a.a.m.ermens.clinical.case.2.html 2012-03-08 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/19899/richard.van.wijk.clinical.case.1.html 2012-03-08 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/19868/alberto.zanella.%26.leticia.ribeiro.clinical.cases.of.membrane.disorders.html 2012-02-03 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/19866/maria.domenica.cappellini.iron.overload.and.chelation.therapy.html 2012-02-03 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/19865/patricia.aguilar.martinez.welcome.to.participants.html 2012-03-12 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/17976/annalisa.ruggeri.cord.blood.transplant.and.very.rare.anaemias.html 2012-01-09 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/17974/andrea.mosca.quality.controls.for.the.diagnosis.of.rare.red.cell.disorders.html 2012-01-09 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/17973/regis.peffault.de.latour.paroxysmal.nocturnal.haemoglobinuria.html 2012-01-09 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/17972/paul.coppo.microangiopathic.haemolytic.anaemias.-.ttp.hus.%28.haemolytic.uraemic.html 2012-01-09 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/17971/sigbjorn.berentsen.cold-antibody.mediated.autoimmune.hemolytic.anemia.html 2012-01-09 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/17970/norbert.ahrens.autoimmune.haemolytic.anaemias.by.warm.antibodies.html 2012-03-08 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/17969/joan-lluis.vives-corrons.clinical.case.3.html 2012-01-09 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/17968/richard.van.wijk.normal.and.defective.red.blood.cell.metabolism.abnormalities.html 2012-01-09 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/17967/joan-lluis.vives-corrons.closing.talk.of.day.1.html 2012-01-09 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/17966/jean.charles.deybach.erythropoietic.porphyrias.html 2012-01-09 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/17963/leticia.ribeiro.hereditary.elliptocytosis.pyropoikilocytosis.and.south-east.html 2012-03-11 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/17962/alberto.zanella.hereditary.spherocytosis.html 2012-01-09 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/17961/maria.domenica.cappellini.clinical.cases.html 2012-01-09 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/17960/alison.may.hereditary.sideroblastic.anaemias.html 2012-01-09 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/17959/carole.beaumont.rare.inherited.anaemias.due.to.defects.in.the.erythroblastiron.html 2012-01-09 monthly 0.5 https://elearning.esh.org/esh/2012/enerca/17954/gulbis.beatrice.what.are.very.rare.anaemias.html 2012-03-07 monthly 0.5 https://elearning.esh.org/esh/2011/esh.isth.course/17339/saskia.middeldorp.recurrent.fetal.loss.and.thrombophilia.html 2012-01-06 monthly 0.5 https://elearning.esh.org/esh/2011/esh.isth.course/17338/sylvia.haas.novel.antithrombotic.drugs.html 2011-10-27 monthly 0.5 https://elearning.esh.org/esh/2011/esh.isth.course/17337/marcel.levi.disseminated.intravascular.coagulation.html 2011-12-21 monthly 0.5 https://elearning.esh.org/esh/2011/esh.isth.course/17335/ph.g.de.groot.antiphospholipid.syndrome.html 2011-10-27 monthly 0.5 https://elearning.esh.org/esh/2011/esh.isth.course/17334/anna.falanga.cancer.and.thrombosis.html 2011-10-27 monthly 0.5 https://elearning.esh.org/esh/2011/esh.isth.course/17330/gordon.lowe.arterial.thrombosis.pathogenesis.epidemiology.html 2011-10-27 monthly 0.5 https://elearning.esh.org/esh/2011/esh.isth.course/17328/frits.rosendaal.venous.thrombosis.etiology.pathogenesis.and.prognosis.html 2011-10-27 monthly 0.5 https://elearning.esh.org/esh/2011/esh.isth.course/17327/pieter.reitsma.genetic.risk.factors.of.arterial.and.venous.thrombosis.html 2011-10-27 monthly 0.5 https://elearning.esh.org/esh/2011/esh.isth.course/17326/bjorn.dahlback.control.mechanisms.of.coagulation.html 2011-10-27 monthly 0.5 https://elearning.esh.org/esh/2011/esh.isth.course/17325/alan.nurden.inherited.platelet.bleeding.disorders.diagnosis.and.treatment.html 2011-10-27 monthly 0.5 https://elearning.esh.org/esh/2011/esh.isth.course/17323/pier.mannucci.management.of.coagulation.disorders.complications.and.prevention.html 2011-10-27 monthly 0.5 https://elearning.esh.org/esh/2011/esh.isth.course/17322/flora.peyvandi.rare.bleeding.disorders.html 2011-10-27 monthly 0.5 https://elearning.esh.org/esh/2011/esh.isth.course/17320/pieter.reitsma.molecular.genetics.of.coagulation.html 2011-10-27 monthly 0.5 https://elearning.esh.org/esh/2011/esh.isth.course/17319/david.lane.biochemistry.of.the.coagulation.systems.html 2011-10-27 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12606/faculty.presenters.debate.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12604/faculty.presenters.debate.html 2012-03-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12601/jeroen.janssen.residual.normal.stem.cells.can.be.detected.in.newly.diagnosed.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12598/benjamin.hanfstein.the.prognostic.significance.of.molecular.and.cytogenetic.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12597/paolo.vigneri.high.bcr-ablis.expression.levels.at.diagnosis.and.after.3.and.6.html 2012-04-03 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12596/david.t.yeung.switching.to.nilotinib.vs.imatinib.dose.escalation.for.patients.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12595/athina.giannoudis.correlation.of.hoct1.genetic.polymorphisms.with.the.clinical.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12594/jamshid.khorashad.bcr-abl.compound.mutations.in.cml.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12592/wolfgang.warsch.jak-2.is.clearly.an.important.therapeutic.target.in.cml.no.html 2012-03-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12590/min.chen.jak-2.is.clearly.an.important.therapeutic.target.in.cml.yes.html 2012-03-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12588/giovanni.martinelli.there.is.a.definite.need.to.target.stem.cells.no.html 2012-01-26 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12586/charles.schiffer.all.cml.patients.should.start.treatment.with.2g-tki.no.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12585/philippe.rousselot.maintenance.of.a.stable.ccyr.is.an.adequate.therapeutic.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12584/michele.baccarani.maintenance.of.a.stable.ccyr.is.an.adequate.therapeutic.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12583/giuseppe.saglio.stopping.tki.can.now.be.recommended.in.selected.partients.no.html 2012-01-26 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12581/franois-xavier.mahon.stopping.tki.can.now.be.recommended.in.selected.patients.html 2012-03-23 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12579/stephen.o.brien.how.do.we.define.the.best.front-line.therapy.for.cml.and.can.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12578/jorge.cortes.a.phase.1.study.of.dcc-2036.an.oral.novel.inhibitor.of.abl.kinase.html 2012-03-27 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12574/susan.branford.multiple.non-resistant.low-level.bcr-abl1.mutations.in.cml.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12572/jorge.cortes.updated.phase.1.data.on.ponatinib.a.pan-bcr-abl.inhibitor.in.cml.html 2012-03-27 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12571/carlo.gambacorti-passerini.the.bela.trial.18-month.update.on.safety.and.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12570/yi-fen.lu.distinct.graft-vs-leukimic.stem.cell.of.early.or.delayed.donor.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12566/jerry.radich.man.versus.machine.a.semi-automated.platform.for.bcr-abl.qpcr.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12563/yoshiro.maru.regulation.of.mature.versus.immature.conformation.of.bcr-abl.html 2012-11-14 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12562/wolfgang.warsch.targeting.stat5.in.cml.mechanism-of-action.of.jak2.tyrosine.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12561/piotr.kopinski.rac2.-.mitochondrial.respiratory.chain.complex.iii.signaling.html 2012-05-17 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12558/oliver.hantschet.keynote.lecture.10.years.of.imatinib.resistance-.heaps.of.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12557/yashodhara.dasgupta.sensitivity.to.imatinib.in.bcr-abl1-positive.cml.cells.is.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12556/thomas.o.hare.irreversibel.apoptosis.commitment.of.cml.cells.following.acute.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12553/faculty.presenters.general.discussion.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12552/kathryn.roberts.identification.of.novel.kinase-activating.rearrangements.in.html 2011-10-03 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12550/king.pan.ng.a.novel.bim.polymorphism.mediates.resistance.to.bcr-abl.inhibitors.html 2012-04-10 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12547/vignir.helgason.inhibition.of.the.pi3k.akt.mtor.pathway.induces.cell.death.and.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12544/paolo.gallipoli.evaluation.of.the.efficacy.and.mechanism.of.action.of.the.jak2.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12542/sharon.lim.targeting.of.a.novel.mnk-eif4e-b-catenin.axis.in.blast.crisis.cml.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12536/christian.hurtz.bcl6.is.required.for.the.initiation.and.maintenance.of.cml.html 2011-10-03 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12535/min.chen.a.novel.ahi-1-bcr-abl-jak2.interaction.complex.mediates.cellular.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12534/mike.deininger.finding.the.soft.spot.targeting.cml.stem.cells.html 2011-09-22 monthly 0.5 https://elearning.esh.org/esh/2011/cml.13th/12532/john.goldman.cml.reminiscences.and.dreams.html 2012-03-23 monthly 0.5 https://elearning.esh.org/esh/2011/video/8112/didi.jasmin.extract.from.film.institut.universitaire.d.hmatologie.de.l.html 2011-06-17 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6826/michael.angastiniotis.epidemiology.and.prevention.programmes.on.thalassaemia.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6824/douglas.higgs.keynote.lecture.expression.of.haemoglobin.genes.in.2011.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6823/jan.traeger-synodinos.prevention.of.thalassaemia.and.sickle.cell.disease.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6822/gulbis.beatrice.prevention.of.thalassaemia.and.sickle.cell.disease.neonatal.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6821/john.porter.clinical.cases.of.sickle.cell.disease.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6820/swee.lay.thein.clinical.cases.of.sickle.cell.disease.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6819/john.porter.thalassaemia.and.sickle.cell.disease.pathophysiology.evaluation.of.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6817/alina.ferster.haematopoietic.stem.cell.transplantation.%28hsct%29.in.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6816/frederic.cotton.laboratory.diagnosis.of.abnormal.haemoglobins.phenotype.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6815/dimitris.loukopoulos.haemoglobins.with.abnormal.functions.pathophysiology.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6814/jacques.elion.frequent.haemoglobin.variants.hb.c.hb.e.hb.d.-.epidemiology.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6813/patricia.aguilar.martinez.methodologies.and.laboratory.diagnosis.-2.molecular.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6812/joan-lluis.vives-corrons.methodologies.and.laboratory.diagnosis.-1.including.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6811/swee.lay.thein.sickle.cell.disease.in.the.adult.emerging.complications.and.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6810/mariane.de.montalembert.sickle.cell.disease.%28scd%29.in.the.young.clinical.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6809/maria.domenica.cappellini.clinical.cases.of.thalassaemia.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6808/douglas.higgs.%5Balpha%5D-thalassaemia.other.forms.-.atrx.syndromes.thalassaemia.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6807/douglas.higgs.%5Balpha%5D-thalassaemia.clinical.findings.genetic.basis.molecular.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6805/swee.lay.thein.-thalassaemia.molecular.defects.genotype.phenotype.relationship.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2011/enerca/6804/dimitris.loukopoulos.structure.genetic.control.and.synthesis.of.haemoglobin.html 2011-05-03 monthly 0.5 https://elearning.esh.org/esh/2010/12th/5728/john.barrett.welcome.to.washington.html 2011-01-13 monthly 0.5 https://elearning.esh.org/esh/2010/12th/5567/charles.schiffer.musical.interlude.html 2011-04-06 monthly 0.5 https://elearning.esh.org/esh/2010/12th/5566/john.goldman.closing.comments.html 2010-09-24 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5379/doctor.lodovico.balducci.ethics.of.the.management.of.the.older.patients.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5242/jane.apperley.allogeneic.stem.cell.transplantation.in.elderly.patients.is.it.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5241/jean-jacques.kiladjian.other.mpn.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5240/philippe.rousselot.cml.in.the.elderly.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5239/vincent.levy.treatment.of.cll.in.the.elderly.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5238/christian.buske.indolent.lymphoma.in.the.elderly.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5236/h.tilly.diffuse.large.b-cell.lymphoma.in.the.elderly.html 2010-08-20 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5235/franois.pein.helping.the.patient.how.to.focus.on.the.real.problems.after.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5234/doctor.lodovico.balducci.special.lecture.the.caregiver.of.the.older.aged.person.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5233/michel.delforge.prophylaxis.and.management.of.toxicities.induced.by.novel.agents.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5232/thierry.facon.treatment.of.multiple.myeloma.in.the.elderly.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5231/jean-luc.harousseau.are.current.concepts.in.the.treatment.of.multiple.myeloma.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5230/joan.blad.monoclonal.gammopathies.and.multiple.myeloma.diagnostic.criteria.and.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5229/a.r.delannoy.biology.and.treatment.of.all.in.the.elderly.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5228/claude.gardin.management.of.aml.in.the.elderly.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5227/aline.renneville.biology.of.aml.in.the.elderly.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5226/rose.christian.the.role.of.iron.chelation.therapy.in.elderly.patients.with.mds.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5225/odile.beyne-rauzy.quality.of.life.and.functional.tests.in.elderly.patients.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5224/pierre.fenaux.hypomethylating.agents.and.chemotherapy.in.higher.risk.mds.in.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5223/pierre.fenaux.treatment.of.anaemia.of.lower.risk.mds.in.the.elderly.transfuse.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5222/reinhard.stauder.mds.a.disease.of.very.elderly.patients.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5220/doctor.lodovico.balducci.neutropenia.and.infection.in.older.patients.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5219/claire.falandry.pharmacology.of.ageing.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5218/mario.barbagallo.functional.assessment.of.the.elderly.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5217/g.gambassi.comorbidity.polymorbidity.and.polypharmacy.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5216/m.rainfray.life.expectancy.and.frailty.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5214/i.irminger-finger.biology.of.ageing.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5213/a.j.cruz-jentoft.epidemiology.of.ageing.in.europe.and.in.the.world.clinical.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/elderly/5212/doctor.lodovico.balducci.a.panorama.on.ageing.anaemia.in.the.elderly.html 2010-08-03 monthly 0.5 https://elearning.esh.org/esh/2010/ITP/4953/david.kuter.consents.agreement.html 2010-05-15 monthly 0.5 https://elearning.esh.org/esh/2010/ITP/4730/adrian.c.newland.future.therapies.html 2010-05-15 monthly 0.5 https://elearning.esh.org/esh/2010/ITP/4729/bob.olsson.ctl-mediated.itp.html 2010-05-28 monthly 0.5 https://elearning.esh.org/esh/2010/ITP/4727/raphael.clynes.fc.receptors.html 2010-05-15 monthly 0.5 https://elearning.esh.org/esh/2010/ITP/4726/alan.h.lazarus.recent.advances.in.fc.receptor-dependant.therapies.html 2010-05-28 monthly 0.5 https://elearning.esh.org/esh/2010/ITP/4725/marc.michel.anti-cd20.monoclonal.antibodies.old.and.new.html 2010-05-28 monthly 0.5 https://elearning.esh.org/esh/2010/ITP/4724/david.kuter.clinical.studies.with.tpo.mimetics.html 2010-05-15 monthly 0.5 https://elearning.esh.org/esh/2010/ITP/4723/david.kuter.thrombopoietin.mimetics.old.and.new.html 2010-05-28 monthly 0.5 https://elearning.esh.org/esh/2010/ITP/4722/hans.wadenvik.splenectomy.is.the.best.option.for.induction.of.durable.html 2010-06-03 monthly 0.5 https://elearning.esh.org/esh/2010/ITP/4721/ameet.sarpatwari.how.useful.is.the.indium.labelled.platelet.survival.study.html 2010-05-28 monthly 0.5 https://elearning.esh.org/esh/2010/ITP/4719/douglas.b.cines.pathogenesis.of.itp.html 2010-05-28 monthly 0.5 https://elearning.esh.org/esh/2010/ITP/4718/stan.urbaniak.peptide.therapy.for.patients.with.itp.html 2010-06-03 monthly 0.5 https://elearning.esh.org/esh/2010/ITP/4717/john.w.semple.mouse.models.of.itp.html 2010-06-03 monthly 0.5 https://elearning.esh.org/esh/2010/ITP/4716/karina.yazdanbakhsh.autoimmune.mechanisms.and.t.regulatory.cell.disturbances.html 2010-06-03 monthly 0.5 https://elearning.esh.org/esh/2010/ITP/4715/andy.weyrich.megakaryocyte.differentiation.and.platelet.production.html 2010-06-03 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4300/martin.jdersten.case.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4299/arjan.van.de.loosdrecht.case.flow.cytometry.in.myelodysplastic.syndromes.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4298/barbara.bain.new.aspects.of.mds.and.not.yet.mds.morphology.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4256/guillermo.garcia-manero.high-risk.mds.hidaci.and.ongoing.trials.at.clinical.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4255/michael.lubbert.decitabine.in.mds.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4254/pierre.fenaux.azacytidine.in.mds.html 2009-12-16 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4251/neil.young.immunosupression.in.low-risk.mds.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4250/eva.hellstrom-lindberg.growth.factor.treatment.of.low-risk.mds.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4248/nicolaus.krger.non.myelomablative.stem.cell.transplantation.html 2010-01-25 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4247/theo.de.witte.ablative.sct.preceding.chemotherapy.html 2009-12-16 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4246/guillermo.garcia-manero.management.and.treatment.of.thrombocytopenia.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4245/dt.bowen.treatment.of.transfusion.iron.overload.in.mds.the.con-chelation.view.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4244/rose.christian.treatment.of.transfusion.iron.overload.in.mds.the.pro-chelation.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4241/martin.jdersten.treatment.of.5q-.the.con-lenalidomide.view.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4240/pierre.fenaux.treatment.of.5q-.the.pro-lenalidomide.view.html 2009-12-16 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4238/simone.boehrer.clonal.evolution.and.leukaemic.transformation.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4237/michaela.fontenay.molecular.biology.and.genetic.pathways.in.low-risk.mds.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4236/jaroslaw.maciejewski.molecular.biology.and.genetic.pathways.in.mds.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4235/eva.hellstrom-lindberg.apoptosis.and.erythroid.failure.in.low-risk.mds.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4233/rose.ann.padua.animal.models.-.genetically.modified.mice.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4231/jaroslaw.maciejewski.mds.research.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4229/pierre.fenaux.therapy.related.mds.html 2009-12-16 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4226/joop.jansen.tet2.mutations.in.mds.and.mpns.html 2010-01-05 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4224/dt.bowen.chronic.myelomonocytic.leukaemia.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4222/martin.jdersten.clinical.presentation.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4221/dt.bowen.epidemiology.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4220/barbara.bain.new.aspects.of.mds.and.not.yet.mds.morphology.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4218/arjan.van.de.loosdrecht.role.of.flow.cytometry.in.mds.diagnostics.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4217/brigitte.schlegelberger.cytogenetics.and.molecular.genetics.in.mds.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4216/anna.porwit.diagnosis.and.who.2008.classification.of.mds.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4215/henrik.hasle.childhood.mds.and.jmml.biology.diagnosis.and.treatment.html 2009-12-15 monthly 0.5 https://elearning.esh.org/esh/2009/MDS/4214/neil.young.pathophysiologic.links.between.marrow.failure.genomic.instability.html 2009-12-16 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3786/john.goldman.what.does.the.future.hold.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3785/charles.schiffer.debate.do.we.need.monitoring.for.fish-negative.patients.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3784/giuseppe.saglio.debate.do.we.need.monitoring.for.fish-negative.patients.%28for%29.html 2010-03-24 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3783/john.goldman.debate.do.we.need.to.target.quiescent.stem.cells.%28against%29.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3782/tessa.holyoake.debate.do.we.need.to.target.quiescent.stem.cells.%28for%29.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3779/paolo.salomoni.inhibiting.autophagy.in.cml.therapy.html 2009-12-31 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3778/danilo.perrotti.forskolin.of.fty720.for.cml.in.advanced.phase.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3776/gianantonio.rosti.front-line.use.of.dasatinib.and.nilotinib.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3775/jorge.cortes.where.next.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3774/franois-xavier.mahon.stim.update.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3773/carlo.gambacorti-passerini.imatinib.longterm.effects.study.in.cml.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3772/david.marin.factors.determining.an.optimal.molecular.response.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3770/delphine.rea.im.plus.pegylated.inf-%26%23945.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3769/tim.hughes.future.prospects.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3766/rocco.piazza.resistance.profile.of.bosutinib.using.a.high.throughput.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3765/bruno.quesnel.glucocorticoid.induced.leucine.zipper.overcomes.tki.resistance.html 2009-12-31 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3762/daniela.cilloni.foxo.involvement.in.cml.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3759/agnes.yong.ex.vivo.expanded.nk.cells.to.target.quiescent.lsc.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3758/satu.mustjoki.expansion.of.functional.pre-existing.memory.t-cells.during.tki.html 2010-01-04 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3757/katy.rezvani.effect.of.tkis.on.normal.immune.responses.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3756/richard.clark.how.and.when.to.use.immunotherapy.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3755/shaoguang.li.novel.molecular.pathways.in.lsc.using.mouse.models.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3754/michael.melkus.generation.of.an.in.vivo.bcr-abl.t315i.embryonic.stem.cell.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3750/rick.van.etten.can.murine.models.still.be.improved.html 2009-12-31 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3749/anthony.green.the.real.role.of.jak2-v617f.html 2009-09-11 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3748/jiang.xiaoyan.targeting.cml.stem.progenitor.cells.by.combining.new.abl.and.jak.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3746/giovanni.martinelli.smo.inhibition.to.eradicate.lsc.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3745/marieke.essers.effects.of.ifna.on.lsc.html 2009-12-31 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3743/tessa.holyoake.defining.and.targeting.lsc.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3742/simona.soverini.results.of.snp-arrays.in.various.phases.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3741/feyruz.rassool.alternatives.nhej.is.a.novel.therapeutic.target.in.a.subset.of.html 2009-12-31 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3740/emmanuelle.passegue.hematopoietic.stem.cell.quiescence.promotes.error.prone.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3739/martin.sattler.mitochondrial.origin.of.intracellular.ros.in.cml.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3738/markus.muschen.the.b.cell.mutator.aid.promotes.b.lymphoid.blast.crisis.in.cml.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3735/ilaria.iacobucci.whole.genome.sequencing.of.ph-positive.all.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3734/charles.mullighan.genetic.alterations.in.high-risk.bcr-abl1-like.all.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3732/danilo.perrotti.which.molecular.events.really.underlie.progression.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3729/carlo.gambacorti-passerini.blockage.of.gsk3b.promotes.sensitivity.of.ph%2B.lsc.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3727/yoshiro.maru.chip.works.with.hsc-70.co-chaperone.to.degrade.bcr-abl.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3725/michael.w.deininger.which.molecular.events.are.really.initiating.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3723/steffen.koschmieder.point.mutations.in.pdgfra.in.myeloproliferative.disease.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3721/francois.delhommeau.tet2.alterations.in.the.multistep.onset.of.html 2009-12-29 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3720/brian.druker.icmlf.inaugural.lecture.-.tkis.now.but.what.next.html 2010-01-25 monthly 0.5 https://elearning.esh.org/esh/2009/11th/3719/john.goldman.welcome.html 2010-01-20 monthly 0.5 https://elearning.esh.org/esh/2009/AutoImmune/3206/drew.provan.introduction.html 2009-02-19 monthly 0.5 https://elearning.esh.org/esh/2009/AutoImmune/3024/john.w.semple.overview.of.the.immunology.of.autoimmune.disease.html 2009-02-19 monthly 0.5 https://elearning.esh.org/esh/2009/AutoImmune/3023/faculty.presenters.where.should.we.focus.our.research.in.autoimmune.disease.html 2009-03-13 monthly 0.5 https://elearning.esh.org/esh/2009/AutoImmune/3022/nicole.casadevall.pure.red.cell.aplasia.html 2009-03-13 monthly 0.5 https://elearning.esh.org/esh/2009/AutoImmune/3021/marc.michel.overview.of.evan.s.syndrome.in.children.and.adults.html 2009-03-13 monthly 0.5 https://elearning.esh.org/esh/2009/AutoImmune/3020/stan.urbaniak.current.concepts.in.autoimmune.haemolytic.anaemia.html 2009-06-10 monthly 0.5 https://elearning.esh.org/esh/2009/AutoImmune/3019/roberto.stasi.potential.trigger.factors.in.itp.and.role.of.helicobacter.pylori.html 2009-03-04 monthly 0.5 https://elearning.esh.org/esh/2009/AutoImmune/3018/drew.provan.advances.in.itp.therapy.html 2009-03-04 monthly 0.5 https://elearning.esh.org/esh/2009/AutoImmune/3017/marco.ruggeri.evolution.of.terminology.used.for.itp.a.consensus.statement.html 2009-03-04 monthly 0.5 https://elearning.esh.org/esh/2009/AutoImmune/3016/drew.provan.the.evolution.of.clinical.management.of.itp.html 2009-03-04 monthly 0.5 https://elearning.esh.org/esh/2009/AutoImmune/3015/paul.moss.autoimmune.neutropenia.investigation.and.clinical.management.html 2009-02-25 monthly 0.5 https://elearning.esh.org/esh/2009/AutoImmune/3014/marie.scully.what.s.new.in.ttp.html 2009-02-25 monthly 0.5 https://elearning.esh.org/esh/2009/AutoImmune/3013/steve.devereux.pathogenesis.and.management.of.autoimmune.complications.of.html 2009-02-25 monthly 0.5 https://elearning.esh.org/esh/2009/AutoImmune/3012/ameet.sarpatwari.epidemiology.of.autoimmune.disease.%26.role.of.registry.studies.html 2009-03-03 monthly 0.5 https://elearning.esh.org/esh/2009/AutoImmune/3011/hans.wadenvik.current.understanding.of.t.cells.in.autoimmunity.html 2009-02-19 monthly 0.5 https://elearning.esh.org/esh/2009/AutoImmune/3010/donald.siegel.what.role.do.b.cells.play.in.autoimmunity.html 2009-02-19 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2938/faculty.presenters.panel.discussion.on.donor.choice.html 2008-12-17 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2750/joan.garcia.netcord.organization.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2728/j.j.van.rood.reflections.on.the.anniversaries.of.cb.transplantation.and.netcord.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2727/eliane.gluckman.opening.ceremony.celebration.cord.blood.transplant.history.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2726/marcela.contreras.opening.ceremony.celebration.cord.blood.transplant.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2725/hal.broxmeyer.opening.ceremony.celebration.cord.blood.transplant.history.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2724/arleen.auerbach.conception.to.obtain.hematopoietic.stem.cells.for.transplant.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2723/yves.beguin.debate.is.there.a.place.for.autologous.cord.blood.banking.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2722/gregorio.garrido.debate.is.there.a.place.for.autologous.cord.blood.banking.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2716/francesco.frassoni.direct.intra-bone.%28ibm%29.transplant.of.cord.blood.cells.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2715/juliet.barker.reduced.intensity.conditioning.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2714/celso.arrais.rodrigues.cord.blood.transplantation.for.lymphoma.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2713/elizabeth.j.shpall.methods.for.promoting.engraftment.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2711/hal.broxmeyer.mechanistic.insights.into.engraftment.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2710/mark.walters.haemoglobinopathies.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2709/franco.locatelli.cord.blood.transplantation.in.children.with.haematological.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2708/j.boelens.stemcell.transplantation.in.hurler.syndrome.html 2009-01-22 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2707/john.wagner.double.cord.blood.transplant.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2706/vanderson.rocha.unrelated.cord.blood.for.adults.with.acute.leukaemia.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2705/antonio.picardi.cord.blood.or.non.t-cell.depleted.haploidentical.transplant.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2703/r.willemze.influence.of.kir.mismatching.in.the.outcome.of.cord.blood.transplant.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2702/richard.champlin.natural.killer.cells.in.cord.blood.and.stem.cell.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2701/c.m.bollard.virus.specific.t.cells.from.cord.blood.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2700/fred.falkenburg.immune.properties.of.cord.blood.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2699/gianpietro.dotti.genetic.modification.of.cord.blood.t.cells.for.anti-leukemic.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2698/dominique.charron.resetting.the.immune-clock.stemcellness.vs.diversity.html 2008-11-27 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2697/jose.a.cancelas.stem.cells.and.microenvironment.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2696/ornella.parolini.isolation.and.characterization.of.cells.from.human.term.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2695/j.kurtzberg.cord.blood.to.treat.neurological.diseases.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2693/n.m.fisk.early.fetal.msc.in.maternal.%26.fetal.tissue.repair.html 2009-01-24 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2692/mervin.c.yoder.re-defining.human.circulating.endothelial.progenitor.cells.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2690/i.bernstein.notch.signalling.in.haematopoietic.stem.cell.differentiation.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2689/mark.weiss.the.umbilical.cord.as.a.stem.cell.source.cells.derived.from.wharton.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2688/colin.mcguckin.embryonic.like.cells.from.umbilical.cord.blood.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2687/g.kgler.functional.characterization.of.stem.cell.subpopulations.in.cord.blood.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2685/m.ratajczak.cord.blood-derived.very.small.embryonic.like.%28vsel%29.stem.cells.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2684/laurence.petz.debate.is.there.a.place.for.autologous.cord.blood.banking.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2683/laurence.petz.the.unrealized.potential.of.umbilical.cord.blood.units.for.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2682/bertram.lubin.sibling.cord.blood.banking.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2681/cristina.navarrete.london.cord.blood.bank.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2680/eva.calderon.latin.america.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2679/shunichi.kato.report.from.japan.and.asia.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2678/paolo.rebulla.biological.resource.centre.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/20th-cord-blood/2677/michael.boo.challenges.in.the.international.exchange.of.cbus.html 2009-01-13 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2526/pier.paolo.pandolfi.targeting.malignant.stem.cells.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2525/stephen.obrien.lessons.from.clinical.trials.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2524/charles.schiffer.what.would.it.take.to.displace.imatinib.as.first.line.html 2011-03-04 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2523/moshe.talpaz.therapeutic.thoughts.for.the.future.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2522/franck.nicolini.t315i.in.chronic.phase.an.epidemiologic.study.html 2009-01-23 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2521/andreas.hochhaus.dynamics.of.mutated.clones.in.vivo.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2520/ali.turhan.t315i.mutated.bcr-abl.expression.in.adult.and.es.cell.derived.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2519/michael.w.deininger.tki.resistance.mutations.and.more.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2518/angelo.michele.carella.interferon.after.stopping.imatinib.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2515/susan.branford.the.value.of.molecular.monitoring.for.imatinib.treated.patients.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2514/michele.baccarani.defining.response.tkis.and.treatment.recommendations.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2513/tim.hughes.predictive.assays.for.de-novo.cml.patients.receiving.tki.therapy.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2511/gianantonio.rosti.nilotinib.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2510/neil.shah.dasatinib.html 2009-01-19 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2508/jorge.cortes.outstanding.issues.with.tkis.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2504/john.engen.conformational.dynamics.in.wild-type.abl.drug.resistant.mutants.and.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2500/heiko.van.der.kuip.inhibiting.abl.compromises.dna.repair.in.bcr-abl.negative.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2499/alistair.reid.submicrosopic.genomic.lesions.in.cml.at.diagnosis.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2498/simona.soverini.application.of.snp-array.technology.to.cml.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2495/martin.sattler.basis.and.effects.of.genomic.instability.html 2009-02-11 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2494/markus.muschen.the.b-cell.lineage.specific.mutator.aid.%28activation-induced.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2492/emmanuelle.passegue.molecular.basis.of.hsc.and.myeloid.progenitor.compartment.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2491/steffen.koschmieder.inducible.mouse.models.of.leukemia.html 2009-01-15 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2490/daniela.cilloni.drosophila.model.to.study.bcr-abl.pathway.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2489/gary.gilliland.murine.models.of.mpd.as.tools.for.accessing.targeted.therapy.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2488/kimmo.porkka.expansion.of.anti-leukemic.anti-host.t.nk.cells.during.dasatinib.html 2009-01-08 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2486/fabrizio.pane.prame-specific.ctls.and.transgenic.t.cells.to.target.cml.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2485/hans.stauss.immunotherapy.with.gene.modified.t.cells.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2484/agnes.yong.cml.stem.cells.as.targets.for.cellular.and.immunotherapy.html 2009-01-08 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2483/marieke.essers.ifn-%26%23945.activates.quiescent.hscs.in.vivo.html 2009-01-14 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2481/katy.rezvani.ctls.and.vaccine.strategies.in.cml.html 2009-01-08 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2480/robert.sackstein.eradication.of.the.leukemia.stem.cell.html 2009-01-08 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2479/yun.zhao.differentially.expressed.and.novel.transcripts.in.chronic.phase.cml.html 2009-01-08 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2476/giuseppe.saglio.role.of.foxo.in.the.persistence.of.the.leukemic.progenitors.in.html 2009-01-08 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2475/jiang.xiaoyan.properties.of.cd34%2B.cml.cells.that.correlate.with.clinical.html 2009-01-08 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2473/tessa.holyoake.novel.approaches.to.target.cancer.stem.cells.in.cml.html 2009-01-08 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2470/mohammad.azam.mutagenesis.to.probe.kinase.regulation.html 2009-01-08 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2467/ilaria.iacobucci.more.on.ikaros.in.ph-positive.leukemias.html 2009-01-08 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2466/charles.mullighan.genomic.determinants.of.lineage.and.disease.progression.in.html 2009-01-08 monthly 0.5 https://elearning.esh.org/esh/2008/tenth-cml/2465/addolorata.maria.coluccia.dissecting.the.role.of.gsk3b.in.cml.stem.myeloid.html 2009-01-08 monthly 0.5